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The massive increase in sample size of genetic cohorts, combined with an increase
in the collection of data on social-scientific outcomes in these datasets, has made
it possible to study many socio-economically relevant individual characteristics
from a genetics perspective. In economics, the subfield that studies the genetic
architecture of socioeconomic outcomes and preferences is often called genoeco-
nomics. Ultimately, genoeconomics can help economics in four different ways:
genes can be used as measures of previous latent variables, genes can uncover
biological mechanisms, genes can be used as control variables or instrumental
variables, and genes can be used to target policy interventions. In this thesis, I de-
velop and compare some methods that can be used in genoeconomics, and I show
through empirical studies how genetically informed study designs can give new
insights to economists. The methods developed and compared in this thesis foster
the use of genes as instrumental variables and help further the understanding of
genetic relationships across socio-economically relevant characteristics. The main
empirical applications in this thesis concern smoking behaviour, entrepreneur-
ship, and the structure of the brain. This first chapter provides an overview of
the thesis, including a discussion of the research questions it addresses and the
implications resulting from the answers to these questions.
1
1.1 M O T I VA T I O N
Economics is the social science that studies the production, distribution, and
consumption of goods and services (Krugman and Wells, 2015). All these activities
require choices from so-called economic agents (individuals or organizations), as
resources are scarce. Over the past few decades, it has been convincingly shown
that all human traits (including preferences) are heritable (Polderman et al.,
2015, Turkheimer, 2000). Moreover, significant associations have been found
between genetic variants and preferences such as risk aversion (Linnér et al.,
2019), health behaviours such as smoking (Gelernter et al., 2015), and indicators
of socio-economic status such as educational attainment (Lee et al., 2018). The
use of insights from genetics to increase our understanding of how economic
agents make their choices is called ‘genoeconomics’ by Benjamin et al. (2008). In
this thesis, I develop and compare methods to foster the further emergence of the
field of genoeconomics, and I perform genetically informed empirical analyses to
better understand smoking behaviour, entrepreneurship, and the structure of the
brain.
In their article, Benjamin et al. (2012a) discuss four promises of how genoeco-
nomics can contribute to economics. The first promise is that genes can be used
as a direct measure for a previously latent variable. Sometimes, it can be difficult
to measure an individual’s preferences. However, in some cases, it is possible to
proxy these preferences by using an individual’s genetic profile. For example, one
can potentially use genetic information to determine whether an individual is
likely to be risk averse (Linnér et al., 2019) or to have particular abilities (Lee
et al., 2018).
The second promise relates to the uncovering of biological mechanisms using
genetic data. Genetic data can be used not only to test existing hypotheses about
the biological constitutes of behaviour but also to generate new hypotheses. For
example, Benjamin et al. (2012a) discuss an earlier experiment by Kosfeld et al.
(2005) showing that individuals who received a dose of the neuropeptide oxytocin
exhibit high levels of trusting behaviour. This experiment suggests that oxytocin
causally influences trusting behaviour. Using genes that encode the receptor
for oxytocin, one can test whether this hypothesis is true. New insights and
hypotheses about the biological foundation of behaviour may, however, result
from unexpected associations between certain markers in the DNA and individual
characteristics. This often occurs in a genome-wide association study (GWAS), in
which the trait of interest is associated with a large genome-wide set of genetic
variants. In such GWASs, one often finds significant associations between the
trait of interest and genetic variants for which the biological function is still poorly
understood. As such, it could happen that a GWAS on time-preferences generates
2
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new hypotheses about biological mechanisms influencing human behaviour.
Third, genes can be used as an instrumental variable or as a control variable
in empirical models. Using genes as an instrumental variable may help to es-
tablish causal effects in cases in which randomization is difficult or unethical.
For example, it is arguably unethical to use a form of randomization in which
some individuals are not allowed to obtain education to estimate the impact of
education on someone’s lifetime salary. However, one could instead use genes
that are associated with educational attainment as an instrumental variable to
investigate whether education causally influences someone’s salary. As the distri-
bution of genes is random conditional on family fixed effects, it is still possible
to make causal interferences if there are significant salary differences between
individuals with a high and low genetic endowment for education. Given the her-
itable nature of human behaviour, genes could also be used as a regular control
in order to remove some of the residual variance. This may be particularly useful
in an experimental setting in which the recruitment of participants is difficult
or costly. Consider for example an experiment in which one is interested in the
differences in risk preferences between males and females (these experiments
can be costly as the participants usually get a financial reward based on their
choices to mimic reality as closely as possible). Because of the heritable nature
of risk preferences (Benjamin et al., 2012b, Linnér et al., 2019), controlling for
genetic endowments towards risk preferences may lower the residual variance
in these experiments and thus, stronger inferences can be obtained. By adding
this information, the uncertainty (standard errors) in the sex effect estimates are
lower and thus, a smaller sample size is needed for testing the hypothesis.
Fourth, genes could be used for targeting interventions. In medicine, there
are already programmes in which individuals with a high genetic risk to develop
diseases such as breast cancer are given treatments before they actually develop
the disease in order to improve the quality of life of these individuals. Similarly,
one could think of using genetic screening for children who are likely to develop
dyslexia. We could think of giving these children extra attention in school early
on to reduce the difficulties they have with reading compared to their peers.
In this thesis, I contribute to the realization of the four promises outlined by
Benjamin et al. (2012a). In the first part of this thesis, related to the third promise
of Benjamin et al. (2012a), I look into methods and techniques using genetic
markers as instrumental variables. These so-called Mendelian randomization
studies constitute Chapters 2 and 3. In the second part, I use so-called polygenic
risk scores to describe pathways from genes to entrepreneurship (Chapter 4)
and to explain why individuals make different choices in response to an increase
in tobacco excise taxes (Chapter 5). This part relates to the second and fourth
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promises of Benjamin et al. (2012a). Last, in the third part, I develop a method
to understand to what extent traits are genetically related (Chapter 6). With
this method, it is possible to estimate what part of a correlation between two
traits is shared because they are influenced by the same genetic variants. As
such, this chapter contributes to the realization of the first and second promises
of Benjamin et al. (2012a).
The remainder of this introductory chapter is organized as follows. In Section
1.2, I will give a short description of the main methods used in genoeconomics
and of the chapters in this thesis. The research questions and main findings
will be presented in Section 1.3. Next, in Section 1.4, I will address the question
of how the chapters in this thesis contribute to the fulfilment of the promises
of genoeconomics outlined in the present section. Finally, in Section 1.5 I will
discuss my contribution to each chapter, and I give an overview of the publication
status of the chapters in this thesis.
1.2 R E S E A R C H T O P I C S
In this section, I provide a brief description of the human genome, and I discuss
methods used in genoeconomics to analyse genetic data. Thereafter, I discuss the
research topics of my thesis. Parts of this section are taken from chapters 3, 4,
and 6 of this thesis.
1.2.1 The human genome
A complete human genome consists of 23 pairs of chromosomes, from which the
23rd pair determines the biological sex of an individual. One of each pair of
chromosomes is inherited from the mother, and the other is inherited from the
father. A chromosome is composed of two intertwined strands of deoxyribonucleic
acid (DNA), each made up of a sequence of nucleotide molecules. There are
four different nucleotide molecules in the DNA: adenine, cytosine, thymine, and
guanine. Adenine on one strand is always paired with thymine on the other
strand, and cytosine is always paired with guanine. These combinations are
called base pairs. Every human genome consists of approximately 3 billion base
pairs. The stretches of base pairs in the DNA coding of a protein are called genes.
There are approximately 20,000 genes in the human genome with varying lengths.
A random pair of individuals share approximately 99.9% of their DNA (National
Human Genome Research Institute, 2018b), and most genetic differences across
population members can be attributed to single nucleotide polymorphisms (SNPs,
pronounced “snips”). Therefore, genoeconomists focus primarily on SNPs when
analysing heritable genetic variation. A SNP is defined as a location in the DNA
4
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strand at which two different nucleotides are present in the population. Each
of the two possible nucleotides is called an allele for that SNP. The allele that
is least common in the population is called the minor allele; the other allele
is called the major allele. For each SNP, an individual’s genotype is coded as
0, 1 or 2, depending on the number of minor alleles present. Individuals who
inherited the same allele from each parent are called homozygous for that SNP
(and have genotype 0 or 2), while individuals who inherited different alleles are
called heterozygous (and have genotype 1). SNPs can be found in every part of
the genome, within genes or in regions in between genes, and may influence the
production of proteins. In the human genome, there are approximately 85 million
SNPs with a minor allele prevalence of at least 1% (The 1000 Genomes Project
Consortium, 2015). When relating so many SNPs xi j (coded as 0, 1, or 2) to a




β j xi j +εi, (1.1)
with intercept µ, SNP effects β j and residual term εi, it is evident that this
is an overidentified model with fewer individuals I than SNPs J (Benjamin
et al., 2012a). For this purpose, two basic approaches have been developed to
deal with the overidentification problem. Hypothesis-driven methods such as
the candidate gene approach do not consider all J SNPs, and hypothesis-free
methods such as the Genome-Wide Association Study consider all J SNPs but not
in one model. The candidate gene approach consists of testing a subset of genetic
variants for association with the outcome of interest. These genetic variants
are selected based on what is known or believed about their biological function
(Benjamin et al., 2012a,b, Ebstein et al., 2010). This approach resembles the
classic method of justifying and then testing a hypothesis. A clear advantage
of this approach is that the interpretation of revealed significant relationships
is relatively straightforward. However, it turns out that findings of candidate
gene studies often fail in replications of the experiment (Benjamin et al., 2012a,b,
Ioannidis, 2005, Rietveld et al., 2014a). In principle, a theoretical framework
guides empirical research in reducing the number of hypotheses being tested.
However, the analytical rigor that a theory-guided approach provides is not
helpful in the context of behavioural genetics because it is difficult to reduce
the number of plausible hypotheses purely on theoretical grounds. For instance,
70% of all genes (approximately 14,000) are expressed in the brain (Ramsköld
et al., 2009), and for many of these genes (and hence the SNPs within these
genes), a seemingly plausible relation between genes and behaviour could be
hypothesized ex ante. As a matter of fact, in 2012, the editor of the leading field
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journal Behaviour Genetics issued an editorial policy on candidate gene studies
of behavioural traits that reads “The literature on candidate gene associations
is full of reports that have not stood up to rigorous replication” and that went
on to say “. . . it now seems likely that many of the published findings of the last
decade are wrong or misleading and have not contributed to real advances in
knowledge” (Hewitt, 2012). This editorial policy outlines the strict quality criteria
that candidate gene studies must meet to be considered for publication. Most
importantly, the editors stressed the importance of sufficient statistical power in
genetic discovery studies (Hewitt, 2012). An alternative to the candidate gene
study is the GWAS. A GWAS is a hypothesis-free approach to genetic discovery
because no prior selection is made on the set of SNPs used in the analysis. To deal
with the overidentification problem, a GWAS runs a single regression for every
SNP. In a GWAS, a simple regression is performed according to the following
simple regression model:
yi =µ+ xi jb j +εi, (1.2)
where yi is the value of the phenotype for individual i, µ is the intercept, and xi j
is an indicator variable that takes values 0, 1 or 2 if the genotype of individual i
at SNP j is aa, Aa or AA, respectively. The corresponding allelic effect of SNP
j for each trait is b j. Hence, millions of regressions are performed in a GWAS.
An advantage of the hypothesis-free study design of a GWAS is that it makes
the need to correct for multiple testing transparent. If the null hypothesis of
no association is true for all these millions of SNPs, one still finds a p-value
< 0.05 for 5% of the SNPs. Therefore, in a GWAS, the significance threshold
is set to 0.05/1,000,000 = 5×10−8 (“genome-wide significance”) because of the
approximately 1 million independent SNPs in the human genome (adjacent
SNPs in the genome are often inherited together). A clear disadvantage of this
approach is that GWASs may prioritize SNPs for which the biological function is
yet unknown or unclear.
1.2.2 Part I: Mendelian randomization
In this part of the thesis, I investigate how we can use genetic variants identified
in a GWAS as being associated with a particular outcome as instrumental vari-
ables in empirical models. Because of the genetic nature of these instrumental
variables, this technique is called Mendelian randomization (MR). This promising
method for making causal inferences is already very often used in medicine and
is gaining much traction in economics, for example, to estimate the causal effects
of health conditions on healthcare cost (Dixon et al., 2016) and to analyse the
6
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relationship between education and obesity (Böckerman et al., 2017)).
The main rationale of the MR method is as follows. Consider a model for
J genetic variants G1,G2, . . . ,GJ that are independent in their distributions, a
modifiable exposure X , an outcome variable Y , and a (unobserved) confounder U
(a variable that influences both our exposure X and our outcome variable Y , as
previously described by Palmer et al. (2008) and Bowden et al. (2017b)). I assume
that all relationships between the variables are linear and homogeneous without
effect modification, meaning that the same causal effect is estimated by any valid
instrumental variable (IV) (Didelez and Sheehan, 2007). A visual representation
of the model is shown in Figure 1.1.
FIGURE 1.1 – Illustrative diagram showing the model assumed for genetic
variant G j, with effect φ j on the unobserved confounder U , effect γ j on expo-
sure X , and direct effect α j on outcome Y . The causal effect of the exposure
on the outcome is θ. Dotted lines represent possible ways the instrumental
variable assumptions could be violated.
The summary-level MR methods considered in this thesis work take the
association between a genetic variant and the exposure (beta-coefficient β̂X j and
standard error σX j ) and the association between the genetic variants and the
outcome (beta-coefficient β̂Y j and standard error σY j ) for each variant G j as
established in a GWAS as input. The causal effect of the exposure on the outcome






The ratio estimate θ̂R j is a consistent estimate of the causal effect if variant G j
satisfies the IV assumptions (Didelez and Sheehan, 2007). In case of multiple
genetic variants, one can obtain an efficient estimator by taking a weighted
combination of the ratio estimates.
However, there are some considerable doubts about whether the assumptions
of instrumental variable regression hold in Mendelian randomization studies. In
the first chapter of this part (Chapter 2), I study the MR-Egger method that has
been developed to verify the robustness of MR estimates. In the second chapter of
this part (Chapter 3), I compare nine robust Mendelian randomization methods
from a theoretic and empirical viewpoint. In this chapter, I use a simulation
study to compare the performance of the various methods.
Chapter 2: A note on the use of Egger regression in Mendelian random-
ization studies
Compared to most studies in economics, where we have only one or a few in-
struments, we can have dozens or hundreds of instruments when we use SNPs
as instruments. This may strengthen the power to detect causal effects. How-
ever, given that we do not fully understand the exact function of all these SNPs,
there is doubt if all our instruments satisfy the required conditions to be valid.
Hence, several robust methods have been developed. One of the robust methods
is MR-Egger regression, that tries to adjust for the average “pleiotropic” effect.
Pleiotropy means that a genetic variant influences the outcome not only through
the exposure and thus, the exclusion restriction of IV regression is violated. By
including an intercept in the regression of the first stage effects on the second
stage effects, MR-Egger aims to control for possible pleiotropy. MR-Egger is often
used as a robustness check in Mendelian randomization studies. In this chapter,
I inspect the underlying assumptions for this method and the merits of using this
method as a robustness check.
Chapter 3: A comparison of robust Mendelian randomization methods
using summary data
In the third chapter, I compare nine robust Mendelian randomization methods
that rely on summary data. The methods I investigate are the weighted me-
dian method, the mode-based estimator, MR-PRESSO, MR-Robust, MR-Lasso,
MR-Egger, the contamination mixture, MR-Mix, and MR-RAPS. I compare the
methods regarding their theoretical properties and inspect their performance
in an extensive simulation model in which some of the instrumental variable
assumptions are not met. I also compare the robust methods in an empirical
example considering the effect of BMI on coronary artery disease risk.
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1.2.3 Part II: Polygenic risk scores
This part of my thesis concerns the use of polygenic risk scores in empirical
models. In the fourth chapter, I use polygenic risk scores to describe pathways
from genes to entrepreneurship. In the fifth chapter, I use polygenic risk scores
as a source of heterogeneity in the response to changes in smoking excise taxes.
Below, I will give a short explanation of how one can construct these polygenic
risk scores.
GWASs have made it clear that individual SNPs typically explain less than
0.02% of the variance in a behavioural outcome (Chabris et al., 2015). Hence,
individually, genetic variants are practically useless for inclusion in empirical
studies. However, the tiny explanatory power of individual genetic variants
has encouraged researchers to develop methods that combine individual genetic
variants into so-called polygenic risk scores with larger explanatory power. A




β j xi j, (1.4)
where PGSi is the value for the polygenic risk score for individual i, β j is the
regression coefficient of SNP j from the GWAS, and xi j is the genotype of indi-
vidual i for SNP j (coded as 0, 1 or 2). This simple approach has been shown to
be effective in the out-of-sample prediction of behavioural outcomes. For exam-
ple, Rietveld et al. (2013) found only three SNPs significantly associated with
educational attainment at the genome-wide significance level. Each SNP ex-
plained approximately 0.02% of the variance in educational attainment. However,
the polygenic risk score based on all SNPs (including the non-significant ones)
explained approximately 2.5% of the variance. This percentage increases with
the sample size of the GWAS (Dudbridge, 2013). For example, the most recent
polygenic risk score for educational attainment now explains 9.4% of the variance
(Lee et al., 2018).
Chapter 4: A decade of research on the genetics of entrepreneurship: a
review and view ahead
Entrepreneurship has been shown to be heritable. However, there have not
been any robust associations found between SNPs and entrepreneurship despite
several attempts. Through an extensive literature review I try to answer why
we have not yet found any associations. Given that there has been no significant
association found at this time, I suggest taking an alternative approach to linking
genes to entrepreneurship. Namely, I argue that one should use polygenic risk
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scores for a range of traits to investigate the genetic background of entrepreneur-
ship. In an empirical application using data from the US Health and Retirement
Study, I explain entrepreneurship using the polygenic risk scores for traits in the
mental health domain. Furthermore, I look ahead at how genetics can contribute
to the field of entrepreneurship.
Chapter 5: Does the genetic predisposition to smoking moderate the
response to tobacco excise taxes?
Tobacco use is one of the leading causes of preventable death. Over the past
decades, public policies have been effective in reducing the prevalence of smoking.
One of the most often used policy instruments to reduce tobacco consumption is
the imposition of excise taxes, as they are easy to implement. However, over the
past 20 years, the decrease in tobacco consumption has stalled. Some individuals
do not seem to alter their behaviour despite these increases in excise taxes. In this
chapter, I show that polygenic risk scores are predictive for smoking behaviour
(measured as smoking initiation and smoking intensity). Next, I identify whether
there can be a difference in response to increased excise taxes based on these
polygenic risk scores.
1.2.4 Part III: Multivariate GREML
In this part of my thesis, I develop a multivariate extension of genome-based
restricted maximum likelihood (GREML), which is a method for variance compo-
nent estimation. With this method, one can estimate what fraction of a trait is
heritable and to what extent different traits are genetically related. In addition,
I implement the method such that it allows one to perform the estimations in a
much more computationally efficient manner than does the current benchmark.
Below, I will give the main idea behind variance component estimation. If all
genetic variants influencing a trait are known, they can be added into one single
model for the trait of interest yi as follows:







where µ is the intercept, g i is the total genetic contribution of all SNPs for
individual i, m is the total number of causal genetic variants, uk is the scaled
effect of causal SNP k, and sik is standardized genotype of individual i at SNP k
(that is, sik = xik −2 fk/
√
2 fk (1− fk) with fk the frequency of the minor allele at
locus k). Observe that (1.5) can be rewritten in matrix notation as y=µ1+g+ε
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where G (= m−1SS>) is the genetic relationship matrix between pairs of in-
dividuals at causal loci. With the equation above, the estimate for SNP-based
heritability h2 of a trait is σ2g/(σ
2
g+σ2e ). This model can be extended to a multivari-
ate model, such that the model can estimate heritability and genetic relatedness
among traits simultaneously.
Chapter 6: Multivariate GREML reveals shared genetic architecture
between brain regions and behavioural traits
To estimate the genetic correlations across multiple traits (> 2) using genome-
wide data, one typically applies bivariate methods repeatedly. This pairwise
bivariate approach has important disadvantages. First, combining pairwise
bivariate correlation estimates into a cross-trait correlation matrix does not nec-
essarily yield a positive (semi)-definite correlation matrix. Second, the pairwise
bivariate approach does not yield a complete sampling correlation matrix for all
parameters of interest. Third, the current bivariate approaches fail to exploit
large computational efficiency gains that are possible within a multivariate con-
text. In this study, I propose a novel multivariate method that addresses these
three issues under a design with balanced data. The model is parametrized such
that the resulting correlation matrix is always positive (semi-)definite. To ensure
numerical stability of the method, a quasi-Newton algorithm is used to optimize
the log-likelihood. In this chapter, I use the developed method to analyse the
genetic structure of the brain using the UK Biobank imaging data. Moreover, I
investigate genetic correlations with several behavioural outcomes.
1.3 R E S E A R C H Q U E S T I O N S A N D R E S U LT S
The five chapters in this thesis answer six research questions. In the current
section, I describe these research questions and present the main results.
How appropriate is MR-Egger analysis as a robustness check in MR
studies? (Chapter 2)
Throughout this chapter, I analyse the MR-Egger method from both a theoretical
and empirical perspective to answer my research question. The MR-Egger regres-
sion relies on the assumption that the strength of the gene-exposure association
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(the first stage) is uncorrelated with the strength of the pleiotropic effects across
instruments (this is called the instrument strength independent of direct effect
(InSIDE) assumption). Since in practice one cannot test whether the InSIDE as-
sumption (the key assumption for MR-Egger that is different from the exclusion
restriction used by IVW) holds, one cannot judge which of the two estimates is
closer to reality. Hence, using this method as a sole robustness check is prone to
unwarranted conclusions. Of course, MR-Egger can be used as a sensitivity check
but should be treated as a fallible check in tandem with other analyses to assess
the plausibility of the causal effect estimate (Burgess and Thompson, 2017).
What robust Mendelian randomization methods work best when some
of the instrumental variable assumptions are violated? (Chapter 3)
In this chapter, I compare nine robust methods for Mendelian randomization
based on summary data that can be implemented using standard statistical
software. The methods are reviewed in three different ways: by reviewing the
theoretical properties, in an extensive simulation study and in an empirical
example. From a theoretical point of view, these methods have different consis-
tency assumptions. The three main strategies used to come up with a consistent
estimator are to use a consensus approach (weighted median and mode-based
estimator), an outlier removal/downweigh approach (MR-PRESSO, MR-Robust,
and MR-Lasso), and the modelling approach (MR-Egger, contamination mix-
ture, MR-Mix, and MR-RAPS). Each of these three approaches has its merits
depending on the type of violations there may be. In the simulation study, I
vary the type of violation and the number of genetic variants used per method.
With up to 30% of the instruments being invalid, most methods are able to still
come up with correct type 1 errors. Once I increase the percentage of invalid
instruments, most methods start to break down. Overall, judging by the mean
squared error, the contamination mixture method performs the best. The other
methods perform better according to different metrics. In the empirical example,
I estimate the effect of body mass index on coronary artery disease risk. In total,
I use 94 genome-wide significant variants. In general, most variants suggest
a harmful effect of increased BMI on CAD risk. However, there is apparent
heterogeneity in the IV estimates from the different genetic variants. All meth-
ods, except the MR-Mix method, agree that there is a positive effect of BMI on
coronary artery disease risk. Nevertheless, the methods that detect outliers vary
in terms of how lenient or strict they are in identifying outliers. Taking this
all into consideration, I encourage researchers to use robust methods from all
categories (consensus approach, outlier removal/downweigh approach, and the
modelling approach) in their empirical applications. For example, an investigator
12
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could perform the weighted median method (majority valid assumption), the
contamination mixture method (plurality valid assumption), and the MR-Egger
method (InSIDE assumption). If there are a few clear outliers in the data, then
an outlier-robust method such as MR-PRESSO analysis (best used with few
very distinct outliers) or MR-Robust analysis could also be performed. While I
am hesitant to make a definitive recommendation, as each method has its own
strengths and weaknesses, this set of methods would be a reasonable compromise
between performing too few methods and thus not adequately assessing the IV
assumptions and performing so many methods that the clarity is obscured.
Why has the identification of robust associations between genetic vari-
ants and entrepreneurship been unsuccessful in the last decade? (Chap-
ter 4)
Despite several attempts over the last decade, no significant robust association
between a genetic variant and entrepreneurship has been found. Despite working
with the required sample size as calculated by Koellinger et al. (2010), Van der
Loos et al. (2013) were unable to find any significant associations. The past
years of research in behavioural genetics have shown that a single SNP typically
explains less than 0.02% of the variance (Chabris et al., 2015, Rietveld et al.,
2014a). In hindsight, the effect size estimates used in the power analyses by
Koellinger et al. (2010) were too large. This is the reason why Van der Loos
et al. (2013) have not been able to find any robust associations. This lack of
power due to an insufficient sample size has been the reason why we have not
been able to find any robust associations yet. A back-of-the-envelope calculation
using the individual variance explained per SNP of 0.02% obtained from (Chabris
et al., 2015, Rietveld et al., 2014a) suggests that a sample size of at least 200,000
individuals is required to identify a SNP at a genome-wide significance level
with 80% power. Despite the rapidly increasing sample sizes (of mostly medical
cohorts), the currently available sample sizes for entrepreneurship in genetic
cohorts are still insufficient. This is due to measures for entrepreneurship are
often not included in these datasets. Smaller datasets, such as the US Health
and Retirement Study, and the English Longitudinal study of Ageing, do include
entrepreneurship variables; however, these are still not of sufficient size at the
moment to do a GWAS that is sufficiently powered.
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Would the identification of associations between genetic variants and
entrepreneurship help to advance the field of entrepreneurship research?
(Chapter 4)
Benjamin et al. (2012a) outlined four different motives for studying the inter-
section of genetics and economics (and entrepreneurship as well). Section 1.1
already discusses these promises in detail. First, studies using directly observed
genes may reveal the genetic pathways and mechanisms underlying behaviour
and may lead to a more complete understanding of entrepreneurial behaviour.
Second, these studies have the potential to provide measures for constructs that
are difficult to measure empirically. Third, based on someone’s genetic profile,
interventions may be channelled. In this vein, entrepreneurship scholars argue
that the prediction of entrepreneurial behaviour using genetic data could have
practical applications in business and for individual decision-making (Nicolaou
et al., 2008a, Nicolaou and Shane, 2010, Shane, 2010). Fourth, genes can be used
to enrich otherwise non-genetic models. For example, the inclusion of control
variables for genetic endowments may absorb the residual variance in regres-
sion models or experimental settings and allow for stronger statistical inference
(DiPrete et al., 2018a, Rietveld and Webbink, 2016). In some instances, it could
also be possible to infer causal relationships in observational data by using genes
as instrumental variables (Van Kippersluis and Rietveld, 2018, Von Hinke et al.,
2016). Hence, the use of genes may be instrumental to obtain a better under-
standing the effects of environmental factors. Regarding the first two promises, I
have seen that for behavioural outcomes (such as entrepreneurship), one should
not expect values of R2 in excess of 0.02% for individual SNPs. Hence, it is
unlikely that such a SNP will provide much information about the mechanisms
underlying entrepreneurship behaviour. In contrast to focusing on individual
genetic variants, there are good arguments for shifting the attention to polygenic
risk scores that summarize the contribution of several genetic variants to a trait.
Regarding the third and fourth promises (the use of genetic information to predict
individual behaviour and to enrich otherwise nongenetic models), the current
state of the behavioural genetics literature as well as the analyses presented
in Chapter 4 make clear that the added value of genetics for entrepreneurship
scholars should be thought of in terms of enriching population-level models rather
than improving individual-level prediction (Morris et al., 2019). Van der Loos
et al. (2013) show that all SNPs together may explain up to 25% of the differ-
ences in entrepreneurial behaviour between individuals. Even if one is able to
realize this prediction R2, the likelihood of the misclassification of individuals
into occupational groups remains great. Hence, early speculations about the
use of molecular genetic data for understanding and predicting entrepreneur-
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ship (Shane, 2010) remain premature, at a minimum. Even though it may be
useful to capture some of the (otherwise residual) variance in polygenic risk
scores, the gene-based prediction of individual entrepreneurial behaviour will
remain of limited value for individuals and entities such as governments and
banks. Nevertheless, capturing residual variance in polygenic risk scores may
improve the understanding of the effects of environmental factors. In so-called
gene-by-environment (“GxE”) studies (Keller, 2014, Thompson, 2017), polygenic
risk scores could also be used to investigate how entrepreneurship results from
the interplay between genetic endowments and environmental factors.
Does the genetic predisposition to smoking moderate the response to
tobacco excise taxes? (Chapter 5)
To answer this research question, I use a restricted version of the US Health
and Retirement Study longitudinal data (1992-2014) that includes the postal
codes of individuals. I link the individual’s postal codes to the Tax Burden on
Tobacco dataset from Orzechowski and Walker (2016) to obtain yearly state-level
information about levied tobacco excise taxes. I interact polygenic risk scores for
smoking initiation and smoking intensity with state excise tax rates on tobacco.
My analyses show that someone’s genetic propensity to smoking moderates the
effect of tobacco excise taxes on smoking behaviour, but only along the extensive
margin (smoking vs. not smoking). The results along the intensive margin (the
amount of tobacco consumed) are inconclusive. Even in a restricted sample of
smokers only, I am unable to find significant results along the intensive margin.
These findings suggest that excise taxes are an effective method to reduce tobacco
usage, even among the group with a high genetic predisposition towards smoking.
Even more, those with a high genetic predisposition to smoking respond most
strongly to changes in tobacco excise taxes.
Can a multivariate extension of GREML be formulated such (i) that the
resulting estimates yield a valid genetic and environmental covariance
matrix (i.e., positive (semi-)definite) and (ii) that the procedure is com-
putationally feasible? (Chapter 6)
In this chapter, I develop a multivariate extension of GREML. Based on a Broy-
den–Fletcher–Goldfarb–Shanno (BFGS) algorithm, this method uses an itera-
tive procedure to obtain unbiased estimates of the genetic and environmental
variance-covariance matrix for balanced data of P traits observed for N in-
dividuals. By changing the parameters over which I optimize to a Cholesky
decomposition, I ensure that the variance estimates are positive (semi-)definite.
To ensure that the model is computationally feasible, I rewrite the log-likelihood
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and the gradient in terms of the eigen decomposition of an N × N GRM and
transformations of P×P matrices of parameters. Using this transformation, I am
able to reduce the complexity of the problem from the order O(NP6) to an order
of O(NP5). In an empirical application using P = 86 traits from N = 14,341 unre-
lated individuals from the UK Biobank imaging study, I show that the current
implementation of our method is computationally feasible. Our method reveals
distinct clusters of genetic correlations between brain areas, as well as genetic
correlations between brain regions and behavioural traits. The findings fit with
how the neuroscience literature considers the development of the brain taking
place.
1.4 C O N C L U S I O N A N D I M P L I C A T I O N S
In this section, I elaborate how the chapters in this thesis contribute to the
promises of genoeconomics discussed in Section 1.1. I discuss how the findings
of this thesis help the emerging field of genoeconomics and the general field of
economics in a broader context. Next, to this, I explain how the methodological
contributions of this thesis will eventually help us in empirical applications by
using genes as control variables and/or instrumental variables. I also explain how
genes can be used to measure predispositions to (mental) diseases and economic
outcomes, which may result in targeted interventions to prevent undesired
outcomes. Furthermore, I look ahead by discussing directions for future research
on the intersection of genes and economics. In chapters 2 and 3, Mendelian
randomization methods are analysed and compared to give guidance on what set
of robust methods researchers should use to assess the reliability of Mendelian
randomization estimates. In the future, once the number of large-scale genetic
association studies on economic choices and outcomes has further increased, this
review of methods can be used to inform causal inference in economics. There has
been much debate about whether genes meet all the requirements to be a valid
instrument. This debate is mostly about the validity of the exclusion restriction
in empirical applications (Taylor et al., 2014). With the methods studied in these
chapters, researchers will be able to make robust interferences even if some
genes violate the IV assumptions. These methods will be very useful in the near
future, as randomized clinical trials are often difficult or unethical to perform
in economics. With the increasing number of genetic variants that are linked to
socio-economically relevant characteristics, I believe Mendelian randomization
studies will gain even more traction. Nevertheless, there remain some potential
sources of bias that robust methods are unable to solve (such as selection bias,
population stratification, dynastic effects and assortative mating), but they can be
solved by within-family Mendelian randomization studies, as recently suggested
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by Davies et al. (2019). Due to the increased availability of data from related
individuals in large cohort studies, this approach will lead to new opportunities
to overcome potential sources of biases that may currently hamper Mendelian
randomization studies. Chapters 4 and 5 show that polygenic risk scores may
help to explain economic choices and outcomes at the population level. It has
been known for decades that these choices and outcomes are heritable, but only
since the last few years, due to the large amount of publicly available GWAS
results, has it been possible to capture these genetic effects with polygenic risk
scores. The results in this thesis offer a new way to explain heterogeneity in
entrepreneurship and smoking behaviours. However, for individual prediction,
the misclassification rate is still very high, and polygenic risk score prediction
does not seem promising. Given that polygenic risk scores are only predictive at
the population level, considering the use of genes for targeted policy interventions
is premature. If we will ever be able to predict sufficiently well at individual
level using genetic information (which I doubt), it could not only lead to positive
interventions but also to genetic discrimination. Therefore, I believe it is of utmost
importance to have ethical discussions about the desirability of individual-level
predictions using genes. As such, I consider the current provision of individual
genetic prediction profiles by companies such as Leadership Consultants and
Goldmen Genetics as premature and threatening. In chapter 6, I develop a
method that is able to estimate the genetic correlation between economic choices
and outcomes for a large number of traits simultaneously. As soon as a large
dataset with a sufficient number of economic choices and outcomes becomes
available, this method is available to reveal whether there is genetic overlap
between certain traits. The results obtained with this method may help to
understand the preferences and decisions of individuals in a more comprehensive
manner. Using heritability estimates and genetic correlation for informing policy
is not straightforward, as outlined by Goldberger (1979) and Manski (2011).
Nevertheless, (co-)heritability estimates are descriptive facts that constrain the
set of plausible theories regarding heterogeneity in preferences and abilities.
Relatedly, significant heritability estimates for economic outcomes indicate that
genetic endowment can bias the effect of environmental variables on outcomes
of interest if not adequately controlled for. An example would be that parental
genetic endowments influence not only the child’s genotype (which leads to
differences in behaviour) but also influences the child’s environmental exposures
(through the pathway of the behaviour of the parents). Kong et al. (2018) have
shown that this type of “genetic nurture” indeed exists.
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1.5 I N D I V I D U A L C O N T R I B U T I O N S A N D P U B L I C A T I O N S T A T U S P E R
C H A P T E R
This section discusses my contributions to each chapter in the present thesis. The
current chapter (1), I wrote independently, although I received valuable feedback
on drafts of it from my supervisors. The research idea of Chapter 2 came from my
daily supervisor, Dr. Rietveld. The first draft of this chapter was written by Dr.
Rietveld and myself. I was responsible for the data analysis. Professors Groenen
and Thurik had a supervisory role and were responsible for the final checks.
During the 2017 Mendelian Randomization Conference in Bristol, I received the
reserve poster prize for my presentation of this chapter.
After discussions with Dr. Rietveld about robust Mendelian randomization
methods, I came up with the idea for Chapter 3 myself. In the Mendelian
Randomization Conference of 2017, the development of new (robust) Mendelian
randomization methods was flourishing, and I considered it to be of importance
for practical users to have an overview of the different robust methods available.
For this project, I decided to team up with Dr. Burgess, who is an expert in
Mendelian randomization. Dr. Burgess was happy to host me for a period of
three months at the MRC Biostatistics Unit in Cambridge. For this chapter, we
came up with a simulation setup together. Thereafter, I performed the extensive
simulation study, conducted the empirical analyses, and wrote the first draft
of the chapter. Afterwards, Dr. Burgess edited the draft manuscript, and we
alternately improved and changed parts of it.
Chapter 4 resulted from intense discussions with Professor Thurik and Dr.
Rietveld. Given that no new sufficiently large genetic datasets that include
entrepreneurship-related variables had become available in recent years, not
much progress had been made regarding the genetic analysis of entrepreneurship
since the first GWAS on self-employment in 2013. Dr. Rietveld suggested that we
could use the proxy-phenotype approach in the US Health and Retirement Study
to circumvent this barrier. I performed the data analysis and was responsible for
writing the first draft of this chapter. Afterwards, Dr. Rietveld, Prof. Thurik and
I edited the manuscript in several rounds.
I came up with the research idea for Chapter 5 myself. Dr. Rietveld helped me
with the data acquisition and the positioning of the paper within the literature. I
wrote the first draft of this chapter. Thereafter, Dr. Rietveld and I alternately
improved and changed parts of it. The original idea for Chapter 6 came from Dr.
de Vlaming. Together with Prof. Groenen, he performed the first derivations of
the model. These derivations constituted a chapter in his PhD thesis, which he
defended in 2017. At the suggestion of Dr. Rietveld, I joined the research for this
project. I started by implementing the method in MATLAB. Thereafter, I devoted
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considerable time to fine-tuning the optimization algorithm. I also performed
preliminary empirical analyses of the US Health and Retirement Study. Dr.
Koellinger was responsible for constructing the UK Biobank brain phenotypes.
Together with Dr. de Vlaming, I performed the quality control and empirical
analyses using the UK Biobank data. Dr. Jansen was responsible for interpreting
the findings in light of the neuroscience literature. I wrote the first draft of this
chapter, and together with Prof. Groenen and Dr. Rietveld, I rewrote parts of
the initial draft. For the new version of the chapter (not included in this thesis),
which is based on a larger sample resulting from a new release of brain imaging
data in UK Biobank, I performed the empirical analysis alone. The publication
status of each chapter is shown in Table 1.1. This table also shows where I have
presented the projects throughout my PhD trajectory.
TABLE 1.1 – Publication status of the chapters.
Chapter Title Reference Presentations Publication status
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A note on the use of Egger regression in
Mendelian randomization studies
Eric A.W. Slob, Patrick J.F. Groenen, A. Roy Thurik, Cornelius A.
Rietveld
Abstract
A large number of epidemiological studies uses genetic variants as instrumental
variables to infer causal relationships. Given that these methods rely on strong
assumptions that are not testable, MR-Egger regression has been proposed to
correct for pleiotropic effects. In this study, we compare the bias between MR-
Egger and the IVW estimate, and look at two empirical examples where we
inspect the ‘InSIDE’ assumption. Our findings suggest that the use of MR-Egger
as robustness check of IVW estimates is prone to unwarranted conclusions about
the causal effect estimate, because in empirical settings the assumption that
InSIDE holds is often questionable.
This chapter is based on Slob et al. (2017).
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2.1 I N T R O D U C T I O N
A large number of epidemiological studies uses genetic variants as instrumental
variables to infer causal relationships (Smith and Ebrahim, 2003, Burgess et al.,
2015). For a genetic variant to be a valid instrument in these so-called Mendelian
randomization (MR) studies, three assumptions need to hold: (i) The genetic
variant is associated with the exposure of interest (relevance assumption); (ii)
The genetic variants should be independent of all confounders (independence
assumption); (iii) The genetic variants only effects the outcome through the
exposure of interest (exclusion restriction). Without specific knowledge about the
biological mechanisms affected by genetic variants, it is virtually impossible to
prove that the exclusion restriction holds for a specific genetic variant (Glymour
et al., 2012). For example, genetic variants may have pleiotropic effects on both
the exposure and the outcome through different biological pathways (Solovieff
et al., 2013).
Several methods and techniques have been developed to tackle the possi-
ble problem of pleiotropy in Mendelian randomization studies. In this journal,
Bowden and colleagues recently proposed to use Egger regression to correct
for pleiotropic effects of genetics variants (Bowden et al., 2015). Using simula-
tions they show that MR-Egger provides unbiased estimates of causal effects if
pleiotropy is balanced (i.e., the direct effects are uniformly distributed around
zero). Also in case of directional pleiotropy (i.e., the direct effects are uniformly
distribution around a non-zero value) MR-Egger performs well, but only as
long as the instrument-exposure and instrument-outcome associations are in-
dependent. This so-called “InSIDE” assumption is a relaxation of the exclusion
restriction. MR-Egger produces biased results if the InSIDE assumption does not
hold, in particular in a one-sample setting in which values for the instrument-
exposure association and the instrument-outcome association are obtained in
the same sample. Bowden and colleagues acknowledge this in their appendix:
“We conclude that IV analysis with weak instruments in a one-sample setting
is troublesome, and that these difficulties are not resolved by the application of
MR-Egger regression”.
Nevertheless, MR-Egger is currently often used in epidemiological studies as
a robustness check on results obtained with regular Mendelian randomization
analysis without proper discussion whether the InSIDE assumption holds. For
example, a recent MR study states: “We used a second method of Mendelian
randomisation, the Egger method, as a sensitivity analysis if the instrumental
variables test result was noteworthy. This method is more robust to potential vio-
lations of the standard instrumental variable assumptions. (...) so this method is
less susceptible to confounding from potentially pleiotropic variants (...)”(Tyrrell
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et al., 2016). This is an incorrect use of MR-Egger, and hence the conclusions
about the robustness of the findings are unwarranted in this study.
Another recent study derived the exact bias of the IVW and MR-Egger esti-
mators (Bowden et al., 2017a). This study recognizes that in some settings where
the InSIDE assumption does not hold, the bias of the MR-Egger estimator can be
larger than the bias of the regular Inverse-Variance Weighting (IVW) estimator.
However, no practical conclusions are drawn from this finding. For the purpose
of the present note, we draw the following conclusion: We conclude that the use
of MR-Egger as robustness check of IVW estimates is prone to unwarranted
conclusions about the causal effect estimate, because in empirical settings the
assumption that InSIDE holds is often questionable. We will illustrate this con-
clusions by showing that in two illustrative analyses by Bowden and colleagues
(Bowden et al., 2015, 2017a) the InSIDE assumption does not seem to hold, and
that it is not possible in these examples to evaluate whether the MR-Egger is
less biased than the IVW estimator.
2.2 M E T H O D S
Following Bowden and colleagues, we deal with a Mendelian randomization study
with N participants (Bowden et al., 2015). For each participant i, we measure
J genetic variants (G i1, . . . ,G iJ), a modifiable exposure (X i), and an outcome
(Yi). The genetic variants are assumed to take values 0, 1, or 2, representing
the number of alleles of a biallelic single nucleotide polymorphism (SNP). The
confounder Ui is a function of the genetic variants and an independent error
term (εUi ), but is assumed to be unknown. The exposure X i is a linear function
of the genetic variants, the confounder and an independent error term (εXi ).
The outcome Yi is a linear function of the genetic variants, the exposure, the
confounders and an independent error term (εYi ). The causal effect of the exposure
on the outcome is β. γ j represents the effect of the instrument on the exposure.
The coefficients α j for each genetic variant j represent the direct effects of the
genetic variants on the outcome that are not mediated by the exposure. The
total effect of each variant on the outcome comprises the direct effect (α j), and
the indirect effects via the exposure (βγ j) and the confounder (φ j). The model













α jG i j +βX i +Ui +εYi . (2.3)
We denote the estimate for the instrument-exposure association by γ̂ j and the
estimate for the instrument-outcome association by Γ̂ j. With Inverse Variance
Weighting (IVW), an estimate for the causal effect β̂ j is obtained by dividing
Γ̂ j by γ̂ j. This ratio equals β+ (α j +φ j)/(γ j +φ j) (derivation given in the article
by Bowden and colleagues (Bowden et al., 2017a)), and hence the bias in the
estimation of β is a function of α j, φ j, and γ j. With multiple genetic variants,
the IVW estimator is a weighted average of the ratio of estimates calculated
using each genetic variant in turn. In the article by Bowden and colleagues, the















, where σY j is the standard error in the regression of the outcome
on the jth genetic variant (Bowden et al., 2017a). In MR-Egger, the absolute
values of Γ̂ j are regressed on the absolute values of γ̂ j in order to estimate β.
Furthermore, Bowden and colleagues find that the bias in the estimation of β
with MR-Egger equals (σαρα,γ+ (1+β)σφρφ,γ)/σγ, where σ denotes the standard
deviation of a parameter and ρ the correlation (Bowden et al., 2017a). Hence,
in MR-Egger the bias is a function of σα, ρα,γ, β, σφ, ρφ,γ and σγ (note that
MR-Egger requires σγ > 0; this is called the ‘Variation in Instrument Strength’
assumption by Bowden and colleagues (Bowden et al., 2017a)).
As long as the InSIDE assumptions holds, the bias in MR-Egger is zero if
both the sample size and the number of instruments increase to infinity (Bowden
et al., 2015). Although Bowden and colleagues point to some empirical evidence
that may suggest that the InSIDE assumption holds for some traits (Bowden
et al., 2016), in general the assumption is quite strong and – more importantly –
very difficult to test, since α j is typically unknown. Thus, from a practical point
of view, it is important to know in which settings the bias of MR-Egger is really
















∣∣∣∣∣∣∣∣∣= |BiasIVW| . (2.4)
Since there are so many unknown parameters in (2.4), it is hard to assess which
of the two biases is the largest in a Mendelian randomization study. At first sight,
the left hand side seems smaller, since the bias is mostly based upon covariances
and not on real effect sizes. Yet, to show that this is not necessarily the case, we
simplify by considering a model where there is no unobserved confounder. In that
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Consider a situation where we have relatively strong instruments that all have
approximately similar strength, such that γ j ∼N(0.4,0.1). Let there be some
directional pleiotropy with an equal variance that is equal to the instrument
variance, such that α j ∼N(0.1,0.1) and let it be positively correlated with γ j,
such that ρα,γ = 0.3. Now, the expected bias of the MR-Egger estimate is equal
to 0.1×0.3/0.1= 0.3 and the expected bias of the IVW estimate is approximately
0.1/0.4= 0.25. Hence, in this setting the bias of the MR-Egger estimate is larger
than the bias of the IVW estimate.
In empirical research settings, it is hard to evaluate whether the IVW esti-
mator is more biased than the MR-Egger estimator. For example, Bowden et al.
(2015) estimate the effect of systolic blood pressure on coronary heart disease
risk. With IVW the effect is estimated to be 0.054 (log odds ratio per 1 mmHg
change in blood pressure), and with MR-Egger it is estimated to be 0.015 (same
units). In the Appendix, we show that the approximated correlation between
the first stage effects γ and the direct effect α is −0.26. Hence, the InSIDE
assumption is violated and this makes it impossible to conclude whether the
smaller effect estimate obtained with MR-Egger is due to a smaller true effect
β or to a change in the bias part of the MR-Egger estimate. In another study,
Bowden and colleagues analyze the causal role of plasma urate concentration on
coronary heart disease risk (Bowden et al., 2017a). In the appendix, we show in
this model the approximated correlation between the first stage effects γ and the
direct effects α is even −0.35. Hence, again it is unclear whether the IVW or the
MR-Egger estimate is closer to the true β.
2.3 C O N C L U S I O N
In this note, we showed from a practical point of view that the bias of MR-
Egger estimator can be larger than the bias of IVW estimator depending on the
parameters in the model. If the InSIDE assumption does not hold, it is clear
that the MR-Egger procedure cannot guarantee an estimate that is less biased
than the estimate obtained with IVW. The InSIDE assumption is a relaxation
of the exclusion restriction, but it is still a strong assumption in itself. From
a practival point of view, this makes it almost impossible in empirical settings
to judge whether the IVW or MR-Egger estimator is closer to the real value
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of the causal effect, because the validity of the InSIDE assumption cannot be
tested without knowing the true causal effect. Hence, we conclude that the use of
MR-Egger as sole robustness check of IVW estimates is prone to unwarranted
conclusions about the causal effect estimate. Of course, MR-Egger regression
can be used as a sensitivity analysis for Mendelian randomization, but should
be treated as a fallible check and in tandem with other analyses to assess the
plausibility of the causal effect estimate (Burgess and Thompson, 2017). We note
that in some cases, bias from violations of the InSIDE assumption can be solved
by finding a specific subsample for which the first stage effect does not exist (the
effect of the instrument on the exposure is zero). In such a subsample, the direct
effect of a SNP can be estimated, and used to correct the causal effect estimate. A
recent study in this journal shows that this strategy is able to produce unbiased
estimates (Van Kippersluis and Rietveld, 2018).
28
Appendices
2.A A P P R O X I M A T I O N O F T H E C O R R E L A T I O N B E T W E E N T H E F I R S T
S T A G E E F F E C T S A N D T H E D I R E C T E F F E C T S I N T W O E X A M P L E S
Bowden and colleagues analyse the causal effect on systolic blood pressure on
cardiovascular diseases risk using 29 SNPs as instruments (see Table 2.1 for an
overview of the SNPs) (Bowden et al., 2017b). We extracted the estimates of the
first stage effects γ̂ j from Table 1 of the study by the International Consortium
for Blood Pressure Genome-Wide Association Studies (International Consortium
for Blood Pressure Genome-Wide Association Studies, 2011) and the estimator of
the total (reduced form) effect Γ̂ j from the summary data of the CARDIoGRAM
consortium (Schunkert et al., 2011). We aligned the alleles of the SNPs such that
the first stage effect is positive (γ̂ j > 0 for all j). In order to calculate ρα,γ, the
correlation between γ and α, we need to approximate α. For this, we assume the
absence of an unobserved confounder as well as that the reported β̂IVW is the
true causal effect (thus, β= 0.054). Using the relation Γ j =α j +βγ j, we calculate
the direct effect with α j = Γ j −βγ j. This gives an approximated correlation
ρα,γ =−0.26.
We are convinced that this is the best way to approximate ρα,γ because it
follows the standard MR model depicted in equations (2.1)-(2.3) in the main text of
the present note. If we treat β̂MR-Egger as the causal effect and use the same way
of calculating the direct effect, we find an approximated correlation ρα,γ = 0.03.
This is very close to 0, since MR-Egger fits a linear model in which Γ̂ j =β0E+βEγ̂ j.
Thus, the demeaned direct effects, α∗j equal the “error” terms in this relation (the
average pleiotropy ᾱ is captured by the intercept β0E , and only the demeaned
effects remain). The OLS estimation procedure “attempts” to put these “residuals”
orthogonal to the regressors (in our case the instrument strength, γ̂ j). Hence,
with MR-Egger, the correlation between the estimated α j and γ j is very close to
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0. Nevertheless, Figure 2.1 Panel A shows the approximated ρα,γ for a range of
possible causal effects. We observe that ρα,γ approaches 1 when β becomes more
negative, and it approaches -1 when β becomes more positive.
In another study, Bowden and colleagues analyze the causal role of plasma
urate concentration on coronary heart disease risk (see Table 2.2 for an overview
of the SNPs) (Bowden et al., 2017a). The first stage effects γ̂ j are obtained from
Table S3 of the study by White et al. (2016) and the total (reduced form) effect
Γ̂ j from the summary data of the CARDIoGRAM consortium (Schunkert et al.,
2011). With the reported β̂IVW , we find an approximated correlation ρα,γ =−0.35.
When using β̂MR-Egger, we obtain an approximated correlation ρα,γ =−0.04. The
approximated correlation for a range of causal effects is shown in Figure 2.1
Panel B. We observe the same relationship between ρα,γ and β as in Figure 2.1
Panel A.
FIGURE 2.1 – The correlation between the instrument strength and direct
effect for different causal effect estimates. A: The effect of systolic blood
pressure on cardiovascular diseases risk. B: The effect of plasma urate
concentrate on coronary heart disease risk.
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TABLE 2.1 – Summary association results for 29 SNPs associated with
systolic blood pressure (SNPs are ordered as in Table 1 of the study by
the International Consortium for Blood Pressure Genome-Wide Association
Studies (2011)).
SNP Chromosome Position Ref allele Other allele γ̂ Γ̂ α̂
rs2932538 1 113,018,066 G A 0.388 0.022801 0.001849
rs13082711 3 27,512,913 C T 0.315 0.034229 0.017219
rs419076 3 170,583,580 T C 0.409 0.019725 -0.002361
rs13107325 4 103,407,732 C T 0.981 -0.004938 -0.057912
rs13139571 4 156,864,963 C A 0.321 0.066131 0.048797
rs1173771 5 32,850,785 G A 0.504 0.033135 0.005919
rs11953630 5 157,777,980 C T 0.412 0.031746 0.009498
rs1799945 6 26,199,158 G C 0.627 0.005740 -0.028118
rs805303 6 31,724,345 G A 0.376 0.040028 0.019724
rs4373814 10 18,459,978 C G 0.373 0.015007 -0.005135
rs932764 10 95,885,930 G A 0.484 -0.005658 -0.031794
rs7129220 11 10,307,114 A G 0.619 0.040449 0.007023
rs633185 11 100,098,748 G C 0.565 0.013790 -0.016720
rs2521501 15 89,238,392 T A 0.650 0.050969 0.015869
rs17608766 17 42,368,270 C T 0.556 0.088020 0.057996
rs1327235 20 100,917,030 G A 0.340 0.040494 0.022134
rs6015450 20 57,184,512 G A 0.896 0.058069 0.009685
rs17367504 1 11,785,365 A G 0.903 0.023070 -0.025691
rs3774372 3 41,852,418 C T 0.067 -0.018337 -0.021955
rs1458038 4 81,383,747 T C 0.706 0.034433 -0.003691
rs1813353 10 18,747,454 T C 0.569 0.042546 0.011820
rs4590817 10 63,137,559 G C 0.646 0.035467 0.000583
rs11191548 10 104,836,168 T C 1,095 0.109050 0.049920
rs381815 11 16,858,844 T C 0.575 0.048819 0.017769
rs17249754 12 88,584,717 G A 0.928 -0.044766 -0.094878
rs3184504 12 110.368,991 T C 0.598 0.070445 0.038153
rs10850411 12 113,872,179 T C 0.354 0.021469 0.002353
rs1378942 15 72,864,420 C A 0.613 0.000516 -0.032586
rs12940887 17 44,757,806 T C 0.362 0.032434 0.012886
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TABLE 2.2 – Summary association results for 31 SNPs associated with
plasma urate concentration (SNPs are ordered as in Table S3 of the study by
White et al. (2016)).
SNP Chromosome Position Ref allele Other allele γ̂ Γ̂ α̂
rs1471633 1 144,435,096 A C 0.057 -0.015911 0.006654
rs1260326 2 27,584,444 T C 0.069 -0.023890 0.012594
rs12498742 4 9,553,150 A G 0.360 -0.011611 -0.047067
rs2231142 4 89,271,347 T G 0.190 -0.034145 0.003241
rs675209 6 7,047,083 T C 0.056 -0.001211 -0.007852
rs1165151 6 25,929,595 T G 0.078 -0.004236 -0.016933
rs1171614 10 61,139,544 T C 0.079 0.041327 0.028450
rs2078267 11 64,090,690 T C 0.073 0.020768 0.008837
rs478607 11 64,234,639 A G 0.026 -0.012873 -0.017177
rs3741414 12 56,130,316 T C 0.065 0.001895 -0.008684
rs11264341 1 153,418,117 T C 0.050 0.005672 -0.002478
rs17050272 2 121,022,910 A G 0.035 0.033048 -0.038752
rs6770152 3 53,075,254 T G 0.044 0.005058 -0.002111
rs17632159 5 72,467,238 C G 0.039 -0.005710 -0.000647
rs729761 6 43,912,549 T G 0.047 0.010178 0.002517
rs1178977 7 72,494,985 A G 0.047 0.005351 -0.013012
rs10480300 7 151,036,938 T C 0.035 -0.004082 -0.001623
rs2941484 8 76,641,323 T C 0.044 0.008357 -0.015528
rs10821905 10 52,316,099 A G 0.057 0.010269 -0.019560
rs642803 11 65,317,196 T C 0.036 0.039500 0.033632
rs653178 12 110,492,139 T C 0.035 0.077493 0.071788
rs1394125 15 73,946,038 A G 0.043 -0.027942 0.020933
rs6598541 15 97,088,658 A G 0.043 -0.035859 0.028837
rs7193778 16 68,121,391 T C 0.046 -0.004131 -0.011629
rs7188445 16 78,292,488 A G 0.032 -0.011765 -0.016981
rs7224610 17 50,719,787 A C 0.042 0.015338 0.008492
rs742132 6 25,715,550 A G 0.054 0.010673 -0.019475
rs2307394 2 148,432,898 T C 0.029 0.018612 0.013885
rs17786744 8 23,832,951 A G 0.029 0.000176 -0.004551
rs2079742 17 56,820,479 T C 0.043 -0.038280 0.031271
rs164009 17 71,795,264 A G 0.028 -0.015160 0.010596
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A comparison of robust Mendelian
randomization methods using summary data
Eric A.W. Slob, Stephen Burgess
Abstract
The number of Mendelian randomization analyses including large numbers of
genetic variants is rapidly increasing. This is due to the proliferation of genome-
wide association studies, and the desire to obtain more precise estimates of causal
effects. Since it is unlikely that all genetic variants will be valid instrumental
variables, several robust methods have been proposed. We compare nine robust
methods for Mendelian randomization based on summary data that can be im-
plemented using standard statistical software. Methods were compared in three
ways: by reviewing their theoretical properties, in an extensive simulation study,
and in an empirical example. In the simulation study, the best method, judged
by mean squared error was the contamination mixture method . This method had
well-controlled Type 1 error rates with up to 50% invalid instruments across a
range of scenarios. Other methods performed well according to different metrics.
Outlier-robust methods had the narrowest confidence intervals in the empirical
example. With isolated exceptions, all methods performed badly when over 50%
of the variants were invalid instruments. Our recommendation for investigators
is to perform a variety of robust methods that operate in different ways and rely
on different assumptions for valid inferences to assess the reliability of Mendelian
randomization analyses.
This chapter is based on Slob and Burgess (2020).
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3.1 I N T R O D U C T I O N
Mendelian randomization (MR) uses genetic variants as instrumental variables
(IV) to determine whether an observational association between a modifiable
exposure (often also called the intermediate variable under study or risk factor)
and an outcome is consistent with a causal effect (Davey Smith and Ebrahim,
2003, Smith and Ebrahim, 2004). This approach is less vulnerable to traditional
problems of epidemiological studies such as confounding and reverse causality.
With the increasing availability of genome-wide association studies that find
robust associations between genetic variants and exposures of interest (Zheng
et al., 2017, Welter et al., 2014), the potential of this approach is rapidly evolving.
A genetic variant is a valid IV if (i) it is associated with the exposure, (ii) it has
no direct effect on the outcome, and (iii) there are no associations between the
variant and any potential confounders.
There has been much discussion on the potentials and limitations of MR, as
the IV assumptions cannot be fully tested (Davey Smith and Ebrahim, 2003,
Glymour et al., 2012, VanderWeele et al., 2014). Violation of the IV assumptions
can lead to invalid conclusions in applied investigations. In practice, the exclusion
restriction assumption that the proposed instruments (genetic variants) should
not have a direct effect on the outcome of interest is debatable, particularly if the
biological roles of the genetic variants are insufficiently understood (Glymour
et al., 2012, von Hinke et al., 2016).
Some genetic variants are associated with multiple traits (Sivakumaran et al.,
2011, Solovieff et al., 2013). This is referred to as pleiotropy. There are two types
of pleiotropy. Vertical pleiotropy occurs when a variant is directly associated with
the exposure and another trait on the same biological pathway. This does not
lead to violation of the IV assumptions provided the only causal pathway from
the genetic variant to the outcome passes via the exposure. Horizontal pleiotropy
occurs when the second trait is on a different biological pathway, and so there
may exist different causal pathways from the variant to the outcome. This would
violate the exclusion restriction assumption. To solve the problems that arise
due to horizontal pleiotropy, several robust methods for MR have been developed
that can provide reliable inferences when some genetic variants violate the IV
assumptions, or when genetic variants violate the IV assumptions in a particular
way. To our knowledge, a comprehensive review and simulation study to compare
the statistical performance of these different methods has not been performed.
To focus our simulation study and compare the most relevant robust methods
for applied practice, we concentrate on methods that satisfy two criteria. First, the
method requires only summary data on estimates (beta-coefficients and standard
errors) of genetic variant–exposure and genetic variant–outcome associations. We
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exclude methods that require individual participant data (Kang et al., 2016, Guo
et al., 2018, Jiang et al., 2017, Tchetgen Tchetgen et al., 2017), and those that
require data on additional variants not associated with the exposure (O’Connor
and Price, 2018, DiPrete et al., 2018b). This is because the sharing of individual
participant data is often impractical, so that many empirical researchers only
have access to summary data, and for fairness, to ensure that all methods are
using the same information to make inferences. Secondly, the method must be
performed using standard statistical software packages. We exclude methods
requiring convergence checks that cannot be easily automated for a simulation
study (Berzuini et al., 2020) or are computationally infeasible for large numbers
of variants in a reasonable running time (Burgess et al., 2018).
In this article, we review nine robust methods for MR from a theoretical
perspective, and evaluate their performance in a simulation study set in a two-
sample summary data setting. The methods differ in how they estimate a causal
effect of the exposure on the outcome, as well as in the assumptions required for
consistent estimation. We consider the weighted median, mode based estimation,
MR-PRESSO, MR-Robust, MR-Lasso, MR-Egger, contamination mixture, MR-
Mix, and MR-RAPS methods. Some methods take a summarized measure of the
variant-specific causal estimates as the overall causal effect estimate (weighted
median, and mode based estimation), whereas others remove or downweight
outliers (MR-PRESSO, MR-Lasso, and MR-Robust), or attempt to model the
distribution of the estimates from invalid IVs (MR-Egger, contamination mixture,
MR-Mix, and MR-RAPS). We also consider the performance of the methods in an
empirical example to evaluate the causal effect of body mass index on coronary
artery disease risk.
This paper is organized as follows. First, we give an overview of the robust
methods and compare their theoretical properties. Then, we introduce the simu-
lation framework and applied example to compare their properties in practice.
Finally, we discuss the implications of this work for applied practice.
3.2 M E T H O D S
Modelling assumptions and summary data
We consider a model as previously described by Palmer et al. (2008) and Bow-
den et al. (2017b) for J genetic variants G1,G2, . . . ,GJ that are independent
in their distributions, a modifiable exposure X , an outcome variable Y , and a
confounder U . We assume that all relationships between variables are linear and
homogeneous without effect modification, meaning that the same causal effect is
estimated by any valid IV (Didelez and Sheehan, 2007). A visual representation
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of the model is shown in Figure 3.1.
FIGURE 3.1 – Illustrative diagram showing the model assumed for genetic
variant G j, with effect φ j on the unobserved confounder U , effect γ j on expo-
sure X , and direct effect α j on outcome Y . The causal effect of the exposure
on the outcome is θ. Dotted lines represent possible ways the instrumental
variable assumptions could be violated.
We assume that summary data are available on genetic associations with
the exposure (beta-coefficient β̂X j and standard error σX j ) and with the outcome
(beta-coefficient β̂Y j and standard error σY j ) for each variant G j.
Inverse-variance weighted method
The causal effect of the exposure on the outcome can be estimated using a single





The ratio estimate θ̂R j is a consistent estimate of the causal effect if variant G j
satisfies the IV assumptions (Didelez and Sheehan, 2007). If the uncertainty in
the genetic association with the exposure is low, then the standard error of the
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The individual ratio estimates can be combined to obtain a single more
efficient estimate. The optimally-efficient combination of the ratio estimates






















The IVW estimate is equal to the estimate from the two-stage least squares
method that is performed using individual participant data (Burgess et al.,
2016b). It is a weighted mean of the ratio estimates, where the weights are the
inverse-variances of the ratio estimates. The IVW estimate can also be obtained
by weighted regression of the genetic associations with the outcome on the genetic
associations with the exposure:
β̂Y j = θ β̂X j +ε j, ε j ∼N(0,σ2Y j ). (3.4)
However, the IVW method has a 0% breakdown point, meaning that if only
one genetic variant is not a valid IV, then the estimator is typically biased
(Bowden et al., 2016). Bias will be present unless the pleiotropic effects of genetic
variants average to zero (balanced pleiotropy) and the pleiotropic effects are
independent of the genetic variant–exposure associations (see MR-Egger method
below) (Bowden et al., 2017b). With the increasing number of variants used
in MR investigations, it is increasingly unlikely that all variants are valid IVs.
Hence, it is crucial to consider robust estimation methods despite their lower
statistical efficiency (that is, lower power to detect a causal effect).
We proceed to introduce the different robust methods we consider in this study
in three categories: consensus methods, outlier-robust methods, and modelling
methods. A summary table comparing the methods is presented as Table 3.1.
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TABLE 3.1 – Summary comparison of methods.
Method Consistency assumption Strengths and/or weaknesses
Weighted Me-
dian
Majority valid Robust to outliers, sensitive to addi-
tional/removal of genetic variants,
may be less efficient
Mode Based
Estimation
Plurality valid Robust to outliers, sensitive to
bandwidth parameter and addi-
tion/removal of genetic variants,
generally conservative
MR-PRESSO Outlier-robust Removes outliers, efficient with
valid IVs, very high false positive
rate with several invalid IVs
MR-Robust Outlier-robust Downweights outliers, efficient
with valid IVs, high false positive
rate with several invalid IVs
MR-Lasso Outlier-robust Removes outliers, efficient with
valid IVs, high false positive rate
with several invalid IVs
MR-Egger InSIDE Sensitive to outliers, sensitive to
violations of InSIDE assumption,
InSIDE assumption often not plau-
sible, may be less efficient
Contamination
Mixture
Plurality valid Robust to outliers, sensitive to
variance parameter and addi-
tion/removal of genetic variants,
less conservative than MBE
MR-Mix Plurality valid Robust to outliers, requires large
numbers of genetic variants, very






Downweights outliers, sensitive to
violations of balanced pleiotropy as-
sumption
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Consensus methods
A consensus method is one that takes its causal estimate as a summary measure
of the distribution of the ratio estimates. The most straightforward consensus
method is the median method. Rather than taking a weighted mean of the ratio
estimates as in the IVW method, we take the median of the ratio estimates. The
median estimator is consistent (that is, unbiased in large samples) even if up to
50% of the variants are invalid (Bowden et al., 2016). We consider a weighted
version of the median method, where the median is taken from a distribution of
the ratio estimates in which genetic variants with more precise ratio estimates
receive more weight. Here, an unbiased estimate will be obtained if up to 50%
of the weight comes from variants that are valid IVs. We refer to this as the
‘majority valid’ assumption.
A related assumption is the ‘plurality valid’ assumption (Guo et al., 2018). In
large samples, while ratio estimates for all valid IVs should equal the true causal
effect, ratio estimates for invalid IVs will take different values. The ‘plurality
valid’ assumption is that, out of all the different values taken by ratio estimates
in large samples (we term these the ratio estimands), the true causal effect is the
value taken for the largest number of genetic variants (that is, the modal ratio
estimand). For example, the plurality assumption would be satisfied if only 40%
of the genetic variants are valid instruments, provided that out of the remaining
60% invalid instruments, no larger group with the same ratio estimand exists.
This assumption is also referred to as the Zero Modal Pleiotropy Assumption
(ZEMPA) (Hartwig et al., 2017).
This assumption is exploited by the mode based estimation (MBE) method
(Hartwig et al., 2017). As no two ratio estimates will be identical in finite samples,
it is not possible to take the mode of the ratio estimates directly. In the MBE
method, a normal density is drawn for each genetic variant centered at its ratio
estimate. The spread of this density depends on a bandwidth parameter, and
(for the weighted version of the MBE method) the precision of the ratio estimate.
A smoothed density function is then constructed by summing these normal
densities. The maximum of this distribution is the causal estimate.
As these consensus methods take the median or mode of the ratio estimate
distribution as the causal estimate, they are naturally robust to outliers, as the
median and mode of a distribution are unaffected by the magnitude of extreme
values. However, they are still influenced by outliers, as these variants still
contribute to determining the location of the median or mode of a distribution.
These methods can also be sensitive to changes in the ratio estimates for variants
that contribute to the median or mode, and to the addition and removal of
variants from the analysis. Additionally, the methods may not be as efficient as
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those that base their estimates on all the genetic variants.
Outlier-robust methods
Next, we present three outlier-robust methods. These methods either downweight
or remove genetic variants from the analysis that have outlying ratio estimates.
They provide consistent estimates under the same assumptions as the IVW
method for the set of genetic variants that are not identified as outliers.
In the MR-Pleiotropy Residual Sum and Outlier (MR-PRESSO) method (Ver-
banck et al., 2018), the IVW method is implemented by regression using all the
genetic variants, and the residual sum of squares (RSS) is calculated from the
regression equation. The RSS is a heterogeneity measure for the ratio estimates.
Then, the IVW method is performed omitting each genetic variant from the
analysis in turn. If the RSS decreases substantially compared to a simulated
expected distribution, then that variant is removed from the analysis. This
procedure is repeated until no further variants are removed from the analysis.
The causal estimate is then obtained by the IVW method using the remaining
genetic variants.
In MR-Robust, the IVW method is performed by regression, except that
instead of using ordinary least squares regression, MM-estimation is used com-
bined with Tukey’s biweight loss function (Burgess et al., 2016a). MM-estimation
provides robustness against influential points and Tukey’s loss function provides
robustness against outliers. Tukey’s loss function is a truncated quadratic func-
tion, meaning that there is a limit in the degree to which an outlier contributes to
the analysis (Mosteller and Tukey, 1977). This contrasts with the quadratic loss
function used in ordinary least squares regression, which is unbounded, meaning
that a single outlier can have an unlimited effect on the IVW estimate.
In MR-Lasso, the IVW regression model is augmented by adding an intercept
term for each genetic variant (Burgess et al., 2016a). The IVW estimate is the





β̂Y j −θ β̂X j
)2
. (3.5)





β̂Y j −θ0 j −θ β̂X j
)2 +λ J∑
j=1
| θ0 j |, (3.6)
where λ is a tuning parameter. As the regression equation contains more pa-
rameters than there are genetic variants, a lasso penalty term is added for
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identification (Windmeijer et al., 2019). The intercept term θ0 j represents the
direct (pleiotropic) effect on the outcome, and should be zero for a valid IV, but
will be non-zero for an invalid IV. The causal estimate is then obtained by the
IVW method using the genetic variants that had θ0 j = 0 in equation (3.6). A
heterogeneity criterion is used to determine the value of λ. Increasing λ means
that more of the pleiotropy parameters equal zero and so the corresponding
variants are included in the analysis; we increase λ step-by-step until one step
before there is more heterogeneity in the ratio estimates for variants included in
the analysis than expected by chance alone.
The MR-PRESSO and MR-Lasso methods remove variants from the analysis,
whereas MR-Robust downweights variants. These methods will be valuable when
there is a small number of genetic variants with heterogeneous ratio estimates,
as they will be removed from the analysis or heavily downweighted, and so will
not influence the overall estimate. In such a case, these methods are likely
to be efficient, as they are based on the IVW method. The methods are less
likely to be valuable when there is a larger number of genetic variants that are
pleiotropic, particularly if the pleiotropic effects are small in magnitude, and
when the average pleiotropic effect of non-outliers is not zero.
Modelling methods
Finally, we present four methods that attempt to model the distribution of esti-
mates from invalid IVs or make a specific assumption about the way in which the
IV assumptions are violated. The MR-Egger method is performed similarly to
the IVW method, except that the regression model contains an intercept term θ0:
β̂Y j = θ0 +θ β̂X j +ε j, ε j ∼N(0,σ2Y j ). (3.7)
This differs from the MR-Lasso method, as there is only one intercept term, which
represents the average pleiotropic effect. The MR-Egger method gives consistent
estimates of the causal effect under the Instrument Strength Independent of
Direct Effect (InSIDE) assumption, which states that pleiotropic effects of genetic
variants must be uncorrelated with genetic variant–exposure association. As
the regression model is no longer symmetric to changes in the signs of the
genetic association estimates (which result from switching the reference and
effect alleles), we first re-orientate the genetic associations before performing the
regression by fixing all genetic associations with the exposure to be positive, and
correspondingly changing the signs of the genetic associations with the outcome if
necessary. The intercept in MR-Egger also provides a test of the IV assumptions.
The intercept will differ from zero when either the average pleiotropic effect is
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not zero, or the InSIDE assumption is violated. These two conditions (average
pleiotropy of zero and InSIDE assumption satisfied) are precisely the conditions
required for the IVW estimate to be unbiased.
The contamination mixture method assumes that only some of the genetic
variants are valid IVs (Burgess et al., 2019). We construct a likelihood function
from the ratio estimates. If a variant is a valid instrument, then its ratio estimate
is assumed to be normally distributed about the true causal effect θ with variance
σ2R j
. If a variant is not a valid instrument, then its ratio estimate is assumed to
be normally distributed about zero with variance ψ2 +σ2R j , where ψ
2 represents
the variance of the estimands from invalid IVs. This parameter is specified by
the analyst. We then maximize the likelihood over different values of the causal
effect θ and different configurations of valid and invalid IVs. Maximization is
performed in linear time by first constructing a profile likelihood as a function
of θ, and then maximizing this function with respect to θ. The value of θ that
maximizes the profile likelihood is the causal estimate.
The MR-Mix method (Qi and Chatterjee, 2018) is similar to the contamination
mixture method, except that rather than dividing the genetic variants into valid
and invalid IVs, the method divides variants into four categories: (1) variants
that directly influence the exposure only (valid instruments), and (2) variants
that influence the exposure and outcome, (3) that influence the outcome only, and
(4) that neither influence the exposure or outcome (invalid instruments). This
allows for more flexibility in modelling genetic variants, although potentially
leads to more uncertainty in assigning genetic variants to categories.
The MR-Robust Adjusted Profile Score (RAPS) (Zhao et al., 2018) method
models the pleiotropic effects of genetic variants directly using a random-effects
distribution. The pleiotropic effects are assumed to be normally distributed about
zero with unknown variance. Estimates are obtained using a profile likelihood
function for the causal effect and the variance of the pleiotropic effect distribution.
To provide further robustness to outliers, either Tukey’s biweight loss function or
Huber’s loss function (Mosteller and Tukey, 1977) can be used.
Modelling methods are likely to be valuable when the modelling assumptions
are correct, but not when the assumptions are incorrect. For example, the MR-
Egger method requires the InSIDE assumption to be satisfied to give a consistent
estimate. The MR-RAPS method is likely to perform well when pleiotropic effects
truly are normally distributed about zero, but less well when they are not. The
MR-Mix method is likely to require large numbers of genetic variants in order to
correct classify variants into the different categories. The contamination mixture
method is less likely to be affected by modelling assumptions as it does not make
such strict assumptions, but it is likely to be sensitive to specification of the
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variance parameter.
Simulation study
To compare the performance of these methods in a realistic setting, we per-
form a simulation study. Full details of the simulation study are given in the
Supplementary Material.
For each participant i, we simulate data on J genetic variants G i1,G i2, . . . ,G iJ ,
a modifiable exposure X i, an outcome variable Yi, and a confounder Ui (assumed
unknown). The confounder is a linear function of the genetic variants and an
independent error term εUi . The effect of variant j on the confounder is repre-
sented by coefficient φ j (this is zero for a valid IV). The exposure is linear in the
genetic variants, the confounder and an independent error term εXi . The effect of
variant j on the exposure is represented by coefficient γ j. The outcome is linear
in the genetic variants, exposure, confounders and an independent error term εYi .
The effect of variant j on the outcome is represented by coefficient α j (again, this
is zero for a valid IV). The effect of the exposure on the outcome is represented by
θ. The genetic variants are modelled as single nucleotide polymorphisms (SNPs),
with a varying minor allele frequency maf j, and take values 0, 1 or 2. The minor
allele frequencies are drawn from an uniform distribution. The error terms εUi ,
εXi and ε
Y
i each follow an independent normal distribution with mean 0 and unit
variance.












α jG i j +θ X i +Ui +εYi ,
maf j ∼U(0.1,0.5),






In brief, we consider three scenarios:
1. balanced pleiotropy, InSIDE satisfied – invalid IVs have direct effects on
the outcome generated from a normal distribution centered at zero (for
invalid instruments α j ∼N(0,0.15), φ j = 0);
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2. directional pleiotropy, InSIDE satisfied – invalid IVs have direct effects on
the outcome generated from a normal distribution centered away from zero
(for invalid instruments α j ∼N(0.1,0.075), φ j = 0);
3. directional pleiotropy, InSIDE violated – invalid IVs have direct effects
on the outcome generated from a normal distribution centered away from
zero, and indirect effects on the outcome via the confounder (for invalid
instruments α j ∼N(0.1,0.075), φ j ∼U(0,0.1)).
We simulated data on J = 10, 30, and 100 genetic variants. A portion of the
genetic variants were invalid IVs (30%, 50% and 70%), and the direct effects
of the variants explain 10% of the variance in the exposure. Summary genetic
associations were calculated for the exposure and the outcome on non-overlapping
sets of individuals, each consisting of 10 000 individuals (Haycock et al., 2016).
This situation is often referred to as two-sample summary data MR (Pierce and
Burgess, 2013). We considered situations with a null causal effect (θ = 0) and a
positive causal effect (θ = 0.2). In total, 10 000 datasets were generated in each
scenario.
Methods can be compared by many metrics, including bias, empirical power,
and standard deviation of estimates. We use mean squared error, which is the
sum of bias squared plus variance, as the main criterion for comparing methods,
as this provides a compromise between bias and precision. However, the relative
importance of each metric will depend on the specific features of the application.
Empirical example: the effect of body mass index on coronary artery disease risk
We also compare the methods in an empirical example considering the effect
of body mass index (BMI) on coronary artery disease (CAD) risk. Since BMI is
influenced by several biological mechanisms (Monnereau et al., 2016), it is likely
that the exclusion restriction is not satisfied for all associated genetic variants.
Hence it is necessary to use robust methods to analyse these data. Additionally,
we consider methods that detect outliers (MR-Presso, MR-Robust, MR-Lasso,
contamination mixture, MR-Mix, and MR-RAPS), and compare whether the same
outliers are detected in each of these methods.
We take 97 genome-wide significant variants associated with BMI from the
GIANT consortium (Locke et al., 2015). Associations with BMI are estimated
in up to 339,224 participants from this consortium. Associations with coronary
artery disease risk are estimated in up to 60,801 CAD cases and 123,504 controls
from the CARDIoGRAMplusC4D Consortium (Nikpay et al., 2015). Association
estimates for CAD were available for 94 of these variants.
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The scatter plot of the genetic associations with BMI and CAD risk is shown
in Figure 3.2. While most variants seem to suggest a harmful effect of increased
BMI on CAD risk, there is apparent heterogeneity in the IV estimates from
each genetic variant individually, as evidenced by Cochran’s Q test (Q-statistic
= 235.7, P < 0.001). Even after removing the five outliers as judged by the
MR-PRESSO method, which makes use of the heterogeneity statistic to identify
outliers, we still reject the null hypothesis of that the regression model (including
an intercept) fits the regression model with no additional variability than would
be expected by chance (Q-statistic = 125.9, P = 0.005). This suggests that some
of the variants violate the IV assumptions.
FIGURE 3.2 – Scatter plot of genetic associations with BMI (standard devia-
tion units) and coronary artery disease risk (log odds ratios) for 94 variants
taken from the GIANT and CARDIoGRAMplusC4D consortia respectively.
3.3 R E S U LT S
Results of the simulation study are presented in Table 3.2 (10 variants), Table
3.3 (30 variants), and Table 3.4 (100 variants). For each scenario, we present
the mean, median, and standard deviation of estimates across simulations, and
the empirical Type 1 error rate (for a null causal effect) or empirical power (for
a positive causal effect) at a 95% confidence level. The empirical Type 1 error
rate and empirical power are calculated as the proportion of simulated datasets
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where zero was not included in the 95% confidence interval. The mean squared
error across simulations for the different methods with a null causal effect is
presented in Figure 3.3 (Scenario 2), and Figure 3.4 (Scenario 3) for 30 variants.
The corresponding plots for 10 variants (Supplementary Figures 1 and 2) and
100 variants (Supplementary Figures 3 and 4) were broadly similar.
Overall, judging by mean squared error, the contamination mixture method
performed best with 30% and 50% invalid variants. In some scenarios, other
methods had lower mean squared error with 70% invalid variants. However,
with some isolated exceptions, all the methods performed badly with 70% invalid
instruments. Coverage for the contamination mixture method was around 10%
or less when there were up to 50% invalid variants. This was also true for the
MR-Robust method, although that method had slightly lower power to detect
a causal effect in some scenarios. Several other methods performed well in
particular scenarios.
Amongst consensus methods, estimates from the MBE method were less
biased than those from the weighted median method, with lower Type 1 errors.
The weighted median method had slightly higher power to detect a causal effect,
although comparisons of power lose much of their value when a method has
inflated Type 1 error rates. Performance of the MBE method improved as the
number of variants increased. Amongst outlier-robust methods, bias was greater
for the MR-Robust than the MR-Lasso method. The MR-Lasso method generally
had the lower mean squared error when the invalidity was 50% or 70%, but
MR-Robust had the lower Type 1 error rates. Performance of the MR-Robust
method was better when there were at least 30 genetic variants. MR-PRESSO
had biased estimates with inflated Type 1 error rates even with 30% invalid
variants, and performed particularly badly as the number of variants increased.
The modelling methods performed well in some scenarios, but less well in
others. This is unsurprising, as in some scenarios, consistency assumptions for
the methods were satisfied, and in others they were not. The MR-Egger method
performed well in terms of Type 1 error rate in Scenarios 1 and 2, where the
InSIDE assumption was satisfied. Estimates from the method were generally
imprecise with low power. However, power in the MR-Egger method depends
on the genetic associations with the exposure varying substantially between
variants, which was not the case in the simulation study (Burgess and Thompson,
2017). The contamination mixture method performed well with 30% and 50%
valid instruments, with low bias and Type 1 error rates at or below 8% with 10
variants, 10% with 30 variants, and 11% with 100 variants. The MR-Mix method
performed badly throughout, with highly inflated Type 1 error rates in almost all
scenarios with less than 100 instruments and comparatively low power to detect a
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causal effect. It performed slightly better with more genetic variants, although its
performance was still worse than other methods. However, the method performed
much better in a simulation comparison of methods performed by the authors
of the MR-Mix method (Qi and Chatterjee, 2019), in which the data-generating
model was more similar to the model assumed by the MR-Mix method. The MR-
RAPS method performed well in Scenario 1, where its consistency assumption
was satisfied, but less well in other scenarios with inflated Type 1 error rates. Its
performance also worsened as more variants were included in the analysis.











































































































































































































































FIGURE 3.3 – Mean squared errors for the different methods in scenario
2 (directional pleiotropy, InSIDE satisfied) with a null causal effect for 30
variants. Note the vertical axis is on a logarithmic scale.
Empirical example: The effect of body mass index on coronary artery disease
Results from the empirical example are shown in Table 3.5. All methods agree
that there is a positive effect of BMI on CAD risk, except for the MR-Mix method
which gives a wide confidence interval that includes the null. The narrowest
confidence intervals are for the outlier-robust methods (MR-Lasso, MR-Robust,
MR-PRESSO), followed by the modelling methods except MR-Mix and MR-Egger
(contamination mixture, MR-RAPS), then the consensus methods (weighted
median, mode based estimation), and finally MR-Egger and MR-Mix.
While the methods that detect outliers varied in terms of how lenient or
47
TABLE 3.2 – Mean, median, standard deviation (SD) of estimates, and Type
1 error/empirical power (%) with 10 genetic variants.
30% invalid 50% invalid 70% invalid
Null causal effect: θ = 0
Method Mean Median SD T1 error Mean Median SD T1 error Mean Median SD T1 error
Scenario 1: Balanced pleiotropy, InSIDE satisfied
Weighted Median 0.000 0.000 0.071 0.139 0.002 0.001 0.132 0.276 0.002 0.000 0.223 0.481
Mode Based Estimation 0.000 0.000 0.101 0.111 0.002 0.000 0.151 0.268 0.002 0.001 0.224 0.619
MR-PRESSO 0.000 0.000 0.111 0.122 -0.001 0.000 0.178 0.154 0.000 0.001 0.239 0.174
MR-Robust 0.000 0.000 0.029 0.110 0.001 0.001 0.127 0.076 0.002 0.002 0.224 0.104
MR-Lasso 0.001 0.000 0.048 0.042 0.000 0.000 0.088 0.076 0.004 0.001 0.183 0.156
MR-Egger 0.007 0.004 0.419 0.093 0.005 0.008 0.563 0.097 0.006 0.014 0.684 0.098
Contamination Mixture 0.000 0.000 0.025 0.052 0.000 0.000 0.077 0.069 0.002 0.000 0.379 0.126
MR-Mix 0.000 0.000 0.274 0.225 -0.001 0.000 0.431 0.292 0.000 0.000 0.561 0.356
MR-RAPS 0.000 -0.001 0.106 0.039 0.001 0.000 0.172 0.062 0.001 0.000 0.226 0.083
Scenario 2: Directional pleiotropy, InSIDE satisfied
Weighted Median 0.013 0.006 0.060 0.140 0.036 0.016 0.108 0.287 0.084 0.036 0.175 0.500
Mode Based Estimation 0.007 0.001 0.081 0.114 0.020 0.006 0.122 0.264 0.059 0.030 0.180 0.585
MR-PRESSO 0.028 0.013 0.079 0.132 0.069 0.031 0.133 0.168 0.122 0.071 0.182 0.214
MR-Robust 0.003 0.002 0.031 0.106 0.042 0.023 0.105 0.084 0.115 0.094 0.169 0.152
MR-Lasso 0.008 0.005 0.044 0.056 0.024 0.012 0.082 0.125 0.075 0.035 0.161 0.283
MR-Egger 0.001 -0.006 0.329 0.093 0.000 -0.013 0.408 0.091 -0.005 -0.012 0.477 0.095
Contamination Mixture 0.000 0.001 0.025 0.059 0.003 0.001 0.056 0.078 0.060 0.006 0.281 0.137
MR-Mix 0.045 0.016 0.200 0.247 0.084 0.023 0.301 0.331 0.144 0.050 0.399 0.443
MR-RAPS 0.039 0.030 0.082 0.053 0.081 0.071 0.128 0.095 0.130 0.119 0.165 0.152
Scenario 3: Directional pleiotropy, InSIDE violated
Weighted Median 0.022 0.011 0.071 0.179 0.073 0.030 0.137 0.384 0.135 0.080 0.188 0.599
Mode Based Estimation 0.013 0.002 0.090 0.132 0.044 0.011 0.148 0.317 0.094 0.051 0.192 0.621
MR-PRESSO 0.047 0.023 0.095 0.155 0.113 0.063 0.153 0.223 0.179 0.147 0.185 0.301
MR-Robust 0.004 0.002 0.032 0.106 0.069 0.040 0.121 0.109 0.169 0.152 0.171 0.216
MR-Lasso 0.013 0.008 0.050 0.073 0.050 0.024 0.108 0.203 0.122 0.067 0.180 0.415
MR-Egger 0.049 0.024 0.326 0.098 0.066 0.042 0.411 0.097 0.048 0.034 0.464 0.096
Contamination Mixture 0.000 0.000 0.025 0.060 0.005 0.001 0.061 0.080 0.079 0.009 0.273 0.163
MR-Mix 0.064 0.026 0.207 0.283 0.125 0.040 0.304 0.375 0.196 0.080 0.391 0.529
MR-RAPS 0.062 0.050 0.091 0.085 0.132 0.118 0.132 0.182 0.188 0.180 0.160 0.262
Positive causal effect: θ =+0.2
Method Mean Median SD Power Mean Median SD Power Mean Median SD Power
Scenario 1: Balanced pleiotropy, InSIDE satisfied
Weighted Median 0.201 0.200 0.069 0.979 0.201 0.200 0.131 0.939 0.200 0.201 0.221 0.877
Mode Based Estimation 0.198 0.200 0.102 0.983 0.192 0.199 0.156 0.945 0.183 0.193 0.235 0.867
MR-PRESSO 0.199 0.200 0.106 0.860 0.202 0.201 0.166 0.734 0.200 0.202 0.232 0.564
MR-Robust 0.200 0.200 0.033 0.953 0.201 0.201 0.129 0.506 0.199 0.200 0.225 0.282
MR-Lasso 0.200 0.200 0.052 0.962 0.201 0.201 0.091 0.906 0.198 0.200 0.189 0.774
MR-Egger 0.199 0.201 0.442 0.166 0.199 0.199 0.549 0.122 0.197 0.193 0.660 0.113
Contamination Mixture 0.200 0.200 0.028 0.997 0.202 0.201 0.074 0.959 0.228 0.204 0.399 0.704
MR-Mix 0.210 0.203 0.242 0.562 0.219 0.205 0.370 0.612 0.224 0.210 0.522 0.644
MR-RAPS 0.200 0.200 0.108 0.538 0.201 0.202 0.168 0.309 0.197 0.201 0.228 0.222
Scenario 2: Directional pleiotropy, InSIDE satisfied
Weighted Median 0.214 0.207 0.060 0.991 0.240 0.216 0.114 0.978 0.285 0.242 0.175 0.952
Mode Based Estimation 0.205 0.201 0.081 0.983 0.219 0.204 0.129 0.961 0.248 0.226 0.180 0.917
MR-PRESSO 0.225 0.213 0.072 0.945 0.267 0.232 0.129 0.849 0.319 0.274 0.177 0.729
MR-Robust 0.204 0.203 0.034 0.954 0.244 0.225 0.109 0.646 0.315 0.301 0.168 0.555
MR-Lasso 0.209 0.206 0.047 0.985 0.225 0.213 0.085 0.971 0.274 0.239 0.161 0.926
MR-Egger 0.200 0.188 0.323 0.215 0.199 0.187 0.407 0.153 0.196 0.187 0.462 0.133
Contamination Mixture 0.201 0.201 0.030 0.997 0.206 0.201 0.085 0.968 0.286 0.210 0.307 0.823
MR-Mix 0.252 0.228 0.175 0.613 0.291 0.240 0.265 0.664 0.353 0.276 0.367 0.738
MR-RAPS 0.238 0.229 0.080 0.825 0.285 0.275 0.127 0.675 0.329 0.322 0.164 0.595
Scenario 3: Directional pleiotropy, InSIDE violated
Weighted Median 0.225 0.212 0.074 0.994 0.272 0.233 0.137 0.985 0.339 0.287 0.185 0.975
Mode Based Estimation 0.211 0.201 0.092 0.983 0.239 0.211 0.147 0.961 0.290 0.252 0.189 0.940
MR-PRESSO 0.243 0.223 0.086 0.925 0.307 0.262 0.149 0.835 0.379 0.342 0.182 0.759
MR-Robust 0.205 0.204 0.036 0.945 0.271 0.244 0.122 0.651 0.372 0.353 0.168 0.651
MR-Lasso 0.216 0.210 0.053 0.991 0.250 0.226 0.109 0.981 0.326 0.274 0.179 0.964
MR-Egger 0.248 0.225 0.330 0.245 0.266 0.242 0.408 0.183 0.251 0.236 0.458 0.155
Contamination Mixture 0.201 0.201 0.029 0.996 0.209 0.202 0.082 0.970 0.317 0.217 0.318 0.850
MR-Mix 0.274 0.240 0.180 0.654 0.327 0.260 0.260 0.713 0.405 0.319 0.357 0.788
MR-RAPS 0.263 0.251 0.090 0.872 0.329 0.316 0.134 0.797 0.389 0.378 0.158 0.759
Abbrevations: T1 error: Type 1 error.
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TABLE 3.3 – Mean, median, standard deviation (SD) of estimates, and Type
1 error/empirical power (%) with 30 genetic variants.
30% invalid 50% invalid 70% invalid
Null causal effect: θ = 0
Method Mean Median SD T1 error Mean Median SD T1 error Mean Median SD T1 error
Scenario 1: Balanced pleiotropy, InSIDE satisfied
Weighted Median 0.000 0.000 0.033 0.085 -0.001 0.000 0.066 0.168 -0.002 -0.002 0.134 0.333
Mode Based Estimation 0.000 0.000 0.029 0.052 0.000 0.000 0.063 0.127 0.000 -0.001 0.136 0.494
MR-PRESSO 0.000 0.000 0.052 0.208 -0.001 0.000 0.091 0.276 -0.002 0.000 0.145 0.351
MR-Robust 0.000 0.000 0.023 0.069 0.000 0.000 0.075 0.024 -0.001 -0.004 0.172 0.054
MR-Lasso 0.000 -0.001 0.025 0.038 0.000 0.000 0.036 0.061 -0.001 0.000 0.081 0.111
MR-Egger 0.004 0.003 0.319 0.068 0.006 0.002 0.400 0.073 -0.010 -0.008 0.464 0.074
Contamination Mixture 0.000 0.000 0.022 0.062 0.000 0.000 0.030 0.078 -0.002 0.001 0.177 0.127
MR-Mix 0.000 0.000 0.141 0.052 0.000 0.000 0.215 0.053 0.002 0.000 0.321 0.036
MR-RAPS -0.001 -0.001 0.077 0.019 0.000 -0.003 0.132 0.041 -0.002 -0.004 0.178 0.055
Scenario 2: Directional pleiotropy, InSIDE satisfied
Weighted Median 0.011 0.009 0.031 0.100 0.031 0.021 0.066 0.235 0.083 0.048 0.127 0.438
Mode Based Estimation 0.001 0.000 0.026 0.049 0.006 0.003 0.054 0.132 0.040 0.026 0.113 0.454
MR-PRESSO 0.024 0.016 0.042 0.230 0.071 0.047 0.089 0.424 0.145 0.119 0.134 0.584
MR-Robust 0.003 0.002 0.022 0.065 0.034 0.026 0.067 0.030 0.149 0.140 0.133 0.159
MR-Lasso 0.004 0.003 0.023 0.058 0.014 0.011 0.039 0.135 0.061 0.039 0.097 0.340
MR-Egger 0.004 -0.004 0.228 0.073 0.001 -0.005 0.285 0.074 -0.002 -0.008 0.328 0.071
Contamination Mixture 0.001 0.001 0.020 0.064 0.001 0.001 0.028 0.085 0.015 0.003 0.141 0.140
MR-Mix 0.018 0.006 0.135 0.078 0.041 0.010 0.216 0.107 0.096 0.010 0.355 0.119
MR-RAPS 0.046 0.042 0.058 0.051 0.110 0.105 0.099 0.160 0.179 0.175 0.129 0.273
Scenario 3: Directional pleiotropy, InSIDE violated
Weighted Median 0.022 0.017 0.042 0.168 0.067 0.040 0.095 0.401 0.156 0.114 0.155 0.668
Mode Based Estimation 0.002 0.001 0.033 0.057 0.016 0.006 0.073 0.172 0.077 0.048 0.140 0.531
MR-PRESSO 0.050 0.035 0.061 0.397 0.132 0.108 0.114 0.653 0.232 0.216 0.146 0.816
MR-Robust 0.004 0.004 0.023 0.052 0.059 0.045 0.080 0.041 0.224 0.216 0.136 0.335
MR-Lasso 0.008 0.007 0.025 0.086 0.033 0.024 0.054 0.267 0.123 0.089 0.130 0.597
MR-Egger 0.092 0.074 0.234 0.105 0.099 0.090 0.277 0.091 0.094 0.089 0.312 0.084
Contamination Mixture 0.000 0.001 0.020 0.062 0.002 0.002 0.029 0.093 0.026 0.005 0.156 0.166
MR-Mix 0.029 0.010 0.141 0.095 0.056 0.010 0.220 0.139 0.125 0.020 0.327 0.154
MR-RAPS 0.082 0.075 0.068 0.174 0.172 0.165 0.103 0.415 0.256 0.251 0.124 0.591
Positive causal effect: θ =+0.2
Method Mean Median SD Power Mean Median SD Power Mean Median SD Power
Scenario 1: Balanced pleiotropy, InSIDE satisfied
Weighted Median 0.200 0.200 0.035 0.998 0.201 0.200 0.066 0.978 0.202 0.202 0.135 0.908
Mode Based Estimation 0.199 0.199 0.032 0.997 0.197 0.198 0.062 0.982 0.187 0.193 0.143 0.870
MR-PRESSO 0.199 0.200 0.050 0.983 0.200 0.200 0.089 0.928 0.202 0.202 0.142 0.846
MR-Robust 0.200 0.200 0.025 0.997 0.200 0.199 0.077 0.668 0.203 0.204 0.170 0.271
MR-Lasso 0.200 0.200 0.026 1.000 0.200 0.200 0.038 0.996 0.201 0.201 0.080 0.942
MR-Egger 0.200 0.199 0.311 0.149 0.209 0.211 0.396 0.120 0.196 0.196 0.462 0.102
Contamination Mixture 0.201 0.201 0.023 1.000 0.201 0.200 0.032 0.997 0.215 0.203 0.194 0.943
MR-Mix 0.209 0.200 0.141 0.606 0.211 0.200 0.233 0.793 0.182 0.170 0.353 0.200
MR-RAPS 0.199 0.199 0.075 0.644 0.201 0.202 0.131 0.345 0.202 0.204 0.177 0.231
Scenario 2: Directional pleiotropy, InSIDE satisfied
Weighted Median 0.212 0.210 0.033 1.000 0.232 0.222 0.065 0.998 0.289 0.255 0.132 0.989
Mode Based Estimation 0.200 0.199 0.031 0.998 0.205 0.203 0.052 0.989 0.236 0.224 0.116 0.950
MR-PRESSO 0.223 0.216 0.042 1.000 0.267 0.247 0.083 0.999 0.344 0.319 0.134 0.995
MR-Robust 0.203 0.203 0.025 0.999 0.237 0.229 0.070 0.821 0.353 0.344 0.135 0.731
MR-Lasso 0.204 0.204 0.025 1.000 0.216 0.213 0.041 1.000 0.266 0.244 0.101 0.994
MR-Egger 0.202 0.194 0.222 0.217 0.197 0.188 0.277 0.150 0.204 0.197 0.331 0.126
Contamination Mixture 0.201 0.201 0.022 1.000 0.203 0.203 0.034 0.999 0.234 0.206 0.193 0.969
MR-Mix 0.230 0.210 0.141 0.461 0.263 0.220 0.232 0.518 0.328 0.230 0.378 0.502
MR-RAPS 0.248 0.244 0.059 0.969 0.307 0.303 0.099 0.881 0.381 0.376 0.131 0.837
Scenario 3: Directional pleiotropy, InSIDE violated
Weighted Median 0.225 0.219 0.045 1.000 0.270 0.244 0.096 1.000 0.361 0.320 0.158 0.998
Mode Based Estimation 0.202 0.201 0.039 0.995 0.215 0.206 0.072 0.986 0.270 0.245 0.137 0.963
MR-PRESSO 0.247 0.234 0.058 1.000 0.326 0.302 0.108 1.000 0.429 0.415 0.146 0.999
MR-Robust 0.206 0.205 0.026 0.997 0.265 0.251 0.084 0.781 0.427 0.419 0.137 0.838
MR-Lasso 0.209 0.208 0.027 1.000 0.235 0.226 0.056 1.000 0.326 0.293 0.131 0.999
MR-Egger 0.289 0.269 0.231 0.316 0.305 0.295 0.276 0.250 0.297 0.293 0.314 0.201
Contamination Mixture 0.201 0.202 0.023 1.000 0.204 0.203 0.036 0.999 0.248 0.209 0.208 0.974
MR-Mix 0.241 0.215 0.150 0.505 0.288 0.223 0.248 0.593 0.362 0.250 0.366 0.546
MR-RAPS 0.281 0.274 0.068 0.990 0.371 0.365 0.102 0.976 0.459 0.454 0.125 0.974
Abbrevations: T1 error: Type 1 error.
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TABLE 3.4 – Mean, median, standard deviation (SD) of estimates, and Type
1 error/empirical power (%) with 100 genetic variants.
30% invalid 50% invalid 70% invalid
Null causal effect: θ = 0
Method Mean Median SD T1 error Mean Median SD T1 error Mean Median SD T1 error
Scenario 1: Balanced pleiotropy, InSIDE satisfied
Weighted Median 0.000 0.000 0.025 0.069 -0.001 0.000 0.041 0.124 0.000 0.000 0.077 0.234
Mode Based Estimation 0.000 0.000 0.024 0.038 0.000 0.000 0.035 0.082 0.000 0.000 0.084 0.333
MR-PRESSO 0.000 0.000 0.025 0.134 0.000 0.001 0.047 0.224 0.000 -0.001 0.083 0.313
MR-Robust 0.000 0.000 0.020 0.052 0.000 0.001 0.053 0.024 0.000 -0.001 0.126 0.044
MR-Lasso 0.000 0.000 0.019 0.042 0.000 0.000 0.029 0.072 0.000 0.000 0.055 0.120
MR-Egger -0.001 -0.001 0.195 0.067 -0.001 0.000 0.252 0.069 -0.003 -0.005 0.296 0.065
Contamination Mixture 0.000 0.000 0.019 0.064 0.000 0.000 0.029 0.088 0.002 0.000 0.211 0.136
MR-Mix 0.000 0.000 0.075 0.038 -0.001 0.000 0.072 0.024 0.000 0.000 0.058 0.000
MR-RAPS 0.000 -0.001 0.053 0.016 -0.001 0.000 0.095 0.036 0.000 -0.003 0.133 0.052
Scenario 2: Directional pleiotropy, InSIDE satisfied
Weighted Median 0.013 0.012 0.023 0.105 0.033 0.029 0.039 0.258 0.087 0.071 0.084 0.537
Mode Based Estimation 0.000 0.000 0.020 0.037 0.004 0.003 0.030 0.089 0.034 0.030 0.067 0.351
MR-PRESSO 0.022 0.018 0.026 0.294 0.071 0.062 0.056 0.628 0.162 0.150 0.096 0.856
MR-Robust 0.004 0.004 0.018 0.051 0.042 0.038 0.047 0.040 0.193 0.189 0.100 0.425
MR-Lasso 0.004 0.004 0.017 0.077 0.020 0.018 0.029 0.242 0.076 0.066 0.067 0.617
MR-Egger 0.001 -0.003 0.143 0.062 -0.002 -0.005 0.180 0.059 0.003 0.001 0.210 0.058
Contamination Mixture 0.000 0.001 0.017 0.061 0.001 0.001 0.025 0.090 0.018 0.005 0.160 0.156
MR-Mix 0.005 0.000 0.074 0.034 0.004 0.000 0.072 0.035 0.006 0.000 0.070 0.007
MR-RAPS 0.058 0.056 0.042 0.142 0.140 0.138 0.072 0.435 0.233 0.232 0.097 0.663
Scenario 3: Directional pleiotropy, InSIDE violated
Weighted Median 0.027 0.025 0.027 0.258 0.077 0.065 0.062 0.619 0.184 0.163 0.116 0.881
Mode Based Estimation 0.001 0.001 0.021 0.042 0.010 0.008 0.035 0.120 0.065 0.054 0.087 0.465
MR-PRESSO 0.053 0.047 0.040 0.658 0.152 0.142 0.079 0.943 0.276 0.270 0.103 0.993
MR-Robust 0.007 0.007 0.019 0.054 0.078 0.071 0.059 0.080 0.292 0.289 0.099 0.805
MR-Lasso 0.010 0.009 0.018 0.153 0.049 0.043 0.041 0.575 0.165 0.151 0.097 0.927
MR-Egger 0.119 0.114 0.148 0.162 0.141 0.138 0.178 0.159 0.123 0.124 0.194 0.114
Contamination Mixture 0.001 0.001 0.017 0.069 0.003 0.003 0.026 0.107 0.021 0.009 0.135 0.199
MR-Mix 0.007 0.000 0.073 0.037 0.008 0.000 0.070 0.034 0.007 0.000 0.068 0.006
MR-RAPS 0.104 0.101 0.049 0.545 0.224 0.221 0.076 0.896 0.330 0.327 0.090 0.976
Positive causal effect: θ =+0.2
Method Mean Median SD Power Mean Median SD Power Mean Median SD Power
Scenario 1: Balanced pleiotropy, InSIDE satisfied
Weighted Median 0.200 0.200 0.028 1.000 0.201 0.201 0.043 0.996 0.201 0.200 0.078 0.939
Mode Based Estimation 0.199 0.199 0.025 1.000 0.199 0.199 0.036 0.998 0.192 0.192 0.085 0.908
MR-PRESSO 0.200 0.200 0.026 1.000 0.201 0.200 0.047 0.993 0.201 0.200 0.083 0.934
MR-Robust 0.200 0.200 0.021 1.000 0.201 0.202 0.055 0.896 0.200 0.200 0.126 0.373
MR-Lasso 0.200 0.200 0.020 1.000 0.201 0.201 0.031 1.000 0.200 0.200 0.057 0.986
MR-Egger 0.200 0.200 0.199 0.212 0.199 0.200 0.248 0.146 0.206 0.206 0.298 0.130
Contamination Mixture 0.202 0.202 0.021 1.000 0.203 0.204 0.031 1.000 0.228 0.206 0.253 0.977
MR-Mix 0.203 0.200 0.091 0.979 0.191 0.200 0.105 0.873 0.028 0.000 0.103 0.001
MR-RAPS 0.201 0.201 0.054 0.880 0.201 0.199 0.095 0.504 0.201 0.202 0.133 0.332
Scenario 2: Directional pleiotropy, InSIDE satisfied
Weighted Median 0.214 0.213 0.025 1.000 0.237 0.233 0.043 1.000 0.290 0.275 0.086 1.000
Mode Based Estimation 0.199 0.199 0.023 1.000 0.203 0.203 0.033 1.000 0.229 0.226 0.071 0.986
MR-PRESSO 0.222 0.219 0.027 1.000 0.271 0.263 0.056 1.000 0.362 0.351 0.095 1.000
MR-Robust 0.205 0.205 0.020 1.000 0.247 0.243 0.051 0.995 0.395 0.390 0.100 0.982
MR-Lasso 0.205 0.205 0.019 1.000 0.223 0.220 0.032 1.000 0.281 0.270 0.071 1.000
MR-Egger 0.201 0.198 0.144 0.325 0.203 0.199 0.182 0.229 0.201 0.199 0.213 0.187
Contamination Mixture 0.202 0.202 0.019 1.000 0.204 0.204 0.028 1.000 0.256 0.211 0.271 0.995
MR-Mix 0.208 0.200 0.094 0.641 0.211 0.200 0.098 0.899 0.055 0.000 0.136 0.061
MR-RAPS 0.260 0.257 0.043 1.000 0.342 0.340 0.073 0.997 0.434 0.431 0.098 0.994
Scenario 3: Directional pleiotropy, InSIDE violated
Weighted Median 0.230 0.228 0.029 1.000 0.282 0.271 0.065 1.000 0.389 0.369 0.116 1.000
Mode Based Estimation 0.201 0.200 0.024 1.000 0.210 0.208 0.039 0.999 0.263 0.252 0.088 0.988
MR-PRESSO 0.252 0.246 0.039 1.000 0.349 0.339 0.077 1.000 0.474 0.468 0.100 1.000
MR-Robust 0.209 0.209 0.022 1.000 0.287 0.280 0.063 0.986 0.495 0.492 0.097 0.999
MR-Lasso 0.212 0.212 0.021 1.000 0.254 0.248 0.045 1.000 0.372 0.359 0.096 1.000
MR-Egger 0.321 0.314 0.146 0.640 0.343 0.339 0.180 0.534 0.327 0.323 0.194 0.420
Contamination Mixture 0.203 0.203 0.020 1.000 0.206 0.205 0.031 1.000 0.268 0.217 0.269 0.995
MR-Mix 0.211 0.205 0.094 0.730 0.211 0.200 0.101 0.900 0.058 0.000 0.150 0.033
MR-RAPS 0.306 0.303 0.050 1.000 0.426 0.424 0.077 1.000 0.531 0.529 0.088 1.000
Abbrevations: T1 error: Type 1 error.
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FIGURE 3.4 – Mean squared errors for the different methods in scenario
3 (directional pleiotropy, InSIDE violated) with a null causal effect for 30
variants. Note the vertical axis is on a logarithmic scale.
strictly they identified outliers, they agreed on the order of outliers (Supplemen-
tary Table 3). The MR-Robust method was the most lenient, downweighting two
variants as outliers. Each subsequent method in order of strictness identified all
previously identified variants as outliers. MR-PRESSO excluded the two variants
identified by MR-Robust plus an additional three variants. MR-RAPS identified
these five plus an additional two variants. MR-Lasso identified an additional
three variants, 10 in total. The contamination mixture method identified an
additional 14 variants, 24 in total. MR-Mix identified an additional 21 variants,
45 in total. This suggests that any difference between results from outlier-robust
methods are likely due to the strictness of outlier detection, rather than due
to intrinsic differences in how the different methods select outliers. In several
methods, the threshold at which outliers are detected can be varied by the an-
alyst (for example, by varying the penalization parameter λ in MR-Lasso, or
the significance threshold in MR-PRESSO). In practice, rather than performing
different outlier-robust methods, it may be better to concentrate on one method,
but vary this threshold. In our example, some of the variants that were the most
pleiotropic in terms of their associations with other measured risk factors were
only removed from the analysis by the MR-Mix method (Supplementary Table 3).
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TABLE 3.5 – Estimates and 95% confidence intervals (CI) for the effect of BMI
on coronary artery disease risk from robust methods. Estimates represent log
odds ratios for CAD risk per 1 kg/m2 increase in BMI.
Method Causal estimate (95% CI) CI width
Weighted Median 0.376 (0.206, 0.546) 0.340
Mode Based Estimation 0.382 (0.181, 0.583) 0.402
MR-PRESSO 0.410 (0.309, 0.511) 0.202
MR-Robust 0.425 (0.325, 0.526) 0.201
MR-Lasso 0.442 (0.354, 0.530) 0.176
MR-Egger 0.481 (0.165, 0.796) 0.631
(intercept) -0.003 (-0.011, 0.005)
Contamination Mixture 0.490 (0.372, 0.602) 0.230
MR-Mix 0.425 (-0.283, 1.133) 1.416
MR-RAPS 0.390 (0.308, 0.546) 0.238
3.4 D I S C U S S I O N
In this paper, we have provided a review of robust methods for MR, focusing on
methods that can be performed using summary data and implemented using
standard statistical software. We have divided methods into three categories:
consensus methods, outlier-robust methods, and modelling methods. Methods
were compared in three ways: by their theoretical properties, including the
assumptions required for the method to give a consistent estimate, in an extensive
simulation study, and in an empirical investigation.
While the use of robust methods for MR analyses with multiple genetic vari-
ants is highly recommended, it is not practical or desirable to perform and report
results from every single robust method that has been proposed. Guidance is
therefore needed as to which robust methods should be performed in practice. As
an example, if an investigator performed the MR-PRESSO, MR-Robust, and MR-
Lasso methods, they would have assessed robustness of the result to outliers, but
they would not have not assessed other potential violations of the IV assumptions.
The categorization of methods proposed here is not the only possible division of
methods, but we hope it is practically useful. For instance, the contamination
mixture and MR-Mix methods make the same ‘plurality valid’ assumption as the
MBE method, and so could have been placed in the same category.
The similarity and ubiquity of the ‘outlier-robust’ and ‘majority/plurality
valid’ assumptions should encourage investigators to consider methods that
make alternative assumptions, such as the MR-Egger method. While the InSIDE
assumption is often not plausible (Burgess and Thompson, 2017), the MR-Egger
method and the intercept test have value in providing a different route to test-
ing the validity of an MR study. Another potential choice is the constrained
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3. A comparison of robust Mendelian randomization methods using summary data
IV method, which uses information on measured confounders to construct a
composite IV that is not associated with these confounders (Jiang et al., 2017).
This method was not considered in the simulation study, as it requires additional
data on confounders and individual participant data. Further methods develop-
ment is needed to develop robust methods for summary data that make different
consistency assumptions.
We encourage researchers to perform robust methods from different cate-
gories, and that make varied consistency assumptions. For example, an investi-
gator could perform the weighted median method (majority valid assumption),
the contamination mixture method (plurality valid assumption), and the MR-
Egger method (InSIDE assumption). If there are a few clear outliers in the data,
then an outlier-robust method such as MR-PRESSO (best used with few very
distinct outliers) or MR-Robust could also be performed. While we are hesitant
to make a definitive recommendation as each method has its own strengths and
weaknesses, this set of methods would be a reasonable compromise between
performing too few methods and not adequately assessing the IV assumptions,
and performing so many methods that clarity is obscured. Another danger of the
use of large numbers of methods is the possibility to cherry-pick results, either
by an investigator seeking to present their results in a more positive light, or a
reader picking the one method that gives a different result (such as the MR-Mix
method in our empirical example).
One important limitation of these methods is the assumption that all valid IVs
estimate the same causal effect. Particularly for complex exposures such as BMI,
it is possible that different genetic variants have different ratio estimates not
because they are invalid IVs, but because there are different ways of intervening
on BMI that lead to different effects on the outcome. This can be remedied
somewhat in methods based on the IVW method by using a random-effects model
(Bowden et al., 2017b), or in the contamination mixture method, where causal
effects evidenced by different sets of variants will lead to a multimodal likelihood
function, and potentially a confidence interval that consists of more than one
region.
In summary, while robust methods for MR do not provide a perfect solution to
violations of the IV assumptions, they are able to detect such violations and help
investigators make more reliable causal inferences. Investigators should perform
a range of robust methods that operate in different ways and make different
assumptions to assess the robustness of findings from a MR investigation.
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Appendices
3.A D E T A I L S O F S I M U L A T I O N S T U D Y
For each participant i, we simulate data on J genetic variants G i1,G i2, . . . ,G iJ ,
a modifiable exposure X i, an outcome variable Yi, and a confounder Ui (assumed
unknown). The confounder is a linear function of the genetic variants and
an independent error term εUi . The effect of variant j on the confounder is
represented by coefficient φ j (this is zero for a valid IV). The exposure is linear in
the genetic variants, the confounder and an independent error term εXi . The effect
of variant j on the exposure is represented by coefficient γ j. The outcome is linear
in the genetic variants, exposure, confounders and an independent error term εYi .
The effect of variant j on the outcome is represented by coefficient α j (again, this
is zero for a valid IV). The effect of the exposure on the outcome is represented by
θ. The genetic variants are modelled as single nucleotide polymorphisms (SNPs),
with a varying minor allele frequency maf j, and take values 0, 1 or 2. The minor
allele frequencies are drawn from an uniform distribution (maf j ∼U(0.1,0.5)).




i each follow an independent normal distribution
with mean 0 and unit variance.
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α jG i j +θ X i +Ui +εYi , (3.11)
maf j ∼U(0.1,0.5), (3.12)





i ∼N(0,1) independently. (3.14)
The causal effect of the exposure on the outcome was either taken as null
(θ = 0) or positive (θ = 0.2). Genetic associations with the exposure γ j are drawn
from a left-sided truncated normal distribution (truncation at 0.15, 0.1, and
0.05, for J = 10, 30, and 100 respectively). The variance of this distribution is
chosen such that the total proportion of variance explained in the exposure by
direct effects of the genetic variants is on average 10%. In scenario 3, the overall
proportion of variance explained in the exposure by genetic variants is slightly
larger, as there is an additional effect of the invalid IVs on the exposure via their
effect on the confounder.
For valid IVs, φ j = 0 and α j = 0. For invalid IVs, in scenario 1 (balanced
pleiotropy, InSIDE satisfied), the effects of the genetic variants on the outcome
are generated from a normal distribution centered at zero (α j ∼ N (0,0.15))
and genetic effects on the confounder are zero (φ j = 0). In scenario 2 (direc-
tional pleiotropy, InSIDE satisfied), the effects of the genetic variants on the
outcome are generated from a normal distribution centered away from zero
(α j ∼N (0.1,0.075)) and genetic effects on the confounder are zero (φ j = 0). In
scenario 3 (directional pleiotropy, InSIDE violated), the direct effects of the ge-
netic variants on the outcome are generated from a normal distribution centered
away from zero (α j ∼N (0.1,0.075)) and genetic effects on the confounder are
generated from a uniform distribution (φ j ∼U (0,0.1)).
Summary genetic association data are calculated by regressing the outcome on
each genetic variant in turn. Individual participant data are generated for 10 000
individuals, where we perform the outcome regressions on all these individuals
to come to the second stage effect estimates and corresponding standard errors.
For the exposure summary genetic associations, we give the true value of the
first stage effect with corresponding theoretical standard error (which is given
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3. A comparison of robust Mendelian randomization methods using summary data
by (
p
N ∗√2∗maf j ∗ (1−maf j))−1, where N is the number of individuals in the
first stage GWAS) with again 10 000 individuals. This represents a two-sample
Mendelian randomization study. We generated 10 000 simulated datasets for
each scenario, and for null and positive causal effects.
Each method is performed using the default options suggested by the authors
of the method, either in the corresponding publication, or in the software code
recommended by the authors. The weighted median method is performed using
inverse-variance weights. The mode based estimation method is performed
using inverse-variance weights, the ‘no measurement error’ assumption, and the
default bandwidth setting (φ= 1). The MR-PRESSO method is performed using
a significance cut-off of p < 0.05 for determining outliers. The MR-Lasso method
is performed using the heterogeneity criterion for selecting the lasso penalty
parameter. The contamination mixture method is performed using the standard
deviation of the ratio estimates multiplied by 1.5 for the variance parameter. For
MR-Mix, we choose an initial value of the probability mass at the null component
as 0.6 and the initial value of the variance of the non-null component as 1×10−5.
As the method performs a grid search, these decisions should not influence the
results. For MR-RAPS, we use the overdispersed robust version with the Huber
loss function. All regression models use random-effects.
The mean squared errors of the different methods are presented in Sup-
plementary Figure 3.5 (10 variants, scenario 2), Supplementary Figure 3.6 (10
variants, scenario 3), Supplementary Figure 3.7 (100 variants, scenario 2), and
Supplementary Figure 3.8 (100 variants, scenario 3). Note that in each case the
vertical axis is on a logarithmic scale. Findings are similar to before among the
different scenarios. We observe again that the performance of the mode based
estimator is the best for the consensus based approach, MR-Robust gets the
best result among the outlier-robust methods, and the contamination mixture
approach has the best performance among the modelling methods.
3.B O U T L I E R S A C C O R D I N G T O D I F F E R E N T M E T H O D S
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TABLE 3.6 – Genetic variants identified as outliers by the different methods
in the Mendelian Randomization study of the effect of BMI on cardiovascular
disease risk and other traits the variants are associated with according to the
NHGRI-EBI Catalog of published genome-wide association studies (Buniello
et al., 2019) (last accessed on 12 July 2019).
Variant Robust PRESSO RAPS Lasso Contam mix Mix Associated traits
rs11191560 X X X X X X
rs2075650 X X X X X X Waist circumference, Hip circumference
rs2176040 X X X X X Waist circumference, Obesity
rs6567160 X X X X X Hand grip strength
rs7903146 X X X X X Hip circumference
rs11727676 X X X X Parental longevity
rs17024393 X X X X
rs11126666 X X X
rs13078960 X X X HDL cholesterol levels, Colorectal cancer, Diver-
ticular disease
rs9914578 X X X
rs1000940 X X











rs492400 X X Hip circumference, Hand grip strength
rs7243357 X X
rs9641123 X X
rs10938397 X Alzheimer’s disease, C-reactive protein, Age-
related macular degeneration, Cerebrospinal
fluid levels, Waist-hip ratio, Waist circumfer-
ence, Longevity, LDL cholesterol, Total choles-
terol, Cognitive decline, Cognitive impairment
score, Cerebral amyloid deposition
rs10968576 X Waist Circumference
rs11030104 X
rs11688816 X Waist circumference, Waist-hip ratio
rs12016871 X Waist circumference, Intelligence
rs13021737 X Waist circumference
rs13191362 X Crohn’s disease
rs13201877 X Waist circumference, Fat-free mass
rs1460676 X Intelligence
rs1516725 X Waist circumference
rs1528435 X Feeling nervous
rs17203016 X
rs2176598 X Body fat percentage, Hip circumference






rs7164727 X Type 2 diabetes, Hip circumference, Waist cir-
cumference, Peak insulin response, Clinical
laboratory measurements, Metabolic syndrome,
Glycated hemoglobin levels, Schizophrenia, Sys-
tolic blood pressure, Pulse pressure, Fasting
blood insulin, Fasting blood glucose, Proinsulin
levels
rs7599312 X Lean body mass
rs7899106 X
Abbrevations: Robust: MR-Robust, PRESSO: MR-PRESSO, RAPS: MR-RAPS, Lasso: MR-:Lasso, Contam mix:
Contamination Mixture, Mix: MR-Mix.
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FIGURE 3.5 – Mean squared error for the different methods in scenario 2 for
10 000 simulations, with directional pleiotropy and InSIDE satisfied with 10
variants.











































































































































































































































FIGURE 3.6 – Mean squared error for the different methods in scenario 3 for
10 000 simulations, with directional pleiotropy and InSIDE violated with 10
variants.
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FIGURE 3.7 – Mean squared error for the different methods in scenario 2 for
10 000 simulations, with directional pleiotropy and InSIDE satisfied with
100 variants.











































































































































































































































FIGURE 3.8 – Mean squared error for the different methods in scenario 3 for








A decade of research on the genetics of
entrepreneurship: a review and view ahead
Cornelius A. Rietveld, Eric A.W. Slob, A. Roy Thurik
Abstract
Studies analyzing the heritability of entrepreneurship indicate that explanations
for why people engage in entrepreneurship that ignore genes are incomplete.
However, despite promises that were solidly backed up with ex-ante power cal-
culations, attempts to identify specific genetic variants underlying the heritable
variation in entrepreneurship have until now been unsuccessful. We describe
the methodological issues hampering the identification of associations between
genetic variants and entrepreneurship, but we also outline why this search will
eventually be successful. Nevertheless, we argue that the benefits of using these
individual genetic variants for empirical research in the entrepreneurship do-
main are likely to be small. Instead, the use of summary indices comprising
multiple genetic variants, so-called polygenic risk scores, is advocated. In doing
so, we stress the caveats associated with applying population-level results to the
individual level. By drawing upon the promises of “genoeconomics”, we sketch
how the use of genetic information may advance the field of entrepreneurship
research.
This chapter is based on Rietveld et al. (2020).
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4.1 I N T R O D U C T I O N
In 2000, the field of psychology concluded the nature-nurture debate to be “over”
by posing that all human behavioral traits are heritable (Turkheimer, 2000). This
“first law” of behavior genetics is backed by a vast body of literature comprising
thousands of heritability studies (Polderman et al., 2015, Turkheimer, 2000).
Since 2008, several studies have shown that this law also holds for entrepreneur-
ship (Nicolaou et al., 2008a,b, Nicolaou and Shane, 2010, Shane and Nicolaou,
2015, Van der Loos et al., 2013, Zhang et al., 2009). Inspired by these findings and
advances in genetics research, Koellinger et al. (2010) provided a sketchy forecast
in this journal of the expected identification of relationships between genetic vari-
ants and entrepreneurship. Nevertheless, despite several attempts in the past
decade (Nicolaou et al., 2011, Quaye et al., 2012, Van der Loos et al., 2011, 2013,
Wernerfelt et al., 2012), no single robust association between a genetic variant
and entrepreneurship has been found. Therefore, the first question we address
in the present study is “Why has the identification of robust associations between
genetic variants and entrepreneurship been unsuccessful in the last decade?” We
answer this question from a methodological point of view. In doing so, we also
provide a review of the literature in this field of research.
The second question we address is “Would the identification of associations
between genetic variants and entrepreneurship help to advance the field of en-
trepreneurship research?” Despite the unsuccessful attempts so far, we provide
methodological and empirical reasons for why we may expect the identification of
the first robust associations between genetic variants and entrepreneurship in the
not too distant future. Entrepreneurship scholars have argued that the prediction
of entrepreneurial behavior using genetic data could have practical applications
in business and for individual decision-making (Nicolaou et al., 2008a, Nicolaou
and Shane, 2010, Shane, 2010). Moreover, several private companies already
offer genetic tests to predict someone’s leadership and managerial qualities1. We
explain how summary indices of genetic variants (so-called polygenic risk scores)
can be used for such prediction analyses, but by drawing on the broader behavior
genetics literature, we stress the caveats associated with applying population-
level results to the individual level. By relating the promises of “genoeconomics”
as outlined by Benjamin et al. (2012a) to entrepreneurship research, we then
sketch how we think the use of genetic information may advance the field of
entrepreneurship research.
To illustrate the answers to our two research questions, we include an empiri-
1For example, such tests are provided by Leadership Consultants
(https://leapership.com/shop/karmagene-dna-based-personality-test/) and Goldmen Genetics
(https://goldmen.eu/).
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cal analysis of data from the US Health and Retirement Study. The inclusion of
the empirical analyses in this study serves three purposes. First, the results of
the analyses show how polygenic risk scores constructed for a range of traits (and
not just entrepreneurship) can help to identify regions in the human genome
particularly important for entrepreneurial behavior. Second, these analyses
illustrate how polygenic risk scores can significantly predict entrepreneurship
(even when proxied by the relatively episodic activity of self-employment). Third,
we use these analyses to illustrate that the estimated relationships between poly-
genic risk scores and entrepreneurship at the population level only marginally
improve the prediction of entrepreneurial behavior at the individual level.
In the following section, we review the studies providing evidence for the heri-
tability of entrepreneurship. By exploiting family-based relationships rather than
molecular genetic information, these studies show that approximately 40% of the
differences in entrepreneurial behavior can be explained by genes. In Section
4.3, we review the molecular genetic analyses of entrepreneurship. We provide a
comprehensive overview and discussion of the methodological approaches taken
to identify relationships between genetic variants and entrepreneurship. Our
empirical analyses are introduced and presented in Section 4.4. Finally, Section
4.5 concludes by discussing the added value of genetics for entrepreneurship
research.
4.2 T H E H E R I T A B I L I T Y O F E N T R E P R E N E U R S H I P
Heritability is a technical term denoting the proportion of observed differences
in a trait among individuals from a certain population that is due to the genetic
differences among these individuals (Visscher et al., 2008). The main challenge
in the estimation of heritability is the statistical separation of the effect of
genes from the effect of the family environment on the trait of interest. One
way to address this challenge is to compare adoptees with biological children.
Using this approach, Lindquist et al. (2015) find that parental entrepreneurship
increases the likelihood of children’s entrepreneurship by 60%. In their Swedish
sample, they show that post-birth factors (i.e., adoptive parents) are two times
more important than pre-birth factors (i.e., biological parents) for explaining
entrepreneurial involvement.
Another, more common approach to separating the effect of genes from the
effect of the family environment is the comparison of monozygotic and dizygotic
twins reared together because the number of available twin samples is much
larger than the available samples of adoptees (Knopik et al., 2016). Monozygotic
twins are genetically identical; however, dizygotic twins are as genetically similar
to each other as regular siblings. Under the assumption that monozygotic and
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dizygotic twins are influenced by their family environment to the same extent,
it is possible to decompose the variance in a trait into three components: the
additive genetic effect, the common environment (family specific) effect, and the
unique (individual specific) environment effect. Nicolaou et al. (2008a,b), Nicolaou
and Shane (2010), Shane and Nicolaou (2015), Van der Loos et al. (2013), Zhang
et al. (2009) use the classical twin study methodology to estimate the heritability
of entrepreneurship in American, British, and Swedish samples2. These studies
draw on a broad range of empirical measures for entrepreneurship, such as
self-employment and the number of start-up efforts, and provide general support
for the heritability of entrepreneurship. Overall, the heritability estimates are
in the neighborhood of 40%, indicating that almost one-half of the differences
in entrepreneurship in these countries can be attributed to genetic differences
across population members.3
Although adoptee and twin studies can establish that genetic factors account
for variation in a trait, they do not identify specific genes or the biological path-
ways through which genes function, because the genetic component is inferred
from family relationships rather than observed in these studies. The comple-
tion of the sequencing of the human genome at the beginning of the present
century (Venter et al., 2001) enabled the identification and measurement of lo-
cations in the human genome that differ among population members and hence
led to the search for the specific genes underlying the heritable variation in
entrepreneurship.
4.3 T H E M O L E C U L A R G E N E T I C A N A LY S I S O F E N T R E P R E N E U R S H I P
4.3.1 The human genome
A complete human genome consists of 23 pairs of chromosomes, from which the
23th pair determines the biological sex of an individual. One of each pair of
chromosomes is inherited from the mother, and the other is inherited from the
father. A chromosome is composed of two intertwined strands of deoxyribonucleic
acid (DNA), each made up of a sequence of nucleotide molecules. There are
four different nucleotide molecules in the DNA: adenine, cytosine, thymine, and
guanine. Adenine on one strand is always paired with thymine on the other
2Nofal et al. (2018) provide a review of the literature about “biology and management”. Studies
analyzing entrepreneurship are also included in this overview. All studies related to entrepreneurship
in their category “Quantitative genetics” are discussed in this section (besides other studies). All
entrepreneurship studies in their category “Molecular Genetics " are discussed in Section 4.3 (again,
besides other studies).
3 Nicolaou et al. (2009) use an extended version of the classical twin study to show that the genes
influencing the tendency to be an entrepreneur and the genes influencing opportunity recognition
partially overlap.
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strand, and cytosine is always paired with guanine. These combinations are
called base pairs. Every human genome consists of approximately 3 billion base
pairs. The stretches of base pairs in the DNA coding of a protein are called
genes. There are approximately 20,000 genes in the human genome with varying
lengths.
A random pair of individuals shares approximately 99.9% of their DNA (Na-
tional Human Genome Research Institute, 2018b), and most genetic differences
across population members can be attributed to single nucleotide polymorphisms
(SNPs, pronounced “snips”). Therefore, behavioral genetics researchers focus pri-
marily on SNPs when analyzing heritable genetic variation. A SNP is defined as
a location in the DNA strand at which two different nucleotides are present in the
population. Each of the two possible nucleotides is called an allele for that SNP.
The allele that is least common in the population is called the minor allele; the
other allele is called the major allele. For each SNP, an individual’s genotype is
coded as 0, 1 or 2, depending on the number of minor alleles present. Individuals
who inherited the same allele from each parent are called homozygous for that
SNP (and have genotype 0 or 2), while individuals who inherited different alleles
are called heterozygous (and have genotype 1). SNPs can be found in every part
of the genome, within genes or in regions in between genes, and may influence
the production of proteins.
In the human genome, there are approximately 85 million SNPs with a minor
allele prevalence of at least 1% (The 1000 Genomes Project Consortium, 2015).
When relating so many SNPs xi j (coded as 0, 1, or 2) to a specific outcome yi in a




β j xi j +εi, (4.1)
with intercept µ, SNP effects β j and residual term εi, it is evident that we
have to deal with an overidentified model with fewer individuals I than SNPs
J (Benjamin et al., 2012a).4 For this purpose, two basic approaches have been
developed to deal with the overidentification problem. Hypothesis-driven methods
such as the candidate gene approach do not consider all J SNPs, and hypothesis-
free methods such as the Genome-Wide Association Study (GWAS) consider all J
SNPs but not in one model. We continue by discussing these two basic approaches
from a methodological point of view, and we review how they have been used for
4 Advanced statistical methods, such as GREML (genome-based restricted maximum likelihood),
use two-step procedures to jointly estimate the explained variance of all SNPs (Yang et al., 2010).
With this method, Van der Loos et al. (2013) show that all SNPs in their sample explain 25% of the
variance in entrepreneurship. However, such approaches do not identify which individual SNPs are
associated with the outcome variable.
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unravelling the genetic architecture of entrepreneurship.
4.3.2 Hypothesis-driven approaches
The candidate gene approach consists of testing a subset of genetic variants for
association with the outcome of interest. These genetic variants are selected
based on what is known or believed about their biological function (Benjamin
et al., 2012a,b, Ebstein et al., 2010). This approach resembles the classic way of
justifying and then testing a hypothesis. A clear advantage of this approach is
that the interpretation of revealed significant relationships is relatively straight-
forward. Adopting this approach, Nicolaou et al. (2011) were the first to report
an association between a SNP in the DRD3 gene (a dopamine receptor gene) and
entrepreneurial behavior in a British sample. Their selection of candidate SNPs
was based on the observation that dopamine receptor genes have been associated
with novelty seeking/sensation seeking and attention deficit hyperactivity dis-
order (ADHD). These traits were reported to be particularly prevalent among
entrepreneurs (Nicolaou et al., 2008b, Antshel, 2017). Unfortunately, Van der
Loos et al. (2011) failed to replicate this association in a Dutch sample seven
times larger than the sample Nicolaou et al. (2011) drew upon.
This non-replication is exemplary for candidate gene studies (Benjamin et al.,
2012a,b, Ioannidis, 2005, Rietveld et al., 2014a). In principle, a theoretical
framework guides empirical research in reducing the number of hypotheses being
tested. However, the analytical rigor that a theory-guided approach provides is
not helpful in the context of behavioral genetics because it is difficult to reduce the
number of plausible hypotheses purely on theoretical grounds. For instance, 70%
of all genes (thus approximately 14,000) are expressed in the brain (Ramsköld
et al., 2009), and for many of these genes (and hence the SNPs within these
genes), a seemingly plausible relation between genes and behavior — including
entrepreneurship — could be hypothesized ex ante. As a matter of fact, in 2012,
the editor of the leading field journal Behavior Genetics issued an editorial policy
on candidate gene studies of behavioral traits that reads “The literature on
candidate gene associations is full of reports that have not stood up to rigorous
replication” and went on to say “. . . it now seems likely that many of the published
findings of the last decade are wrong or misleading and have not contributed
to real advances in knowledge” (Hewitt, 2012). This editorial policy outlines
strict quality criteria that candidate gene studies must meet to be considered for
publication. Most importantly, the editors stressed the importance of sufficient
statistical power in genetic discovery studies (Hewitt, 2012).
Statistical power refers to the probability of rejecting the null hypothesis
when it is not true. Statistical power of 80% or higher is generally considered
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to be adequate (Ellis, 2010). Low statistical power results in a high chance of
false negatives, i.e., non-rejections of the null hypothesis when the alternative
hypothesis is true. Even more problematic, because of the winner’s curse, low
statistical power also results in the overestimation of effect sizes for significant
findings (Benjamin et al., 2018, Button et al., 2013, Wacholder et al., 2004).
Statistical power is (among other things) a function of the effect size (of the SNP),
the size of the analysis sample, and the significance level adopted. Nicolaou and
Shane (2010) report that their identified SNP explained 0.5% of the likelihood of
being an entrepreneur. With their sample of 1,335 individuals, they had only 6%
power to detect such an effect at p < 0.05.5 Hence, it is not surprising that this
finding could not be further replicated (Van der Loos et al., 2013).6
4.3.3 Hypothesis-free approaches
Genome-wide association studies
GWAS is a hypothesis-free approach to genetic discovery because no prior selec-
tion is made on the set of SNPs used in the analysis. To deal with the overidenti-
fication problem, a GWAS runs a single regression for every SNP. Hence, millions
of regressions are performed in a GWAS. An advantage of the hypothesis-free
study design of GWAS is that it makes the need to correct for multiple testing
transparent. If the null hypothesis of no association is true for all these millions
of SNPs, one still finds a p-value < 0.05 for 5% of the SNPs. Therefore, in a GWAS,
the significance threshold is set to 0.05/1,000,000= 5×10−8 (“genome-wide signif-
icance”) because of the approximately 1 million independent SNPs in the human
genome (adjacent SNPs in the genome are often inherited together). A clear
disadvantage of this approach is that GWASs may prioritize SNPs for which the
biological function is yet unknown or unclear.7 Hence, GWAS usually identifies
SNPs that need to be subjected to further analyses to understand the pathways
between the SNPs and the outcome. Close collaboration with geneticists and
biologists in consortia, such as the Gentrepreneur Consortium (Van der Loos
5 In their analysis, Nicolaou and Shane (2010) adopted a significance level of 6×10−4 to account
for the correlation between SNPs. As a result, the power of their analysis was almost zero. To be
adequately powered (80%), one would have needed a sample of 3,643 individuals to find an effect of
0.5% (at p = 6×10−4).
6The working paper by Wernerfelt et al. (2012) reports an association between a genetic poly-
morphism and entrepreneurship (proxied by the number of companies founded) in a sample of 135
participants of an executive education course at Harvard Business School. It is evident that in such a
sample, the same concerns about statistical power hold.
7Relatedly, GWAS models usually use a very small number of control variables to capture the full
relationship between the SNP and the outcome. For example, Van der Loos et al. (2013) control for
only sex, age, and genetic relatedness in their GWAS on self-employment. The use of a small number
of control variables causes the interpretation of the estimated effects to be not as straightforward
because there may be many pathways through which a SNP influences a behavioral outcome.
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et al., 2010) and the Social Science Genetic Association Consortium8, is therefore
a prerequisite for the success of GWAS analysis.
The combination of a very stringent significance level and the small effect
sizes of individual SNPs implies that large samples are needed to be adequately
powered for gene discovery. The typical dataset has only several thousands of
observations, and therefore, datasets need to be combined into mega-analyses or
meta-analyses. In a mega-analysis, individual-level genetic data are merged and
jointly analyzed. However, legal and privacy issues generally make it impossible
to pursue this strategy. In a meta-analysis, the summary results of specific
analyses are combined. The GWAS meta-analysis approach has enabled an un-
precedented surge in genetic discoveries that are consistently replicated (Welter
et al., 2014, Visscher et al., 2017b), including the discovery of genetic associations
with behavioral outcomes such as educational attainment (Lee et al., 2018, Okbay
et al., 2016b, Rietveld et al., 2013), subjective well-being (Okbay et al., 2016a),
and more recently preferences such as attitudes toward risk-taking (Linnér et al.,
2019). The large sample sizes in these studies (N = 1,000,000 in some of them)
could be obtained due to the dramatic decline in the cost of genotyping in the last
decade (National Human Genome Research Institute, 2018a).
In 2010, Koellinger et al. (2010) calculated that at least 30,000 observations
were needed to find a relationship between an individual genetic variant and
entrepreneurship at the genome-wide significance level. Quaye et al. (2012) used
the GWAS approach in a sample of 3,933 British females to assess whether there
are associations between specific SNPs and entrepreneurship. Not surprisingly,
because of the small sample size, they did not find SNPs that are significant
at the genome-wide significance level. Van der Loos et al. (2013) conducted a
large-scale GWAS meta-analysis on entrepreneurship in a combined sample of
53,898 individuals from Europe and the US. Despite the sample size, this study
did not find any genome-wide significant SNPs. Moreover, this study found no
evidence that any of the genes that were previously suggested in the literature
to influence entrepreneurship (Shane, 2010) show significant associations with
entrepreneurship. From a statistical point of view, this null-result could have
been driven by the attenuation of the effect sizes through the meta-analysis of
samples from different countries and with different birth year profiles. However,
GWASs from the past few years on other behavioral outcomes indicate that the
effect sizes used in the power calculations by Koellinger et al. (2010) were too
high.
The past years of research in behavioral genetics showed that individual SNPs
typically explain less than 0.02% of the variance in a behavioral outcome (Chabris
8https://www.thessgac.org/.
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et al., 2015, Rietveld et al., 2014a). These findings imply that a sample of at least
197,984 individuals is needed to identify a SNP at the genome-wide significance
level with 80% power. Hence, by now, we know that the GWAS meta-analysis
of Van der Loos et al. (2013) was underpowered. Although the availability of
genetic data is rapidly increasing, genetic data are collected primarily for medical
purposes, and measures for entrepreneurship are not always available in medical
datasets. There is progress in the collection of genetic data in surveys with an
economic focus (such as the US Health and Retirement Study and the English
Longitudinal Study of Ageing), but at this moment, a sufficiently large analysis
sample for a GWAS on entrepreneurship is not available.
Nevertheless, the heritability estimates for entrepreneurship and the suc-
cessful discovery of SNPs related to other behavioral outcomes indicate that we
can be confident about the eventual success of a GWAS on entrepreneurship.
Visscher et al. (2017b) showed that the number of identified genetic associa-
tions in a GWAS is positively related to the size of the (meta-) analysis sample.
For example, whereas the first GWAS meta-analysis on educational attainment
(N ≈ 100,000) found only three genome-wide significant SNPs (Rietveld et al.,
2013), the second one (Okbay et al., 2016b) identified 74 SNPs (N ≈ 300,000), and
the third one (Lee et al., 2018) identified 1,271 SNPs (N ≈ 1,100,000). Hence,
a GWAS with a sufficiently large sample size — at least four times larger than
the sample of ∼ 50,000 individuals used by Van der Loos et al. (2013) — will also
reveal the SNPs that are associated with entrepreneurship.
Genetic discovery using proxy traits
A novel way to boost statistical power in GWASs is the identification of genetic
associations using a two-step procedure in the so-called proxy-phenotype method.
Rietveld et al. (2014b) introduced this approach to identify genetic associations
with cognitive performance. Similar to entrepreneurship, cognitive performance
is not often measured in genotyped samples. Therefore, the first step in this
method is conducting a large-scale GWAS on a genetically related trait. In the
second step, the genetic variants associated with this proxy trait are tested for
association with the main trait of interest. In this spirit, Rietveld et al. (2014b)
used the results of a GWAS on educational attainment to select 69 independent
SNPs, which were then tested for association with cognitive performance. The
significance threshold adopted in the second step equals α= 0.05/69 rather than
the genome-wide significance threshold of α= 5×10−8.
Linnér et al. (2019) used this approach in their GWAS on risk tolerance to
study the genetic architecture of related traits, such as self-employment. Based
on their main GWAS on risk tolerance, 99 SNPs were selected for further analysis
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regarding their association with entrepreneurship. In the second stage, the dis-
covery GWAS (N = 50,627) results of Van der Loos et al. (2013) were used. Using
a more lenient threshold for significance, Linnér et al. (2019) found one SNP
that was significantly associated with entrepreneurship. The sign of the effect
was in the expected direction, meaning that the SNP was related to higher risk
tolerance and a higher likelihood of being an entrepreneur. Linnér et al. (2019)
claimed in their supplementary materials that “if the association with rs7387531
is robust, this would be the first genetic variant to be found to be significantly
associated with self-employment.” However, in the replication sample (N = 3,271)
of Van der Loos et al. (2013), the effect of the SNP (rs7387531) was in the opposite
direction with p > 0.05, so it seems that the first robust association between a
SNP and entrepreneurship is yet to be identified. Nevertheless, this approach
illustrates that the genetic analysis of related traits may help to find genetic
variants associated with entrepreneurship.
4.3.4 Polygenic risk scores
Individual SNPs typically explain less than 0.02% of the variance in a behavioral
outcome (Chabris et al., 2015), and the GWAS on self-employment by Van der
Loos et al. (2013) has shown that the effects of individual SNPs on entrepreneur-
ship are also small (otherwise they would have been found). Hence, individually,
genetic variants are practically useless for use in empirical studies. However, the
tiny explanatory power of individual genetic variants has encouraged researchers
to develop methods that combine individual genetic variants into so-called poly-
genic risk scores with larger explanatory power. A polygenic risk score is a




β j xi j, (4.2)
where PGSi is the value for the polygenic risk score for individual i, β j
is the regression coefficient of SNP j from the GWAS, and xi j is the genotype
of individual i for SNP j (coded as 0, 1 or 2). This simple approach has been
proven to be effective in the out-of-sample prediction of behavioral outcomes. For
example, Rietveld et al. (2013) found only three SNPs significantly associated
with educational attainment at the genome-wide significance level. Each SNP ex-
9 More advanced methods for constructing polygenic risk scores exist, for example, methods that
better deal with the correlation structure across SNPs within the genome (see, e.g., So and Sham
(2017) and Vilhjálmsson et al. (2015)). However, the main rationale behind these methods is similar
to the basic (still commonly used) approach presented in the main text.
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plained approximately 0.02% of the variance in educational attainment. However,
the polygenic risk score based on all SNPs (including the non-significant ones)
explained approximately 2.5%of the variance. This percentage increased with
the sample size of the GWAS. For example, the most recent polygenic risk score
for educational attainment now explains 9.4% (Lee et al., 2018). The prediction
attempt of Van der Loos et al. (2013) was unsuccessful in the sense that their
polygenic risk score for entrepreneurship captured less than an insignificant
0.2% of the variance. Nevertheless, this percentage will increase if the GWAS for
entrepreneurship increases in terms of sample size (Dudbridge, 2013).
The weights β j used in the calculation of the polygenic risk score capture
almost the full relationship between the SNP and entrepreneurship: the only
control variables used in the GWAS on self-employment by Van der Loos et al.
(2013) are sex, age, and variables to account for genetic relatedness between
individuals. The relationship between someone’s genetic makeup and behavior
is assumed to be extremely complex and to run through many (possibly also
multiplicative) pathways. Therefore, a “direct” relationship between a SNP and
entrepreneurship is unlikely to exist. Many pathways, possibly comprising gene-
gene and gene-environment interactions, are likely to explain the relationship
between a SNP and behavior. Nevertheless, in a GWAS, these pathways are all
included in β j and therefore also in the polygenic risk score. In the spirit of the
proxy-phenotype approach used in GWAS (see Section 4.3.3), we can therefore
use the polygenic risk scores of traits that we think are in the pathway between
some SNPs and entrepreneurship to foster our understanding about the genetic
architecture of entrepreneurship.
One obvious example of such a pathway is risk tolerance. The recent GWAS
by Linnér et al. (2019) on risk tolerance shows how the polygenic risk score for
risk tolerance does indeed predict entrepreneurship out of sample. Although
the explanatory power of this polygenic risk score is relatively small, between
0.57 and 1.36 in terms of (pseudo-)R2 for different proxies of entrepreneurship, it
contributes significantly to the fit of the model. Moreover, the variance explained
is already larger than we may expect it to be for individual SNPs. Risk tolerance
may be an obvious trait to investigate when analyzing the pathway between
SNPs and entrepreneurship. However, other less obvious traits may also be
investigated. For example, earlier research shows that body height is associated
with entrepreneurship (Rietveld et al., 2015). The newest polygenic risk score for
height explains approximately 34.7% of the variance (Yengo et al., 2018). If the
effect of the SNPs explaining entrepreneurship runs through height, we will be
able to find an association between the polygenic risk score for body height and
entrepreneurship.
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Hence, polygenic risk scores constructed for traits other than entrepreneur-
ship may help to identify regions in the human genome that are related to
entrepreneurship. Moreover, these genetic summary indices may facilitate the
gene-based prediction of entrepreneurship. In the next section, we present
empirical analyses that illustrate these two conclusions.
4.4 E M P I R I C A L I L L U S T R A T I O N
For our empirical illustration, we draw on data from the US Health and Retire-
ment Study. The HRS is a representative panel of Americans over 50 years old
and their spouses. The HRS focuses on a variety of labor markets and health
and retirement outcomes. Genetic data were collected from consenting HRS
participants between 2006 and 2012 (Health and Retirement Study, 2012). We
use the RAND HRS Longitudinal File 2014 (V2) for the data on self-employment
(Health and Retirement Study, 2018). This longitudinal data file includes the
harmonized biennial data of the HRS (1992-2014). Our dependent variable indi-
cating whether an individual is self-employed or not is derived from the question:
“Do you work for someone else, are you self-employed, or what?”. The respondents
could answer “for someone else” or “self-employed”. If respondents said they were
self-employed, they were coded as 1, and if they replied that they worked for some
else, they were coded as 0. Self-employment is the most commonly used measure
for entrepreneurship studies drawing on survey data (Parker, 2018), although
engagement in self-employment can be episodic. We restrict our analyses to
those aged between 50 and 65 to exclude individuals active in the labor market
after retirement age. Moreover, following the recommendations of the genotyping
center, we restrict the analysis to individuals of recent European descent to
preempt bias from unobserved relationships between genetic and environmental
factors (Health and Retirement Study, 2012).
For the polygenic risk scores, which are the main independent variables in
our regressions, we use the HRS Polygenic Scores 2006-2012 Genetic Data -
Release 3 (Health and Study, 2018). In the present illustrative analyses, we
use all available polygenic risk scores in this file that relate to mental health10.
We choose to limit ourselves to the polygenic risk scores of only these traits,
as the recent entrepreneurship literature suggests an important link between
entrepreneurship and mental health in terms of person-job fit (Benz and Frey,
2008, Stephan, 2018). In total, we analyze 16 different polygenic risk scores. In
10For some polygenic risk scores, there are multiple versions, reflecting the publication of increas-
ingly large GWAS studies on these traits. In these cases, we use the newest polygenic risk score. For
some other traits, there are separate scores for males, females and the combined sample of males and
females. In these cases, we use the combined score.
74
4. A decade of research on the genetics of entrepreneurship: a review and view ahead
our analyses, we control for sex, birth year (dummies for each birth year), and
survey waves (dummies for each survey wave). We also control for the first ten
principal components of the genetic relationship matrix, as is common in genetic
association studies. The latter ten variables control for the genetic aspects of
common ancestry that could be spuriously correlated with the polygenic risk
scores and the outcome of interest, such as cultural or environmental factors
(Rietveld et al., 2014a). To estimate the relationships between self-employment
and the polygenic risk scores, we use a linear probability model with random
effects (to deal with the time-invariant nature of the polygenic risk scores as well




γkPGSik +δZ it +αi +εit, (4.3)
where SE it is the binary variable indicating the self-employment status of indi-
vidual i at time t, γk is the effect of the polygenic risk score PGSik for trait k, δ is
a vector of coefficients for the vector of control variables Z it, αi is an unobserved
random random variable for individual i, and εit is the residual for individual i
at time t.12
Overall, 31,927 (person-year) observations are available from 7,948 differ-
ent individuals. In this sample, 47% of the individuals are male, the average
age is 57.4 years (with standard deviation 4.1), and 19.9% of the person-year
observations report self-employment. Table 4.1 displays the estimates of the
associations between the different polygenic risk scores and self-employment. We
observe that there are six (out of 16) significant associations at the 5% level: the
polygenic risk scores for ADHD, autism, bipolar disorder, educational attainment,
general cognition, and well-being.13 For these traits, an increase of one standard
deviation leads to an increase or decrease in the likelihood of being self-employed
of approximately 1%. These results indicate that polygenic risk scores can signifi-
cantly predict entrepreneurship (even when proxied by the relatively episodic
11 We present the results of a linear probability model despite the binary nature of our dependent
variable because the interpretation of the regression coefficients in a linear probability model with
random effects is more straightforward than in a logit model with random effects. However, we
note that this choice does not affect our results from a qualitative point of view. In a logit model
with random effects, ADHD, autism, bipolar disorder, educational attainment, and cognition are still
significant at p < 0.05. However, the p-value for well-being (0.062) is slightly above the significance
threshold.
12 In the analysis, we estimate the effect of several polygenic risk scores in one single model. As
some traits are genetically correlated, such as ADHD and bipolar disorder (Faraone and Larsson,
2019), we also analyze models in which we separately include the polygenic risk scores. From a
qualitative point of view, the results are similar to the results presented in the main text.
13 Even with a stringent Bonferroni correction (0.05 divided by the number of polygenic risk scores
analyzed), the association with ADHD remains significant.
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activity of self-employment) and that genes influencing entrepreneurship are
likely to be found in regions in the human genome associated with these six
traits.14
TABLE 4.1 – The association between the polygenic risk scores for traits in
the mental health domain and self-employment (random-effects regression,
Nindividual-year = 31,927, Nindividual = 7,948).
Polygenic risk score Coefficient Standard error p-value
Attention deficit hyperactivity disorder 0.017 0.004 0.000
Anxiety (factor score) 0.001 0.004 0.796
Autism -0.013 0.006 0.049
Bipolar disorder 0.010 0.005 0.047
Depressive symptoms 0.007 0.005 0.187
Educational attainment 0.013 0.005 0.004
Extraversion 0.007 0.004 0.100
General cognition -0.012 0.005 0.010
Major depressive disorder -0.005 0.005 0.367
Mental health (cross disorder) -0.004 0.007 0.558
Neuroticism 0.008 0.006 0.202
Obsessive compulsive disorder -0.001 0.004 0.752
Post-traumatic stress disorder 0.001 0.005 0.900
Schizophrenia 0.005 0.008 0.509
Well-being 0.010 0.005 0.032
Notes: The regression model includes control variables for sex, age, survey waves, and genetic relatedness.
Underlined traits are significant at the 5% level.
At the same time, these results illustrate that the predictive power of these
polygenic risk scores is small (although larger than the predictive power of
individual SNPs). Compared to that of a model without the polygenic risk
scores, the explained variance of this model increased by only 0.42%.15 Table 4.2
shows that, from a prediction point of view (by taking the percentage of person-
year observations in our sample in self-employment 19.9% as the classification
threshold), the correct individual-level prediction of self-employment status
increases only marginally with the current model (0.14% point increase).
4.5 C O N C L U S I O N : A S E C O N D D E C A D E ?
The “quest for the entrepreneurial gene” (Van der Loos et al., 2011) is largely moti-
vated by the struggle of scholars to have a better understanding of entrepreneurs
14For illustration purposes, we analyzed all available mental health related polygenic risk scores
in the Health and Retirement Study in the present study. The set of polygenic risk scores includes
traits for which the link with entrepreneurship in not always evident. Therefore, future studies
may use theoretical or other insights for selecting the most promising candidates from the set of
available polygenic risk scores rather than using them all. However, the fact that ADHD is found to
be the strongest association in our analyses builds confidence in our approach since there are several
nongenetic studies showing a similar link (Verheul et al., 2015, 2016, Antshel, 2017, Wiklund et al.,
2017, Lerner et al., 2019) . Nevertheless, future studies need to replicate the current findings in
independent datasets to investigate their robustness and generalizability.
15 Individual SNPs typically explain less than 0.02% of the variance in a behavioral outcome
(Chabris et al., 2015, Rietveld et al., 2014a).
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TABLE 4.2 – In-sample prediction results for self-employment (versus wage
work) for the models with and without polygenic risk scores; observations
in the top 19.9% (percentage of person-year observations reporting self-
employment in the sample) of the predicted values in each model are classified
as self-employed.
Actual occupation Predicted occupation based on model
without polygenic risk scores
Predicted occupation based on model
with polygenic risk scores
Self-employment Wage work Self-employment Wage work
Self-employment 5.75% 14.11% 5.82% 14.04%
Wage work 14.10% 66.04% 14.03% 66.11%
and entrepreneurship: what makes entrepreneurs decide to start a business,
what motivates them, what makes them successful or fail, and what makes them
different from other people? Various research approaches, as well as tools and
theories from economics, psychology, and sociology, have been proposed and ap-
plied to these questions. However, the answers to “what makes an entrepreneur”
remain uncertain and incomplete (Shane and Venkatamaran, 2000, Parker, 2018).
Empirical evidence that genes may be part of the answer (Nicolaou et al., 2008a,b,
2009, 2011, Shane and Nicolaou, 2015, Van der Loos et al., 2011, 2013, Zhang
et al., 2009) has been received by scholars and the media with both hopes and
enthusiasm, as well as with skepticism and criticism.
Despite several attempts in the past decade, until now, no robust associa-
tion between genetic variants and entrepreneurship has been discovered. Our
overview and discussion of these works gives a clear answer to our first research
question, “Why has the identification of robust associations between genetic vari-
ants and entrepreneurship been unsuccessful in the last decade?”. Irrespective
of whether a hypothesis-driven or hypothesis-free approach was used, genetic
discovery studies on entrepreneurship have until now been underpowered. Nev-
ertheless, based on the results of large-scale genetic discovery studies on other
behavioral traits (such as educational attainment), we may expect that robust
associations between genetic variants and entrepreneurship will be identified if a
sufficiently large sample can be gathered. Datasets that contain both genetic data
and entrepreneurship information are relatively scarce (Van der Loos et al., 2013),
but the advent of large genotyped biobanks such as the UK Biobank (Bycroft
et al., 2018) and the Estonian Biobank (Leitsalu et al., 2015) is currently chang-
ing the landscape. Hence, a sufficiently powered GWAS on entrepreneurship may
soon become feasible.
Because of data constraints, the latest and largest GWAS on entrepreneurship
used self-employment as a proxy for entrepreneurship (Van der Loos et al., 2013).
With more data becoming available, future GWASs of entrepreneurship may bene-
fit from the analysis of an entrepreneurship measure less episodic in nature, such
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as serial or high-performance entrepreneurship. With more precise classification
of individuals into occupational groups, the GWAS becomes more powerful and
hence the chance to detect associations between individual genetic variants and
entrepreneurship becomes larger. Nevertheless, in combination with other GWAS
results, the analysis of the relatively heterogeneous self-employment measure
may help identify specific underlying types of self-employment. For example, by
drawing on GWAS results for schizophrenia and educational attainment, Bansal
et al. (2018) reveal that the binary schizophrenia diagnosis aggregates over at
least two different subtypes. The first type is associated with high intelligence
and bipolar disorder, while the second type is a cognitive disorder that is in-
dependent of bipolar disorder. With GWAS results for many publicly available
traits,16 similar analyses may also be interesting to conduct on self-employment
to possibly identify unexpected subtypes.
However, rather than directly analyzing entrepreneurship, it is possible to
shift attention (at least for the time being) to variables mediating the relationship
between genes and entrepreneurship. Examples of such variables that can
be measured in large samples include traits such as preferences for risk and
uncertainty, confidence, and optimism. In addition to these well-known measures
in the world of entrepreneurship research, one may also consider characteristics
such as body height, body mass index, and mental disorders (possibly in a
hypothesis-free setting). One advantage of this approach is that genetic effects
on more proximate outcomes are likely to be stronger and hence easier to detect,
for a given sample size, than the genetic effects on distal outcomes, such as
entrepreneurship (Rietveld et al., 2014b). By using the proxy-phenotype approach,
as discussed in subsection 4.3.3, it will be possible to identify associations with
entrepreneurship, for example, by using the (publicly available) GWAS results
of Van der Loos et al. (2013) in the second step of the analysis.17 This approach
circumvents to some extent the problem of the currently insufficient sample size
needed for a well-powered GWAS on entrepreneurship.
Although a regular GWAS looks only at the linear association between a ge-
netic variant and entrepreneurship, the genetic architecture of entrepreneurship
may comprise interactions between two or more genetic variants. Theoretically, it
is possible to include cross-products of SNPs as explanatory variables in a GWAS
to advance our understanding of the possibly complex biological mechanisms
that are associated with entrepreneurship. However, in a hypothesis-free setting,
such an approach would also require an even more stringent correction of the
significance level (as the number of statistical tests increases exponentially with
16For example, in the GWAS Catalog (https://www.ebi.ac.uk/gwas/).
17 The results of the GWAS on self-employment by Van der Loos et al. (2013) are publicly available
via www.thessgac.org.
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the number of interacting SNPs). Hence, if we assume the size of the interaction
effects is not larger than the effects of individual SNPs, this approach is unlikely
to be productive in the distant future because of data limitations. The interaction
effect may also be identified with (nonlinear) machine learning techniques. Rela-
tively simple machine learning techniques have been proven to have relatively
high predictive power for traits such as human height (Pare et al., 2017, Lello
et al., 2018). Despite the massive computational burden of these methods, it is
promising to analyze to what extent these techniques are also useful for predict-
ing entrepreneurship. Nevertheless, the biological interpretation of the results
obtained with machine learning techniques is arguably even more difficult than
that of results obtained with a regular GWAS.
To answer our second research question, “Would the identification of associ-
ations between genetic variants and entrepreneurship help to advance the field
of entrepreneurship research?”, we relate the promises of “genoeconomics”, as
outlined by Benjamin et al. (2012a), to entrepreneurship research in light of
the recent development in behavioral genetics. Benjamin et al. (2012a) outlined
four main reasons why the genetic analysis of behavioral traits is important and
relevant. First, studies using directly observed genes may reveal the genetic
pathways and mechanisms underlying behavior and may lead to a more complete
understanding of entrepreneurial behavior. For example, as already discussed
above in light of the findings of Bansal et al. (2018), it may be possible to identify
to what extent different mechanisms and cognitive processes are involved in the
identification and exploitation of business opportunities. Second, these studies
have the potential to provide measures for constructs that are difficult to measure
empirically. Benjamin et al. (2012a) use the example that specific genetic variants
can be used as a proxy for the taste for fatty foods. In this spirit, rather than
using self-reported measures for entrepreneurial intention, one could draw on
the genes related to entrepreneurship. Third, based on someone’s genetic profile,
interventions may be channeled. In this vein, entrepreneurship scholars argue
that the prediction of entrepreneurial behavior using genetic data could have
practical applications in business and for individual decision-making (Nicolaou
et al., 2008a, Nicolaou and Shane, 2010, Shane, 2010). Fourth, genes can be
used to enrich otherwise nongenetic models. For example, the inclusion of control
variables for genetic endowments may absorb the residual variance in regres-
sion models or experimental settings and allow for stronger statistical inference
(DiPrete et al., 2018b, Rietveld and Webbink, 2016). In some instances, it will
also be possible to infer causal relationships in observational data by using genes
as instrumental variables (Van Kippersluis and Rietveld, 2018, Von Hinke et al.,
2016). Hence, the use of genes may be instrumental for better understanding the
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effects of environmental factors.
Regarding the first two promises, we have seen that for behavioral outcomes
(such as entrepreneurship), one should not expect values of R2 in excess of 0.02%
for individual SNPs. Hence, it is unlikely that such a SNP will provide much
information about the mechanisms underlying entrepreneurship behavior. In
contrast to focusing on individual genetic variants, there are good arguments for
shifting our attention to polygenic risk scores that summarize the contribution
of several genetic variants to a trait. A clear advantage of this approach is that
polygenic risk scores can be used as regular variables in empirical research,
and expertise for working with raw genetic data is not necessary, as some poly-
genic risk scores are already publicly available (such as in the HRS).18 In the
present absence of a polygenic risk score for entrepreneurship with significant
explanatory power, we have to shift our focus to the analysis of polygenic risk
scores for entrepreneurship-related traits. By doing so, we also come closer to the
common practice in entrepreneurship research of testing particular hypotheses
(i.e., particular pathways through which genes influence entrepreneurship). For
example, we may hypothesize and test whether the genetic variants contributing
to the development of ADHD are also related to entrepreneurship. In this spirit,
a polygenic risk score can also serve as a proxy for a trait. For example, Patel et al.
(2019) use the polygenic risk score for ADHD to study the influence of ADHD on
entrepreneurship and entrepreneurial performance in a sample of individuals for
which the diagnosis of ADHD was not available.
Regarding the third and fourth promise (the use of genetic information to pre-
dict individual behavior and to enrich otherwise nongenetic models), the current
state of the behavioral genetics literature as well as the analyses presented in the
present study make clear that the added value of genetics for entrepreneurship
scholars should be thought of in terms of enriching population-level models rather
than improving individual-level prediction (Morris et al., 2019). Van der Loos
et al. (2013) show that all SNPs together may explain up to 25% of differences in
entrepreneurial behavior between individuals. Even if we are able to realize this
prediction R2, the likelihood of misclassification of individual into occupational
groups remains great. Hence, early speculations about the use of molecular
genetic data for understanding and predicting entrepreneurship (Shane, 2010)
remain premature, at a minimum. Even though it may be useful to capture
some of the (otherwise residual) variance in polygenic risk scores, the gene-based
18 There is currently an important initiative to make a repository of polygenic risk scores for several
datasets. However, the exact time window of this initiative is unknown (Okbay et al., 2018). More
(future) data sources can be found through portals such as the database of Genotypes and Phenotypes
(dbGaP, Mailman et al. (2007)) and the European Genome-phenome Archive (EGA, Lappalainen et al.
(2015)).
80
4. A decade of research on the genetics of entrepreneurship: a review and view ahead
prediction of individual entrepreneurial behavior will remain of limited value for
individuals and entities such as governments and banks.19
Nevertheless, capturing residual variance in polygenic scores may improve
the understanding of the effects of environmental factors. In so-called gene-
by-environment (“GxE”) studies (Keller, 2014, Thompson, 2017), polygenic risk
scores could be used to investigate how entrepreneurship results from the inter-
play between genetic endowments and environmental factors. For example, a
recent study argues that cultural factors (as proxied by the taste for alcoholic
drinks) may influence how genes shape different types of entrepreneurship (Acs
and Lappi, 2019). In general, a good fit between individuals and their occupations
has been shown to be important for high levels of productivity (Kristof-Brown
et al., 2005). Importantly, the identifiable occurrence of matches and mismatches
between an individual and his or her career choices and the possible impact
on stress and health was a crucial argument for the medical profession to coop-
erate with behavioral researchers in the search for the genes associated with
entrepreneurship (Koellinger et al., 2010, Van der Loos et al., 2010). Because of
the large-scale collections of genetic data and expertise on the biological function-
ing of genes in the medicine and biology fields, the involvement of researchers in
these fields will remain crucial to find associations between genetic variants and
entrepreneurship.
In sum, although the attempts to identify specific genetic variants underlying
the heritable variation in entrepreneurship have until now been unsuccessful,
there is reason to be confident about the eventual success of the “quest for the
entrepreneurial gene” (Van der Loos et al., 2011). The benefits of using individual
genetic variants for empirical research in the entrepreneurship domain are
likely to be small. However, the use of polygenic risk scores may promote the
realization of the promises of genoeconomics for entrepreneurship research.
Although the gene-based prediction of individual entrepreneurial behavior will be
of limited value, the use of polygenic risk scores in models may help to increase
our understanding of which regions in the genome and which combinations of
genetic endowments and environmental circumstances drive entrepreneurship
and person-job fit at the population level.
A C K N O W L E D G E M E N T S
The HRS (Health and Retirement Study) is sponsored by the National Institute
on Aging (grant number NIA U01AG009740) and is conducted by the University
of Michigan.
19Besides, ethical considerations are needed to determine whether such gene-based prediction of




Does the genetic predisposition to smoking
moderate the response to tobacco excise taxes?
Eric A.W. Slob and Cornelius A. Rietveld
Abstract
Tobacco use is one of the leading causes of preventable death. While some
public policies have been effective in reducing the smoking prevalence in the
United States, high tobacco excise taxes do not appear to deter all individuals
from starting smoking nor to make all smokers stop. Here, we analyze whether
someone’s genetic predisposition to smoking may explain why people smoke
despite high tobacco excise taxes. For this purpose, we interact polygenic risk
scores for smoking initiation and smoking intensity with state excise tax rates
on tobacco. Our analyses exploiting longitudinal data (1992-2014) from the US
Health and Retirement Study show that someone’s genetic propensity to smoking
moderates the effect of tobacco excise taxes on smoking behaviour, but only along
the extensive margin (smoking vs. not smoking). The results along the intensive
margin (the amount of tobacco consumed) are inconclusive.
This chapter is currently under review at a journal.
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5.1 I N T R O D U C T I O N
Tobacco use is the leading preventable cause of death in the world, with over
7 millions deaths per year (World Health Organization, 2017). In the United
States, over 480,000 deaths per year are attributable to smoking (US Department
of Health and Human Services, 2014). Tobacco use has been shown to be quite
addictive and hence, quitting is often a tough battle characterized by heavy
withdrawal symptoms (Benowitz, 2008). As a prime instrument to influence
smoking behaviour, governments impose excise taxes on tobacco. Over the past
50 years, the median price of cigarettes has increased from 0.30$ per pack up to
5.70$ (US Department of Health and Human Services, 2014). In the same period,
cigarette consumption per capita decreased from 4000 to about 1000 per year.
Although this decrease cannot entirely be explained by the increase in tobacco
excise taxes, as for example public awareness about the detrimental effects of
smoking also increased in this period, there is considerable evidence about the
effectiveness of raising tobacco excise taxes for reducing smoking (Chaloupka and
Warner, 2000, Institute of Medicine, 2007, MacLean et al., 2016). However, the
decrease in smoking consumption has stalled in the past 20 years (Orzechowski
and Walker, 2016).
Tobacco excise taxes are identical for each member of a society, and a pos-
sible explanation for the stabilizing smoking prevalence may be that for some
individuals it is more difficult than for others to stop smoking. For example,
studies have shown that demand elasticities for tobacco differ between males
and females (Yen, 2005) and across ethnicities (Kandel et al., 2004). Moreover,
behavioural preferenes such as risk aversion (Barsky et al., 1997, Anderson and
Mellor, 2008) and someone’s health status influence smoking behaviour (Jones,
1994, Lahiri and Song, 2000, Clark and Etilé, 2002). There is also clear evidence
that heavy smokers react differently to tobacco excise taxes than less heavy smok-
ers (Nesson, 2017), although the precise mechanism explaining these elasticity
differences is not known. In the present study, we analyze whether someone’s
genetic predisposition to smoking moderates the response to tobacco excise taxes.
Several studies have shown that the heritability of smoking behaviour ranges
between 31-60 % (Bidwell et al., 2016), indicating that genes explain a consid-
erable proportion of the variation in smoking in a population possibly through
their effect on nicotine dependency. It has also been shown that environmental
circumstances such as state policies impact the heritability of smoking: The
heritability of smoking is relatively low in states with relatively high excise
taxes on tobacco and in those with greater controls on cigarette advertising and
the vending machines (Boardman, 2009). Recent large-scale genetic association
studies have found more than 500 genetic variants underlying the heritable
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variation in smoking behaviour (Erzurumluoglu et al., 2019, Liu et al., 2019).
Fletcher shows that individuals carrying one of these genetic variants respond
differently to excise tobacco taxes than those not carrying this genetic variant
(Fletcher, 2012). Hence, such a gene-environment interaction may explain why
certain individuals smoke and others do not.
However, a follow-up study by Fontana (Fontana, 2015) using the same ge-
netic variant shows that Fletcher’s gene-environment interaction could be a
spurious association explained by the effects of population stratification. Pop-
ulation stratification entails an association between genetic subpopulations in
a population and environmental conditions, such as cultural and social norms
(Rietveld et al., 2014a). Besides, recent studies have shown that the predictive
power of individual genetic variants is limited, often below 0.02% for behavioural
outcomes including smoking (Chabris et al., 2015). Hence, low statistical power
may be another reason for why Fontana (Fontana, 2015) could not replicate the
results of Fletcher (Fletcher, 2012).
To deal with the limited predictive power of genetic variants, approaches have
been developed to combine multiple genetic variants into a composite measure.
The most often adopted approach is the construction of so-called polygenic risk
scores (PGSs) (Dudbridge, 2013). To construct a PGS, all genetic variants in a
sample are summed up in a weighted fashion in which each weight is proportional
to the strength of the association between the genetic variant and an outcome
variable as estimated in a genome-wide association study (GWAS) (International
Schizophrenia Consortium, 2009). For example, a recent study shows that poly-
genic scores explain about 4% of the variance in smoking behaviour (smoking
vs. not smoking, and the number of cigarettes consumed per day) out of sample
(Liu et al., 2019). A polygenic score not only makes one well powered for out of
sample prediction, but also enables more powerful gene-by-environment interac-
tion analysis. By using polygenic risk scores, Fontana shows that the interaction
between someone’s genetic predisposition (as captured by the polygenic scores
for educational attainment and smoking intensity) and tobacco excise taxes is in-
significant in a model explaining the intensity of cigarette consumption (Fontana,
2015).
The present study addresses the same question as Fontana, but goes beyond
the study by Fontana (Fontana, 2015) in three ways. First, we use a set of
polygenic scores more directly related to smoking behaviour than Fontana does.
That is, we use polygenic scores for smoking initiation and smoking intensity
whereas Fontana uses polygenic scores for educational attainment and smoking
intensity. Second, through the inclusion of additional data from the two most
recent waves of data collection from the US Health and Retirement Study, our
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analysis has more statistical power than Fontana’s analysis. Third, next to
analyzing the intensive margin (the amount of cigarettes per day), we also
analyze the extensive margin (smoking vs. not smoking). This is important,
because there is severe misreporting by smokers regarding the amount of tobacco
they consume (Gorber et al., 2009).
This study provides the first robust evidence of the existence of a gene-
environment (GxE) interaction influencing smoking behaviour. Establishing
a GxE interaction is often complicated by the fact that individuals with a certain
genetic predisposition may self-select into certain environments (Jencks, 1980).
In this study, we overcome bias from such a gene-environment correlation by
exploiting exogenous variation in the level of tobacco excise rates across states
and years. Our results suggest that individuals with a higher genetic propensity
for smoking respond more heavily to a change in excise taxes compared to indi-
viduals with a lower genetic propensity. Still, the results show that someone’s
genetic propensity to smoking moderates the effect of tobacco excise taxes on
smoking behaviour only along the extensive margin (smoking vs. not smoking).
The results along the intensive margin (the number of cigarettes consumed per
day) are inconclusive.
5.2 D A T A D E S C R I P T I O N
The data used in this study are derived from the US Health and Retirement
Study (HRS) (Juster and Suzman, 1995). The HRS is a longitudinal survey
consisting of approximately 20,000 individuals who were surveyed biennially
since 1992. The respondents in the survey are a representative sample of Amer-
icans over age 50 and their spouses. The HRS aims to analyze the health and
behaviour of individuals approaching or just after retirement. Therefore, the
dataset includes information about for example work status, pension plans, in-
come, health insurance, physical health and functioning, cognitive functioning,
and health behaviours including drinking and smoking (for an overview see Karp
(2007)). From 2006 onwards, the study started to collect genetic data from their
respondents. In the present study, we exploit data collected in the waves from
1992 up to 2014 (12 waves in total) which have been harmonized by the RAND
Corporation.
5.2.1 Smoking behaviour
The main outcome in the present study is smoking behaviour. The current study
uses three different measures of tobacco use that are available in the HRS and
which capture different dimensions of smoking behaviour. The first question
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‘Have you ever smoked cigarettes?’ is used to determine whether an individual
ever smoked cigarettes. With the second question, ‘Do you smoke cigarettes now?’,
it is determined whether an individual is a current smoker. If the individual
answers the second question with ‘yes’, the respondent is asked the question
‘About how many cigarettes or packs do you usually smoke in a day now?’. Based
on the response to this question, the number of cigarettes consumed per day is
determined.
5.2.2 State-level excise tobacco taxes
The Tax Burden on Tobacco dataset (Orzechowski and Walker, 2016) provides us
information about the tax levied by the state on each purchased pack of cigarettes
(based on the state and federal tax in each year). These data were merged with
the HRS data, based on confidential data about the state the HRS respondent
currently lives in. As the HRS contains biennial survey data, we use the tax
levied in the year prior to each survey. For consistency with prior studies and to
facilitate the interpretation of effects as proportional changes in consumption, the
tax levels are logarithmically transformed (Adda and Cornaglia, 2006, Fletcher,
2012).
5.2.3 Polygenic scores
Polygenic scores are used to analyze whether the response to tobacco excise taxes
is moderated by someone’s genetic predisposition to smoking. Most genetic differ-
ences across individuals in a population can be attributed to single nucleotide
polymorphisms (SNPs). A SNP is a location in the DNA strand at which two
different nucleotides can be present in the population. For each SNP, an indi-
vidual’s genotype is coded as a 0, 1 or 2, depending on the number of reference
nucleotides present. Individuals who inherited the same nucleotide from each
parent are called homozygous for that SNP (and have genotype 0 or 2), while
individuals who inherited different nucleotides are called heterozygous (and have
genotype 1). Polygenic risk scores reflect the combined additive influence of SNPs
on a particular outcome.
To construct a polygenic score, SNPs are summed up in a weighted fashion.
The weights reflect the strength of the relationship between a SNP and the
outcome of interest, as estimated in a GWAS. In a GWAS, for each SNP the
following model is estimated:
yi =µ+γm g im +δzi +νi, (5.1)
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where yi is the outcome of interest for individual i, µ is an intercept, γm is the
additive effect of SNP g im, zi is a vector of control variables (e.g., sex and age),
and νi is the residual. Using the effect size estimates γm from (5.1), the polygenic




γm g im, (5.2)
where G i represents the value of the polygenic score for individual i, M is the
total number of SNPs included in the construction of the polygenic score, γm is
the additive effect size of SNP m taken as estimated in the GWAS and g im is the
genotype of individual i at locus m (measured as 0, 1 or 2).
The HRS provides polygenic scores for public distribution based on several
recently conducted large-scale GWASs (Ware et al., 2018). In this study, we
use two polygenic score to measure someone’s genetic predisposition to smoking
behaviour. The first polygenic score is based on the results of a GWAS on smoking
initiation, and measure someone’s genetic predisposition to start smoking. The
second polygenic score is based on the results of a GWAS with the number of
cigarettes smoked per day as dependent variable. As such, the second score
reflects someone’s genetic predisposition to heavy smoking. Hence, the first
polygenic score reflects the genetic predisposition for smoking on the extensive
margin, and the second one reflects the genetic predisposition for smoking on
the intensive margin. The weights for constructing the polygenic scores come
from the GWAS conducted by the Tobacco and Genetics Consortium (Tobacco and
Genetics Consortium, 2010). To facilitate an easy interpretation of the results,
the polygenic scores are standardized such that they have mean 0 and a standard
deviation of 1 in the analysis sample. Higher values reflect a higher genetic
predisposition to smoking behaviour.
5.2.4 Covariates
For comparability purposes, the choice of individual level control variables is
based on the studies by Fletcher and Fontana (Fletcher, 2012, Fontana, 2015). We
include an individual’s gender as a covariate, to control for differences between
males and females. Furthermore, we add the individual’s birth year to account
for possible age specific differences in smoking behaviour. Furthermore, we
added birth year squared, to account for possible non-linearity in age effects. We
account for the socio-economic status of the respondent by including individual
income (as imputed by the RAND Corporation, see (Hurd et al., 2016)) and years
of education (self-reported by participants) in the model.
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Although Fontana controls for the change in health status in his models, we
abstain from it because of possible endogeneity issues. Compared to Fletcher’s
model, we do not control for race/ethnicity because we restrict our sample to indi-
viduals of recent European ancestry. This is a recommendation of the genotyping
center, as this restriction pre-empts possible bias from unobserved relationships
between genetic and environmental factors (i.e., population stratification, (Weir,
2012)). To deal with subtle forms of population stratification in the analysis
sample, we include the first 10 genetic principal components of the genetic re-
lationship matrix as control variables (Ware et al., 2018). It has been shown
that the inclusion of principal components solves the problem of population
stratification adequately in the HRS (Rietveld et al., 2014a).
Finally, we include both state dummies and wave dummies to account for
differences across states and over time.
5.3 M E T H O D S
To test for the presence of an effect of the interaction between someone’s genetic
predisposition to smoking behaviour and tobacco excise taxes on smoking out-
comes, we use a moderation framework for both smoking initiation and smoking
intensity. The baseline regression for smoking initiation is given by:
Sist =α0 +α1Taxst +α2G i +α3G iTaxst +α4X ist +Ss +Dt +εist, (5.3)
where Sist is a binary variable indicating whether individual i residing in state s
in year t smokes or not, Taxst represents the cigarette tax in state s at year t, and
G i is the value of the polygenic score for individual i. X ist represents the vector
of individual-level control variables. The α’s represent the corresponding effect
size estimates for these variables. The vectors Ss and Dt are vectors for state and
year fixed effects. Lastly, εist denotes the error term. Despite the binary nature
of Sist, we estimate the model using linear regression to make the interpretation
of the coefficient more straightforward and to avoid the difficulties surrounding
the estimation of interaction effects in non-linear models.
The response to the taxes in terms of tobacco consumption is estimated by:
Cist =β0 +β1Taxst +β2G i +β3G iTaxst +β4X ist +Ss +Dt +τist, (5.4)
where Cist denotes the number of cigarettes smoked per day by individual i at
time t in state s. In this regression, the β’s are the effect size estimates and τist
is the residual term. We estimate this model both in the full sample and in the
subsample of smokers, because non-smokers are not likely to start smoking after
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an increase of excise taxes.
5.4 R E S U LT S
Table 5.1 contains the descriptive statistics of the analysis sample. It contains
information about the full sample and the subsample of current smokers. Static
variables are constant over the waves of data collection, dynamic variables can
take different values over time. Not surprisingly, the means of the polygenic
scores for smoking behaviour as well as the smoking prevalence and the number
of cigarettes smoked per day are relatively high in the subsample of current
smokers. Besides these differences, there are only small differences between the
full sample and the subsample of smokers with respect to birth year and income.
Figure 5.1 shows that there is a gradual increase of tobacco excise taxes over
time and that there is considerable variation across states regarding the level of
tobacco excise taxes imposed.
TABLE 5.1 – Descriptive statistics analysis sample.
Subsample of
Full sample current smokers
Static variables Mean Std. Dev. Mean Std. Dev.
Female 0.570 0.495 0.563 0.496
Birth Year 1941 11.939 1944 10.473
Years of education 13.265 2.529 12.565 2.349
PGSSmoking Initiation 0.000 1.000 0.140 0.964
PGSSmoking Intensity 0.000 1.000 0.094 1.005
Dynamic variables Mean Std. Dev. Mean Std. Dev.
Currently smoking 0.139 0.346 1.000 0.000
Ever smoked 0.575 0.494 1.000 0.000
Cigaretes per day 2.398 7.394 17.277 11.698
Income 16,323 42,721 16,053 30,775
Married 0.663 0.473 0.616 0.486
Individuals 12,089 2,643
Observations 98,605 13,642
Notes: Std. Dev. = Standard deviation.
Table 5.2 present the results of the model explaining whether an individual
is currently smoking. Column 1 shows that state-level tobacco excise taxes are
negatively associated with the dependent variable, and that the polygenic score
for smoking initiation is positively associated with smoking. Both these results
are in line with expectations. In terms of effect sizes, an increase of excise taxes
by 1% reduces the likelihood of smoking by about 6 percentage points, and an
increase of one standard deviation in the polygenic risk score increases the chance
of smoking by about 2 percentage points.
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FIGURE 5.1 – The average, minimum and maximum tobacco excise taxes
levied per pack of 20 cigarettes in the United States from 1992 to 2014.
In Column 2, the interaction between the state-level tobacco excise taxes and
the polygenic score for smoking initiation has been added to the model. This
interaction term is significantly negative, indicating that high excise taxes on
tobacco make those with a high genetic predisposition for smoking less likely to
smoke. Column 4 shows that upon inclusion of state and wave fixed effects, the
coefficient for the tobacco excise taxes becomes insignificant. This change can
be explained by the fact that tobacco taxes within a state tend to increase in a
monotonic fashion. These dynamics are absorbed by the state and wave dummies.
However, the interaction term between the polygenic score and the tobacco excise
taxes remains statistically significant in Column 3.
Table 5.3 presents the results of the regressions explaining someone’s smoking
intensity (the intensive margin, in terms of cigarettes per day). In Column 1
(Full sample) and Column 4 (Subsample of current smokers), tobacco excise taxes
are significantly negatively associated with the number of cigarettes smoked per
day. In terms of effect sizes, an increase of excise taxes by 1% reduces cigarette
consumption by 1.46 cigarettes per day in the full sample, and 3.29 cigarettes
in the sample of current smokers. The polygenic score is again predictive of
smoking behaviour (one standard deviation increase in the polygenic score leads
to an increase in consumption of 0.17 cigarettes per day in the full sample and
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TABLE 5.2 – Results of the regressions explaining someone’s current smoking
status.
(1) (2) (3)
Log(Tax) -0.060∗∗∗ -0.060∗∗∗ 0.003
(0.004) (0.004) (0.004)
PGSSmoking Initiation 0.020∗∗∗ 0.021∗∗∗ 0.021∗∗∗
(0.004) (0.004) (0.004)
Log(Tax) × PGSSmoking Initiation -0.008∗ -0.010∗∗
(0.003) (0.003)
Female -0.028∗∗∗ -0.028∗∗∗ -0.029∗∗∗
(0.004) (0.005) (0.005)
Birth Year -0.000 0.000 -0.088
(0.078) (0.079) (0.077)
Birth Year2 0.000 0.000 0.000
(0.000) (0.000) (0.000)
Income (in USD 1,000) -0.000∗∗∗ -0.000∗∗∗ -0.000∗∗∗
(0.000) (0.000) (0.000)
Years of Education -0.018∗∗∗ -0.018∗∗∗ -0.017∗∗∗
(0.001) (0.001) (0.001)
Married -0.086∗∗∗ -0.086∗∗∗ -0.090∗∗∗
(0.007) (0.007) (0.007)
State & Wave Dummies No No Yes
Observations 97,984 97,984 97,984
Individuals 12,058 12,058 12,058
R2 0.0737 0.0740 0.0850
Notes: Standard errors in parentheses (clustered by state and indi-
vidual); Coefficients for the principal components are not reported,
but available upon request from the authors; ∗ p < 0.05, ∗∗ p < 0.01,
∗∗∗ p < 0.001.
an increase of 0.47 in the subsample of current smokers). Column 2 and Column
5 show that the interaction effect is negative but insignificant. When comparing
the results in the full sample with those in the subsample of current smokers,
we observe that the effect sizes are relatively large in the latter subsample. The
estimates suggest that current smokers are more receptive to differences in
taxes. This could be explained by the fact that smokers are able to reduce their
smoking intensity, whereas in the full sample the non-smokers are not likely
to change their smoking behaviour (i.e., to start smoking). When adding state
and wave dummies (Column 3 and 6), the effects of the taxes are again rendered
insignificant.
In sum, the present results suggest that the interaction between the state-
level tobacco excise taxes and someone’s genetic predisposition to smoking im-
pacts whether someone smokes or not (the extensive margin), but not the number
of cigarettes someone consumes (the intensive margin).
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TABLE 5.3 – Results of the regressions explaining someone’s current smoking
intensity.
Full sample Subsample of current smokers
(1) (2) (3) (3) (5) (6)
Log(Tax) -1.460∗∗∗ -1.459∗∗∗ 0.024 -3.285∗∗∗ -3.262∗∗∗ -0.111
(0.098) (0.098) (0.146) (0.314) (0.309) (0.457)
PGSSmoking Intensity 0.165∗∗ 0.172∗∗ 0.180∗∗ 0.467∗ 0.455∗ 0.495∗
(0.058) (0.060) (0.061) (0.213) (0.205) (0.217)
Log(Tax) × PGSSmoking Intensity -0.078 -0.080 -0.297 -0.317
(0.059) (0.058) (0.200) (0.197)
Female -0.953∗∗∗ -0.953∗∗∗ -0.991∗∗∗ -3.556∗∗∗ -3.562∗∗∗ -3.825∗∗∗
(0.100) (0.099) (0.101) (0.393) (0.393) (0.403)
Birth Year 0.994 0.985 -1.106 13.490 13.340 12.200
(1.569) (1.568) (1.535) (7.091) (7.102) (7.197)
Birth Year2 -0.000 -0.000 0.000 -0.003 -0.003 -0.003
(0.000) (0.000) (0.000) (0.002) (0.002) (0.002)
Income (in USD 1,000) -0.005∗∗∗ -0.005∗∗∗ -0.007∗∗ -0.008 -0.007 -0.012∗
(0.002) (0.002) (0.002) (0.005) (0.005) (0.006)
Years of Education -0.347∗∗∗ -0.347∗∗∗ -0.340∗∗∗ -0.310∗∗ -0.309∗∗ -0.295∗∗
(0.024) (0.024) (0.023) (0.091) (0.090) (0.088)
Married -1.568∗∗∗ -1.569∗∗∗ -1.659∗∗∗ -0.588 -0.594 -0.973∗∗
(0.125) (0.125) (0.124) (0.303) (0.302) (0.295)
State & Wave Dummies No No Yes No No Yes
Observations 97,955 97,955 97,955 13,491 13,491 13,491
Individuals 12,058 12,058 12,058 2,614 2,614 2,614
R2 0.0597 0.0598 0.0726 0.0648 0.0651 0.0974
Notes: Standard errors in parentheses (clustered by state and individual); Coefficients for the principal
components are not reported, but available upon request from the authors; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗
p < 0.001.
5.5 D I S C U S S I O N A N D C O N C L U S I O N
The present study shows that someone’s genetic predisposition to smoking be-
haviour moderates the impact of tobacco excises taxes on tobacco usage. However,
this interaction does not have a meaningful impact on the total number of
cigarettes consumed. These findings suggest that excise taxes are an effective
method to reduce tobacco usage, even among the group with a high genetic pre-
disposition towards smoking. Even more, those with a high genetic predisposition
to smoking respond most strongly to changes in tobacco excise taxes.
Although Fletcher (Fletcher, 2012) was the first to show that only individuals
with a certain genetic variant respond to increases in excise taxes, Fontana
provided evidence that population stratification was driving these initial results
(Fontana, 2015). However, based on a weighted combination of multiple (approx-
imately 700,000) genetic variants, i.e., a polygenic score, in the present study
we do find again a significant interaction effect along the inclusive margin for
smoking. The sample restriction to individuals of European ancestry and the in-
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clusion of principal components makes that the present findings are not likely to
be driven by (subtle forms of) population stratification. As such, the present find-
ings contribute to the literature analyzing heterogeneity in smoking behaviour
(Nesson, 2017). In line with the findings of Fontana (Fontana, 2015), we do not
find a significant impact of the interaction between the genetic predisposition
to heavy smoking and excise taxes on someone’s smoking intensity. Even in the
subsample of current smokers, we could not detect such an effect.
Considering all findings jointly, it seems puzzling that the interaction between
the genetic predisposition to smoking and tobacco excise taxes does impact the
decision to smoke but not the total number of cigarettes consumed. A possible
solution for this puzzle could be that there is considerable misreporting in the
number of cigarettes smoked, making that the estimated results along the in-
tensive margin are less precise. In the data, the reported number of cigarettes
consumed is often a multiple of 5 which does indeed suggest there may be consid-
erable measurement error present in this variable. Therefore, we caution that
the results along the intensive margin are currently inconclusive.
The present study is not without limitations. Importantly, HRS participants
are only surveyed every two years. In the analyses, we therefore used the excise
taxes one year before each smoking measurement. This may be less suitable if
the response time to increases in excise taxes differs among individuals. Also,
individuals who live close to the border of a state could purchase their tobacco in
the neighbouring state with a lower excise tax on tobacco (Chiou and Muehlegger,
2008). In our analyses, we cannot rule out whether this is driving our results
but we note that this may also be another reason for why the results along the
intensive margin are inconclusive. Another limitation of the current sample is
that it is a representative sample of older Americans only. As over time only the
most addicted individuals are likely to remain smoking, this set of individuals
might be particularly insensitive to change in excise taxes. At the same time, the
prevalence of smoking in this age cohort is relatively high making it particularly
suitable to study smoking behaviour. Therefore, we consider the replication of
the present results in a younger sample to be particularly relevant. Finally,
the polygenic scores used in this study are predictive of smoking behaviour,
but, as outlined by Dudbridge (Dudbridge, 2013), the predictive power of a
polygenic score is (amongst others) a function of the GWAS sample size. A larger
GWAS sample would lead to more accurate effect estimates and hence a more
predictive polygenic score. When such polygenic scores become available, it
may be worthwhile to repeat the present analyses to see whether also genetic
heterogeneity in responses to excise tax can be detected along the intensive
margin for smoking.
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From a policy perspective, our findings suggest that there is genetic hetero-
geneity in response to excise taxes. Individuals with a high genetic predisposition
towards smoking respond stronger to tobacco excise taxes compared to individu-
als with a lower genetic predisposition. Further research is needed to understand
what exactly makes that those with a low genetic propensity for smoking to
respond relatively mildly to changes in tobacco excise taxes. Possibly, the nature
of their smoking behaviour (e.g., recreational use) differs from those with a high
genetic predisposition for smoking (who may be more likely to be addicted to
smoking). If so, the present study suggests that different policies for genetically
different types of individuals are needed to bring down smoking in the population.
Moreover, if true, then the present results provide a possible explanation for why
the decrease in cigarette consumption stalled over the past years: The reasons
for why current smokers keep smoking the number of cigarettes they have been
smoking are difficult to manipulate by further increases of tobacco excise taxes.
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Multivariate GREML finds shared genetic
architecture of 76 brain traits and intelligence
Ronald de Vlaming, Eric A.W. Slob, Philip R. Jansen, Philipp D.
Koellinger, Patrick J.F. Groenen, Cornelius A. Rietveld
Abstract
Global grey matter volume and the sizes of several specific brain areas are pos-
itively associated with intelligence in human populations. Although current
methods are able to estimate bivariate genetic correlations between two of such
traits, they are not able to estimate genetic correlations across more than two
traits simultaneously. We developed a multivariate linear mixed model and
optimization procedure to simultaneously analyze the genetic correlations among
76 brain regions and 10 behavioral outcomes, including intelligence and educa-
tional attainment. Compared to the existing bivariate approach, our method is
faster and able to guarantee the internal consistency of the estimated genetic
correlation matrix. Based on a sample of 14,341 unrelated individuals from the
UK Biobank, we find genetically distinct clusters across brain areas, one of the
’older’ part of the brain (cerebellum and brain stem), and one of the newer part of
the brain (the neocortex). These findings suggest that our current way of thinking
about the brain makes sense from a genetics perspective.
This chapter is based on Slob et al. (2018).
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6.1 I N T R O D U C T I O N
Through Genome-wide Association Studies (GWASs), thousands of single-nucleotide
polymorphisms (SNPs) have been associated with a range of human traits
(Buniello et al., 2019, Visscher et al., 2017a). Still, together these SNPs do
not fully account for the twin heritability of traits. Genome-based Restricted
Maximum Likelihood (GREML) estimation has been developed to estimate the
proportion of the variation in a trait that can be explained by a scan of SNPs
(the so called SNP-heritability) across the whole genome using observed genetic
similarities among unrelated individuals in a population (Yang et al., 2010). The
bivariate extensions of this method enabled the estimation of the genetic correla-
tion between two traits (Lee et al., 2012). One often combines the estimates of
pairwise combinations of traits into a multivariate genetic correlation matrix in
case one is interested in the genetic correlation across more than two traits (e.g.,
Power and Pluess (2015)). However, this ‘pairwise bivariate’ approach may result
in a genetic correlation matrix which is not internally consistent (i.e., it may not
be positive semidefinite). Next to this, the corresponding standard errors of this
‘pairwise bivariate’ genetic correlation matrix do not fully reflect the structure
of the data. We develop a multivariate extension of the GREML method which
guarantees the internal consistency of the resulting genetic correlation matrix,
and which produces corresponding standard errors does reflect the full data
structure.
To deal with the computational complexity of the model, we developed an
improved optimization procedure. With a precomputed eigendecomposition of the
individual-by-individual genomic-relatedness matrix, the computational complex-
ity of our method is of the order NT5 (where N denotes the number of individuals
and T the number of traits). For comparison, the bivariate GREML approach
has a computational complexity of the order NT6. Central in the optimization
procedure is the transformation of the vector of correlated traits into a new vector
of uncorrelated traits. As a result, our procedure improves over the ‘pairwise
bivariate’ approach by guaranteeing that standard errors across traits are correct
by taking into account the full data structure. Hence, the results of methods using
a multivariate genetic correlation matrix as input, such as genomic structural
equation modeling (Grotzinger et al., 2019), may improve when the results of the
method proposed here are used as input compared to when one uses results of
this ‘pairwise bivariate’ method.
We used multivariate GREML to analyze the shared genetic architecture
of the human brain (76 cortical and subcortical structures) and 10 behavioral
traits. Recent GWASs (Zhao et al., 2019, Grasby et al., 2020) reported several
significant genetic correlations between some grey matter volumes and neu-
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ropsychiatric/cognitive and behavioral traits using bivariate LD-score regression
(Bulik-Sullivan et al., 2015) . Whereas we analyze more brain regions than these
studies do (we include both cortical and subcortical areas), the main advantage
of our approach is that we do not need to take the intermediate GWAS step and
hence our inferences are stronger given a certain sample size (see Ni et al. (2018)
for a comparison between LD score regression and GREML).
Our findings suggests that the evolutionary more conserved areas of our
brain are more genetically determined compared to the evolutionary more re-
cent areas of the brain, as the heritability of the older parts (cerebellar and
subcortical structure) is much higher compared to the heritability of the new
parts of the brain (frontal part of the cortex). Furthermore, our multivariate
GREML identifies two clusters in the brain based on genetic correlations: one
in the subcortical areas of the brain (cerebellar and subcortical structures) and
one in the cortical area (including frontal, temporal, and parietal lobes). Our
results confirm that the current way of partitioning the human brain into broad
anatomical areas closely follows the genetic pattern across the regions. When we
link these genetic correlations to our behavioral traits, we can confirm previous
found relationships, such as a relation between the cerebellum and visual spatial
memory. Furthermore, we confirm the strong genetic similarity between intelli-
gence and educational attainment. Next, we find a link between cerebral atrophy
and alcohol consumption. Lastly, a link is found between subjective well-being
and the temporo-occipital part of the middle temporal gyrus.
6.2 D A T A : U K B I O B A N K I M A G I N G S T U D Y
In total, we analyzed 86 phenotypes from UK Biobank (UKB) participants of
European ancestry. Among these phenotypes, are 74 measures of relative grey
matter volume of brain parts obtained using T1-weighted structural imaging.
These volume measures are derived from UKB Category 1101. In the Supplemen-
tary Material, a full description of variables is given. For each subcortical region,
the left and right volume were added and divided by the total volume to come
to relative volumes. Next to these brain measures, we have the total volume
of both grey and white matter, the total volume of grey matter only, and some
other anthropometric measures, such as height, body mass index. Lastly, we
have some behavioral traits: IQ, educational attainment, visual memory, reaction
time, neuroticism, subjective well-being, depression, and alcohol consumption.
We restrict our sample such that we exclude individuals with brain damage
1The original measurements were performed with a standard Siemens Skyra 3T running VD13A
SP4 (as of October 2015) with a standard Siemens 32-channel RF receive head coil. The full UK
Biobank imaging protocol can be found at http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=1977
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(identified using the medical records). Next, we restrict our sample such that we
have fully balanced data. The full pipeline and quality control protocols can be
found in the Supplementary Materials 4.
6.2.1 Phenotypic covariates
Several control variables are included in the models to account for spurious cor-
relations across the phenotypes. We opt for a more conventional set of confounds.
This means we correct for age, age squared, age cubed, sex, sex × age, sex ×
age squared, sex × age cubed, batch number (used as a dummy variable) and an
intercept.
Furthermore, for the IQ-measurement we employ some additional covariates.
Some participants only did the touch screen based test once, whereas others did
multiple touch base tests and even a web based tests. The selection for moments
of measurement and number of tests appears to be non-random. Next to that,
there seems to be a learning effect in these sort of tests, where individuals who
did the test before score higher compared to individuals who did the test for the
first time. Hence, we add covariates for the average IQ-measurement to take into
account learning effects and participation across waves. Last, as there are effects
of being at a certain age at the moment of testing, we use the age at the moment
of testing.
6.2.2 Genetic covariates
To measure genetic relatedness between individuals, we use the genomic related-
ness matrix (Yang et al., 2010). To calculate the GRM, we restrict our SNPs to all
HapMap 3 SNPs (International HapMap 3 Consortium, 2010) and the SNPs that
have imputation quality of over 0.9. This imputation threshold considered to be a
quite conservative approach (Verma et al., 2014). Furthermore, we restrict SNPs
to have at least a minor allele frequency of 1%, a missingness per marker of 5%,
an Hardy-Weinberg-Equilibrium-test p-value below 0.001. These are all standard
quality control filters. Furthermore, we exclude individuals with a SNP-missing
value of 5% and over. For individuals that are too closely related, we drop one
of each pair. We use a relationship cutoff of 0.025, this maximum relatedness
approximately corresponds to cousins two to three times removed.
Next to these corrections to our phenotypes, we also do corrections on the
genetic measurement. As the genotyping of participants in UKB was done in
batches on different platforms, there can be differences in imputation quality
based on these different batches and platforms. After doing an F-test, it turns
out that there is no difference in model fit if we use batch dummies or only a
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platform dummy (P-value = 1.000). Hence, we opt to only correct for the platform
dummies.
Moreover, to control for subtle forms of population stratification in the analysis
sample, we include the leading 20 genetic principal components to account for
population structure (Browning and Browning, 2011). Furthermore, we correct
for the long range-LD regions (Price et al., 2008) as identified by Linnér et al.
(2019).
6.3 M E T H O D S
The most frequently used method to find associations between individual SNPs
and a quantitative trait of interest is a genome-wide association study (GWAS).
In a GWAS, a simple regression is performed in the following simple regression
model
yi =µ+ xikbk +εi, (6.1)
where yi is the value of the phenotype for individual i, µ is the intercept, xik is
an indicator variable that takes values 0, 1 or 2 if the genotype of individual i
at SNP k is aa, Aa or AA, respectively. The corresponding allelic effect of SNP
k for trait is bk, and finally a residual term εi identically and independently




, where σ2e the residual variance for the trait. If all
causal variants are known, they can be added into one single model for the trait:







where g i is the total genetic contribution of all SNPs for individual i, m is the
total number of causal loci , uk is the scaled effect of causal SNP k, and sik is stan-
dardized genotype of individual i at SNP k (that is, sik = xik −2 fk/
√
2 fk (1− fk)
with fk the frequency of the minor allele at locus k). Observe that (6.2) can be
rewritten in matrix notation as y = µ1+g+ ε and g = Su. Now, u is treated
as a random effect that follows the distribution u∼N (0,σ2uI), where σ2u is the
variance of causal effects. As a result, the distribution of the total genetic con-
tribution is multivariate normally distributed as g ∼ N (0,σ2uSS>). Now, σ2g
(= mσ2u) can be interpreted as the variance of the total additive genetic effects.






where G (= m−1SS>) is the genetic relationship matrix between pairs of individ-
uals at causal loci. With the equation above, we can estimate the SNP-based
heritability h2 of a trait as σ2g/(σ
2
g +σ2e).
However, in practice the causal variants are unknown and hence we can-
not obtain the genetic relationship matrix G directly. This G matrix can be
approximated by applying the same formula to a genome-wide sample of SNPs
X∗ instead of S, that is,
A= M−1X∗X∗> , (6.4)
where M is the total number of SNPs used in the standardized genome-wide sam-
ple X∗, such that x∗i j = (xi j −2 f i)/
√
2 f i(1− f i) where again f i is the minor allele
frequency at SNP i. There are more efficient ways of creating this approximation,
see e.g. Yang et al. (2010) and VanRaden (2008).
From here, we extend the previous univariate model in (6.1) to a multivariate
model with T different phenotypes yt. Then, we can model not only the genetic
and environmental variances for each of the T phenotypes but also their covari-
ances in the T ×T matrices VG and VE . Let y now be the stacked vector of all T
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where Z∗ is the N ×P incidence matrix containing the P covariates for N indi-
viduals, γt is a P vector of fixed effects for trait t (hence we allow trait-specific
covariates), X∗ is the N ×M incidence matrix containing all SNPs, βt is an M
vector of additive genetic values for trait t, and εt represents the residual for
trait t. Model (6.5) can equivalently be written as:
y=Zγ+Xβ+ε, (6.6)
where ε∼N(0,VE ⊗IN ) and β∼N(0,VG ⊗IP ). Here, ⊗ denotes of the Kronecker
product and I j is the j× j identity matrix. The main interest here lies in the
genetic covariance matrix VG , of which the off-diagonal elements give information
about the shared genetic architecture between the different traits. Note that for
VG and VE to be covariance matrices, they must be constrained to be positive
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semidefinite.
To estimate the the genetic and environment covariance matrices VG and
VE in the model of equation (6.6), we use a maximum likelihood approach. As
an optimization method, we employ the quasi-Newton approach of the Broyden-
Fletcher-Goldfarb-Shanno (BFGS) algorithm. For this algorithm, computationally
efficient expressions are needed for the log-likelihood, the gradient, and the
average information matrix. These expressions can be found in Supplementary
Material 1. We ensure the positive semidefiniteness of the genetic correlation
matrix (this is a need for internal consistency between the correlations of the
random variables) by optimizing over the triangular elements of the Cholesky
decomposition of the variance-covariance matrix.
6.4 R E S U LT S
From the UK Biobank sample (Sudlow et al., 2015), we selected 14,341 unrelated
individuals. We then estimated their pairwise genetic relationships using all
autosomal SNPs that pass our quality control protocol and retained 14,341
individuals whose pairwise relationship was estimated to be less than 0.025.
We fitted a multivariate mixed linear model to 86 phenotypes using our BFGS
algorithm.
From the proportions of phenotypic variance explained by the autosomal
SNPs (Figure 6.1 a-b), we observe that the SNP-based heritabilities are relatively
high in the cerebellar and subcortical structures of the brain (mean SNP h2:
33% and 31% with average standard error of 5%) and lower in the frontal part
of the cortex (mean SNP h2: 23% with average standard error of 5%). A full
table of heritability estimates with corresponding standard errors can be found in
Supplementary Materials 5. This suggests that the evolutionary more conserved
areas of our brain are more heritable determined compared to more evolutionary
recent areas of the brain (Rakic, 2009), such as the neocortex.
Next, we investigated the extent to which cortical and subcortical areas are
influenced by the same genetic factors. By estimating the genetic correlations
among the relative brain volumes, we observe a cluster of correlations in the
subcortical areas of the brain (cerebellar and subcortical structures, Figure 6.1
c-d). In addition, we identify a second cluster that captures correlations between
cortical correlations, including the frontal, temporal, and parietal lobes.
To identify whether there are specific clusters within the observed genetic
correlation matrix, We used Ward’s method for hierarchical clustering to create
a dendogram (Figure 6.2). We observe five different clusters in the genetic
correlation matrix. The first cluster represents the frontal cortex of the brain, the
second the cerebellum, the third the brain stem, and the last two are a mixture of
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temporal and occipital parts. This suggests that the current way of partitioning
the human brain into these broad anatomical areas closely follows the genetic
differences observed across the regions (Standring, 2015), as the current regions
share a similar genetic architecture.
In order to find clearer links between the behavioral traits and the brain
regions, we create spatial mappings of the genetic correlation with the brain
regions for each behavioral trait. Here we run into the issue that due to our
limited sample size, our standard errors are quite large for the genetic correlation
estimates (average standard error of 0.17). Hence, we will look mostly at effect
sizes instead of significance. Still, our results should be interpreted with great
care due to this limitation. Regarding the genetic correlations between regions
and behavioral traits, we observe a fair positive genetic correlation (ρ = 0.25
with standard error 0.17) between the Cerebellum VIIIb and visual spatial
memory (Figure 6.3 a). This relationship has been suggested in earlier phenotypic
studies (Molinari et al., 2004). For intelligence and educational attainment, the
strongest correlations are found in the frontal lobe region (Figure 6.3 b-c). The
strong genetic similarity between intelligence and educational attainment has
been established in earlier studies (Allegrini et al., 2019). We find a strong
negative genetic correlation between the cerebellum and the number of alcoholic
drinks consumed per week (Figure 6.3 d, average correlation ρ =−0.08, strongest
observed genetic correlation ρ =−0.23 with Vermis VI with standard error 0.16),
which fits with earlier findings that cerebral atrophy is a common feature in
alcoholics (Luo, 2015) 2. For depression, the strongest genetic correlation is
found in the cerebellum (Figure 6.3 e). For subjective well-being, we confirm
the previously observed strong link to the temporooccipital part of the Middle
Temporal Gyrus (Figure 6.3 f)(Song et al., 2019).
2Our findings do not suggest a direction of effect here, as it could be that consuming more alcohol
leads to a reduced cerebellum size, or that a smaller cerebellum leads to individuals consuming more
alcoholic drinks. Previous findings suggest that alcoholic abuse causes cerebral atrophy, hence that
seems to be the most likely explanation.
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FIGURE 6.1 – Spatial mapping of the estimates for SNP-based heritability
and genetic correlation across the different brain regions, SNP-based her-
itability per anatomical area, and genetic correlation table of aggregated
anatomical area. a, Spatial mapping of the SNP-based heritability of the
different brain regions, where blue dots represents a low heritability and
yellow represents a high heritability. b, Boxplot of the SNP-based heritability
per brain region. c, Spatial mapping of the genetic correlation across different
anatomical regions in the brain, where blue vertices represent a negative cor-
relation and red vertices a positive correlation. d, Average genetic correlation
between the different anatomical areas in the brain.
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FIGURE 6.2 – Clusters are identified using Ward’s method with a D2 ward
for hierarchical clustering. This method minimizes the error sum of squares
by agglomerating clusters each step (see Kaufmann and Rousseeuw (1990) for
more details). The colors represent the different clusters, where the number of
clusters is identified using the elbow method.
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FIGURE 6.3 – Spatial mapping of the genetic correlation between brain
regions and the behavioral traits, where blue points represent a negative
correlation and red points a positive correlation. a, Spatial mapping of
the genetic correlation between visual spatial memory (measured using a
pairs-matching test) and the different brain regions. b, Spatial mapping
of the genetic correlation between intelligence (measured using a fluid in-
telligence score) and the different brain regions. c, Spatial mapping of the
genetic correlation between Educational attainment (measured using years of
education) and the different brain regions. d, Spatial mapping of the genetic
correlation between Drinks per week (measured on a logarithmic scale) and
the different brain regions. e, Spatial mapping of the genetic correlation
between depression score (measured by logarithm of first PC of depression
intensity and frequency) and the different brain regions. f, Spatial mapping
of the genetic correlation between subjective well-being (measured by average
happiness over time) and the different brain regions.
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6.5 D I S C U S S I O N
Our multivariate GREML method enabled us to reveal distinct clusters of ge-
netic correlations between brain areas as well as genetic correlations between
brain regions and behavioral traits. We find that there are strong differences
in heritability across the anatomical areas in the brain, where the more central
anatomical areas have higher heritability compared to the outer parts of the
brain. The behavioural traits have even lower heritability. Our findings confirm
that the current way we think of brain anatomy makes sense from a genetic
perspective. Next to this, we find strong genetic correlation between several
behavioural traits and different anatomical areas of the brain.
To ensure our findings were not realised by data ascertainment or spurious
associations, several quality control measures were taken. We carefully adjusted
phenotypes for systematic differences, such as age, and sex, and applied thorough
quality control to the SNP data (see Supplementary Material 4 for the full
pipeline). We restricted our sample such only unrelated individuals of recent
European ancestry were included. To deal with subtle population stratification,
we performed our REML analysis by fitting the first 20 principal component
of the genetic relatedness matrix as covariates. Next to this, we corrected for
the different platforms used for genotyping the study participants. Given the
conservative approach taken in our SNP and individual selection, our results
are unlikely to be biased by population stratification. However, one could opt
for an even more conservative approach as suggested by Alfaro-Almagro et al.
(2020). Their suggested covariates (322 principal components) are able to soak
up 99% of the variance in control variables. However, we opt to not take this
approach as it is unclear what exactly these covariates capture. Furthermore,
it could lead to Berkson’s paradox, which can happen when one adjusts two
independent variables for a potential confound that was actually a consequence
of the independent variables (Berkson, 1946, Zhang, 2008, Pearl et al., 2009).
This leads to a spurious association between the independent variables that can
be incorrectly induced.
To confirm that our results are not only a reflection of the proximity of brain
regions (brain regions physically close could be more strongly correlated), we
reran the multivariate GREML model with covariates for the distance between
the different regions (results available upon request from the authors). Although
the resulting genetic correlations are somewhat smaller (≈ 25% smaller on aver-
age), also after correcting for proximity the main patterns are still observed. This
suggests that our found patterns are not purely driven by proximity between
regions.
In our main analyses, we analyzed relative brain volumes (i.e. relative
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volume of grey matter in Frontal Medical Cortex) . Previous findings suggest
that the size of the brain is positively associated with intelligence (Nave et al.,
2019). Therefore, it might be worthwhile to do the same analyses for absolute
volumes instead of relative volumes, as this relative measure is unable to pick up
differences in total size of the brain. With the new UK Biobank imaging release,
we plan to do this new analysis.
Since some regions in the brain have more sub regions, it could be that our
results may be somewhat driven by this difference, as it places more weight on
the higher represented regions compared to regions with fewer sub regions. To
get a grasp of how this influences our analysis, a robustness check was performed
where all the sub regions were aggregated into one larger region. This did not
have strong effect on the correlations between the brain regions and behavioral
traits.
Genetic correlations are informative about the genetic overlap between sets
of traits (Lynch and Walsh, 1998). The popularity of GREML as a method to
estimate SNP-based heritability, and the importance of the estimation of genetic
correlation, makes us to conclude that the method proposed here may help to
advance our understanding of the multivariate genetic nature of human traits.
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6.A M E T H O D D E R I VA T I O N
A maximum likelihood approach is taken to estimate the genetic and environment
covariance matrices VG and VE in the model of equation (6). In this section, effi-
cient expressions are derived that are fundamental to make their estimation com-
putationally feasible for reasonably large data sets. As an optimization method,
we employ the quasi-Newton approach of the Broyden-Fletcher-Goldfarb-Shanno
(BFGS) algorithm. For this algorithm, computationally efficient expressions are
needed for the log-likelihood, the gradient, and the average information matrix.
To arrive at the algorithm and derive standard deviations of the estimates, the
following steps are taken:
1. Remove the effect of the covariates Z.
2. Reparametrize the covariance matrices VG and VE to guarantee their
positive semi-definiteness.
3. Express the log likelihood.
4. Maximize the likelihood in the unknown covariance matrices VG and VE
by the BFGS algorithm.
5. Formulate efficient expressions for the gradients, the determinants, and
the log likelihood needed for the BFGS algorithm.
6. Estimate the Fisher Information matrix for the variances and genetic
correlation matrix.
7. Derive expressions for the standard errors of the covariance matrices and
heritability estimates using a delta method.
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The multivariate GREML model from the main text is:
y=Zγ+Xβ+ε, (6.7)
where ε∼N(0,VE ⊗ IN ) and β∼N(0,VG ⊗ IM) and the vectors y and ε are of
length NT. Throughout these derivations, we will make use of the fundamental
property of linear combinations of multivariate normal distributed vectors, that
is, if vector δ∼N(µ,Σ), then the linear combination Cδ+m∼N(Cµ+m,CΣC>).
Applying this result to the last two terms of (6.7) implies that the linear sum Xβ+ε
is also normally distributed, that is, Xβ+ε∼N(0,X (VG ⊗IM)X>+VE ⊗IN ).
Step 1. Removing the effects of the covariates Z The main interest in this
paper is in estimating the genetic and environmental covariance matrices VG
and VE , not the weight vectors γ of the covariates. The same covariance matrices
can be obtained by removing the effects of the covariates Z by premultiplying
the phenotype vector y by the anti-projection matrix I−Z(Z>Z)−1 Z>. Additional
computational efficiency can be obtained by using the sparsity in our variance-
covariance structure.
Consider the singular value decomposition of
(
I−Z(Z>Z)−1 Z>)X = PΦQ>
with P the NT ×MT orthonormal matrix of left singular vectors, Φ the MT ×
MT diagonal matrix with nonnegative singular values, and Q the MT × MT




∼N (0,ΦQ> (VG ⊗IM)QΦ+P> (VE ⊗IN )P) . (6.8)
Next, we will look into the partitioned block structure of X and Z to simplify
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Because X has a similar block structure as the antiprojection matrix of Z, more
efficient expressions are possible. Denote the singular value decomposition of
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X∗ =P∗Φ∗Q∗> . (6.10)
This gives us easy expressions for
P=

P∗ 0 . . . 0
0 P∗ . . . 0
| | . . . |
0 0 . . . P∗
= IT ⊗P∗, (6.11)
Φ=

Φ∗ 0 . . . 0
0 Φ∗ . . . 0
| | . . . |
0 0 . . . Φ∗
= IT ⊗Φ∗, (6.12)
Q=

Q∗ 0 . . . 0
0 Q∗ . . . 0
| | . . . |
0 0 . . . Q∗
= IT ⊗Q∗. (6.13)
With these expressions , we can rewrite the variance of ỹ:
Var(ỹ)=ΦQ> (VG ⊗IM)QΦ+P> (VE ⊗IN )P









= (IT ⊗Φ∗) (VG ⊗IM)(IT ⊗Φ∗)+ (VE ⊗IN )
=VG ⊗Φ∗
2 +VE ⊗IN . (6.14)
Hence, ỹ∼N
(
0,VG ⊗Φ∗2 +VE ⊗IN
)
.
Step 2. Ensuring VG and VE to be positive semi-definite For VG and VE
to be covariance matrices, they need to be symmetric and positive semi-definite.
This requirement is enforced by reparametrizing these matrices by their Cholesky
decomposition, that is VG = ΓGΓ>G and VE = ΓEΓ>E where ΓG and ΓE are lower
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triangular matrices.
Step 3. Expression of the log likelihood To find estimates of VG and VE ,
we have to maximize the corresponding log-likelihood (where we denote the











































where ỹ>i is row i of the N ×T matrix Ỹ which is the unstacked version of ỹ.
This likelihood is also described in Yang et al. (2010), and is based upon previous
work by Casella and Searle (1985), Searle et al. (1992), and Harville (1977). This
approach is known as restricted maximum likelihood (REML).
Step 4. Maximize the likelihood by the BFGS algorithm To maximize the
likelihood, we use the quasi-Newton approach of the Broyden-Fletcher-Goldfarb-
Shanno (BFGS) algorithm (Nocedal and Wright, 2006). The reason for doing so is
that BFGS only needs gradient and function evaluations and that the updates
can be computed relatively fast. BFGS is a quasi-Newton method where each
update takes the form:
θk+1 = θk +αkpk, (6.16)
where α is the step size of the line search, k is an iteration counter, and pk is the
search direction defined by:
pk =−B−1k ∇log l (θk) , (6.17)
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with ∇log l (θ) the gradient of log l (θ) and the approximation of the inverse of the
Hessian B−1k+1 is defined by:
sk = θk+1 −θk =αkpk, (6.18)
dk =∇log l (θk+1)−∇log l (θk) , (6.19)
ρk = (s>k dk)−1, (6.20)
B−1k+1 = (I−ρkskd>k )B−1k (I−ρkdks>k )+ρksks>k . (6.21)
Then, the BFGS algorithm is defined by:
1. Given start θ0, convergence tolerance ε> 0, and B−10 = I.
2. k ← 0.
3. While ‖∇log l (θk)‖ > ε.
4. Compute search direction pk =−B−1k ∇log l (θk).
5. Set θk+1 = θk+αkpk where αk is obtained by a Golden section line search.
6. Compute B−1k+1 by (6.21).
7. k ← k+1.
8. End while.
Step 5a. Efficient expressions for evaluating log likelihood The BFGS
algorithm needs to do a line search and evaluate the log likelihood at several
points along the line θk +αpk for different α > 0. We chose to use the Golden
section to do so (Fletcher, 1991). Therefore, fast and efficient computations are
needed to do so.
Denote by V the variance of ỹ, that is V=VG ⊗Φ∗2 +VE ⊗IN . Observe that
this matrix has a block diagonal structure, where each block Vi =φ∗2ii VG+VE . Let
the eigenvalue decomposition of VE be given by DΛD>, where DD> =D>D= IT .







Λ1/2D> , where (6.22)
ṼG =Λ−1/2D>VGDΛ−1/2. (6.23)








































































where κt is the t-th diagonal entry of K, and λt is defined analogously with
respect to Λ. Now, the log determinant of V is given by:















The third part of the log-likelihood in (6.15) can be made computationally easier
































with F=R>Λ−1/2D>. Now, by combining the terms, we have a computationally
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Based on the above, to evaluate log l (θ) with θ = θk +αpk for a given value of
α, the following steps lead to a computationally efficient evaluation.
1. Compute the eigen decomposition of VE =DΛD>.
2. Compute ṼG =Λ−1/2D>VGDΛ−1/2 by (6.23).
3. Compute the eigen decomposition ṼG =RKR>.
4. Compute F=R>Λ1/2D>.































The order of the number of operations to compute the eigen decompositions in
Steps 1 and 3 is O(T3) (Demmel, 1997), and from the expressions it may be
verified that those in Steps 2 and 4 are O(T2), and in Step 5 O(NT2). As in our
applications N À T, the computational costs for a single function evaluation are
of the order O(NT2).
Step 5b. Efficient expressions for evaluating the gradient of the log
likelihood In the BFGS algorithm, we need to evaluate the gradient of the
log-likelihood, ∇log l (θk). For ease of notation we will drop the subscript k in this
section. Then, the gradient ∇log l (θk) has elements ∂log l (θk) /∂θ`. For a given
parameter θ` in set of parameters θ (using index ` without loss of generality),
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the gradient of the log-likelihood is given by:
∂log l (θk)
∂θ`




























Fỹi. Let us now consider an expression for
∂Vi
∂θ1
















Note that this derivative only differs across observations in scale (i.e., scaled
by φ∗
2
ii for i = 1, . . . , N). Also, ∂Γ>G /∂θ` has a special form, that is, it is a T ×T
matrix with all values being zero except a one in the position that corresponds
to θ` in ΓG . Suppose that θ` refers to element j, j′ of ΓG with j ≥ j′ as ΓG is a






results in a T ×T matrix of zeros except

























































































These derivatives of the environment term are equal across observations.
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Step 6. Estimating the Fisher Information Matrix The equations in the
next paragraph rely on the work by Fisher (1922), who introduced the method of
maximum likelihood and the maximum likelihood convergence theorem (Billings-
ley, 1995, p. 357). Here, we use the overview by (Lynch and Walsh, 1998, p.
853-856).
When Estimating a vector of parameters, we can use the Hessian matrix, the
matrix of second partials of the log-likelihood, to approximate the variance of our
parameters. Element i j is given by:




H(θML) refers to the Hessian matrix evaluated at our optimum θML and gives us
a measure of the curvatur eof our log-likelihood function at the optimum. Given
that calculating this Hessian H is a computational burden, we instead opt for a
different approach using the Fisher information matrix I(θML), the negative of
expected value of the Hessian matrix, that is:
I(θML)=−E [H(θML)] . (6.35)
This Fisher information matrix gives a measure of the multidimensional curva-
ture of the log-likelihood. Alternatively, one can calculate it using the expected










Now, the covariance matrix of our maximum likelihood estimates is simply the
inversion of the information matrix:
Var(θ̂ML)=I−1(θ̂ML). (6.37)
As we calculate the Fisher information matrix using the outer product of the
gradient, we have to calculate the gradient once more in this optimum. Now,
we can use (6.36) and (6.37) to calculate the standard errors of our parameter
estimates.
Step 7. Derive standard errors for correlation and heritability esti-
mates The estimation procedure returns the parametrization in terms of θ,
that is, in the Cholesky decompositions of VG and VE . Practically it may be more
interesting to consider instead the covariance matrices VG and VE , correlation
matrix, and the heritability estimates. In this section, the appropriate standard
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errors for these transformations are presented using the delta method.
The delta method states that for some function g(θ̂ML) the function in the






where ∇g(θ) is the gradient of g() with respect to θ. Below, the functions g(θ)
and their gradients are defined to find the estimates of the standard errors
for the heritability, genetic variance-covariance matrix, and genetic correlation
matrix. Note that the derivations for the environmental variance-covariance
matrix and its correlation matrix are equivalent to that its genetic counterpart
and is therefore omitted.
Let vGi j(θ) be element i j of the genetic covariance matrix VG . Then:
vGi j(θ)= θ>AGi
>AGj θ, (6.39)
where AGi is a matrix with zeros and ones such that A
G
i θ selects the row i








Using (6.39) and the gradient derived above and substitute g(θ) in (6.38) by vGi j(θ)
gives the variance of vGi j(θ) and its square root the standard deviation.
















The standard deviation of h2i (θ) can be obtained in an analogue way as for v
G
i j(θ)
using ∇h2i (θ) and the delta method.








6. Multivariate GREML finds shared genetic architecture of 76 brain traits and
intelligence
where we have dropped the superscript G for notational simplicity. Then, its
gradient becomes





Ai>A j +A j>Ai
)
θ













Again, from ∇r i j(θ) and the delta method the standard deviation for r i j(θ) can
be obtained.
6.B D A T A U S A G E F O R C O N S T R U C T I N G P H E N O T Y P E S
Table 6.1 provides an overview of the phenotypes used in our study
TABLE 6.1 – UK Biobank phenotype data used in this study, with correspond-
ing description, measurement units and data fields.
Trait Description Masurement units UK Biobank data field
BMI Logarithm average body
mass index for all mea-
surements
Kg/m2 21001
Depression Score Logarithm of first PC of
depression intensity and
frequency
NA 2050, 2060, 4609, 4620,
5375, 5386, 2090, 2100
Drinks consumed Logarithm drinks per
week
Number of units of
alcohol per week
1558, 1568, 1578, 1588,
1598, 1608, 4407, 4418,
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mm3 25886, 25887
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Volume of grey matter in
Thalamus (left+right)
mm3 25878, 25879
Grey matter in V
Cerebellum
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UK Biobank data field
Grey matter in
VI Cerebellum)
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Volume of grey matter
in VIIIb Cerebellum (ver-
mis)
mm3 25913
Grey matter in X
Cerebellum
Volume of grey matter in
X Cerebellum (left+right)
mm3 25918, 25920
Grey matter in X
Cerebellum)
Volume of grey matter in
X Cerebellum (vermis)
mm3 25919





NA 1920, 1930, 1940, 1950,
1960, 1970, 1980, 1990,
2000, 2010, 2020, 2030
Reaction Time Standardized reaction
time
milliseconds 20023




general how happy are
you? (Average value over
time)
NA 4526, 20458
Visual memory Log standardized visual
memory score
NA 399, 20132
Volume of brain Volume of brain,
grey+white matter
mm3 25010
6.C D A T A C E L L S U S E D F O R I D E N T I F I C A T I O N O F B R A I N D A M A G E
To make sure our find patterns are not due to individuals with brain diseases or
surgical damage, we remove all individuals with brain diseases. In Table 6.2 we
have listed the brain diseases with corresponding ICD10 codes used as exclusion
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criteria.
TABLE 6.2 – Brain diseases with corresponding data fields in the self report
and ICD10 codes.
Disease UK Biobank data field ICD10 code
Dementia or Alzheimer’s dis-
ease
1263 F01, F02, G30
Parkinson’s disease 1262 G20, G21
Chronic degenerative neuro-
logical
1258 G23, G31, G32
Guillain-Barré syndrome 1256 G610
Multiple Sclerosis 1261 G35
Other demyelinating disease 1397 G37
Stroke or ischaemic stroke 1081 G463, G464, I64, I694
Brain cancer 1031 C70, C71, D33
Brain haemorrhage 1491 I60, I61, I62, I691, I692, I693
Brain/intracranial abscess 1245 G060, G07
Cerebral aneurysm 1425 I671, Q282, Q283
Cerebral palsy 1433 G80, A521, A504, I64
Encephalitis 1246 A83, A86, B011, B020, B262,
A85, B004, B582, A84, B050,
B941, G04, A321, G05
Epilepsy 1264 G40, F803
Head injury 1266 S07, T040
Infections of the nervous sys-
tem
1244 A80, A81, A82, A83, A84, A85,
A86, A87, A88, A89
Ischaemic stroke 1583 G45
Meningeal cancer 1031 C70, C793
Meningioma (benign) 1659 D33, D32
Meningitis 1247 G03, A170, A171, A203, G01,
G02, G00, G07
Motor Neuron Disease (ALS) 1259 G122
Neurological injury / trauma 1240
Spina bifida 1524 Q05, Q760
Subdural haematoma 1083 P100
Subarachnoid haemorrhage 1086 I60, S066, P103
Transient ischaemic attack 1082 G45
6.D P I P E L I N E
The pipeline used to get to our results can be found below:
1. Convert geno-pheno link file to stata format
2. Merge phenotype file with file from step 1
3. Export list over overlapping individuals in geno and pheno data
4. Copy HM3 UKB PLINK data
5. Update FID in FAM files
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6. Use PLINK to keep only relevant individuals from step 3
7. Merge across chromosomes
8. Generate list of SNP IDs with imputation quality > 0.9.
9. Use PLINK to extract only SNPS with high imputation quality
• This leaves 600k directly genotyped SNPs included in HM3 + addi-
tional SNPs imputed accurately
10. Regular QC: MAF 0.01, MIND 0.05, GENO 0.05, HWE 0.001
11. Construct GRM, apply relatedness cutoff of 0.025, and inspect lead PCs
12. Drop long-range LD regions from risk GWAS
13. Construct new GRM, apply relatedness cutoff of 0.025 using PLINK, and
inspect lead PCs
14. Export new binary (or gzipped) GRM to Python
15. Keep only phenotype data for individuals in GRM from step 13 (after
rel.cutoff)
16. Drop additional individuals with possible brain damage
17. Curate phenotype data, including generating genotyping-platform dummy
• Exclude individuals with too much missingness on phenotypes, and
vice versa We have opted for balanced data only for now; N=14,341
18. Put pheno-covar observations in same order as GRM using Bash
19. Import data in python & residualise phenotypes w.r.t. covariates
• Covariates = sex, age, age², age³, sex x age, sex x age², sex x age³,
intercept, batch dummies
• Covariates for IQ: replace age by IQage (age at moment of assessment),
and include dummies for participation in various waves.
20. Transform GRM: take A∗ =MAM, where M is anti-projection matrix based
on platform dummy and intercept, and recompute eigenvalue decomposi-
tion: A∗ = [P1,P2]diag(D1,D2)[P1,P2]>. Store GRM, eigenvalue decom-
position, and Y.
21. Calculate values for warm start with bivariate GREML
22. Run M-GREML on relative brain volume + genetic covariates
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6.E H E R I T A B I L I T Y E S T I M A T E S
In Table 6.3, the estimated SNP-heritabilities are shown for all the different
phenotypes.
TABLE 6.3 – The estimated SNP-heritability for the different phenotypes in





Years of Education 0.209 0.049
Visual memory 0.147 0.048
Reaction time 0.128 0.050
Neuroticism 0.159 0.049
Subjective well-being 0.085 0.049
Depressive symptoms 0.117 0.050
Log(drinks per week) 0.160 0.051
Absolute volume of grey matter 0.361 0.049
Absolute volume of grey and white matter 0.412 0.047
Relative volume of grey matter in Frontal Pole 0.255 0.048
Relative volume of grey matter in Insular Cortex 0.460 0.050
Relative volume of grey matter in Middle Frontal Gyrus 0.239 0.048
Relative volume of grey matter in Inferior Frontal Gyrus.
pars triangularis
0.182 0.050
Relative volume of grey matter in Inferior Frontal Gyrus.
pars opercularis
0.138 0.049
Relative volume of grey matter in Precentral Gyrus 0.229 0.049
Relative volume of grey matter in Temporal Pole 0.315 0.048
Relative volume of grey matter in Superior Temporal Gyrus.
anterior division
0.248 0.047
Relative volume of grey matter in Superior Temporal Gyrus.
posterior division
0.244 0.049
Relative volume of grey matter in Middle Temporal Gyrus.
anterior division
0.205 0.049
Relative volume of grey matter in Middle Temporal Gyrus.
posterior division
0.235 0.050
Relative volume of grey matter in Middle Temporal Gyrus.
temporooccipital part
0.252 0.047
Relative volume of grey matter in Inferior Temporal Gyrus.
anterior division
0.235 0.049
Relative volume of grey matter in Inferior Temporal Gyrus.
posterior division
0.232 0.049
Relative volume of grey matter in Inferior Temporal Gyrus.
temporooccipital part
0.224 0.048
Relative volume of grey matter in Postcentral Gyrus 0.245 0.048




Relative volume of grey matter in Supramarginal Gyrus. an-
terior division
0.170 0.049
Relative volume of grey matter in Supramarginal Gyrus. pos-
terior division
0.158 0.048
Relative volume of grey matter in Angular Gyrus 0.178 0.047
Relative volume of grey matter in Lateral Occipital Cortex.
superior division
0.167 0.048
Relative volume of grey matter in Lateral Occipital Cortex.
inferior division
0.188 0.049
Relative volume of grey matter in Intracalcarine Cortex 0.446 0.049
Relative volume of grey matter in Frontal Medial Cortex 0.178 0.050
Relative volume of grey matter in Juxtapositional Lobule
Cortex (formerly Supplementary M
0.175 0.047
Relative volume of grey matter in Subcallosal Cortex 0.391 0.048
Relative volume of grey matter in Paracingulate Gyrus 0.264 0.048
Relative volume of grey matter in Cingulate Gyrus. anterior
division
0.216 0.046
Relative volume of grey matter in Cingulate Gyrus. posterior
division
0.208 0.049
Relative volume of grey matter in Precuneous Cortex 0.287 0.049
Relative volume of grey matter in Cuneal Cortex 0.238 0.048
Relative volume of grey matter in Frontal Orbital Cortex 0.299 0.048
Relative volume of grey matter in Parahippocampal Gyrus.
anterior division
0.300 0.048
Relative volume of grey matter in Parahippocampal Gyrus.
posterior division
0.334 0.047
Relative volume of grey matter in Lingual Gyrus 0.275 0.048
Relative volume of grey matter in Temporal Fusiform Cortex.
anterior division
0.262 0.050
Relative volume of grey matter in Temporal Fusiform Cortex.
posterior division
0.314 0.048
Relative volume of grey matter in Temporal Occipital
Fusiform Cortex
0.245 0.049
Relative volume of grey matter in Occipital Fusiform Gyrus 0.237 0.047
Relative volume of grey matter in Frontal Operculum Cortex 0.236 0.049
Relative volume of grey matter in Central Opercular Cortex 0.296 0.048
Relative volume of grey matter in Parietal Operculum Cortex 0.300 0.049
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Summary
Over the past decades, it has been convincingly shown that all human traits
(including preferences) are heritable. The use of insights from genetics to in-
crease our understanding of how economic agents make their choices is called
“genoeconomics”. In this thesis, I develop and compare methods to foster the fur-
ther emergence of the field of genoeconomics and I perform genetically informed
empirical analyses to better understand smoking behaviour, entrepreneurship,
and the structure of the brain.
The first chapter of this thesis discusses four ways through which genoeco-
nomics can contribute to economics: (i) genes can be used as a direct measure
for a previously latent variable, (ii) genes can uncover biological mechanisms
leading to differences in economic behaviour , (iii) genes can be used as control
or instrumental variables in economic models, and (iv) genes could be used for
targeting interventions. The present thesis contributes to the realization of these
promises by analyzing how genes can be used as instrumental variables (Part
1: Chapters 2 and 3), investigating how genes help to explain why individuals
engage in entrepreneurship and why individuals make different choices in re-
sponse to an increase in tobacco excise taxes (Part 2: Chapters 4 and 5), and
developing a method to better understand the shared genetic architecture of
economic behaviour and other traits (Part 3: Chapter 6).
In the first part of my thesis (Chapters 2 and 3), I compare methods that use
genetic variants as instrumental variables. In situations in which it is difficult
or unethical to perform a randomized controlled trial, these so-called Mendelian
randomization studies may help to infer causal relationships. Because of severe
concerns about whether the assumptions underlying Mendelian randomization
studies hold in practice, several robust Mendelian randomization methods have
been developed. In these chapters, I review their merits from a theoretical point
of view and I use a simulation study to compare their empirical performance in
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order to give clear recommendations to applied researchers using these methods.
In the second part of my thesis (Chapters 4 and 5), I empirically investigate
how genes may help to explain economic behaviour. Individual genetic variants
typically explain only a small fraction of the variance in behaviour, and therefore
I advocate the use of weighted combinations of genetic variants – polygenic risk
scores – in these chapters. In Chapter 4, I use polygenic risk scores to explain why
individuals engage in entrepreneurship. Most interestingly, I find that genetic
variants associated with Attention Deficit/Hyperactivity Disorder are associated
with entrepreneurship. In Chapter 5, I show that polygenic risk scores are
predictive for smoking behaviour (measured as smoking initiation and smoking
intensity). Moreover, my analyses show that someone’s genetic propensity to
smoking moderates the effect of tobacco excise taxes on smoking behavior, but
only along the extensive margin (smoking vs. not smoking).
In the third part of my thesis (Chapter 6), I develop a multivariate version
of Genome-based Restricted Maximum Likelihood (GREML) estimation. With
this method, one can estimate what fraction of a trait is heritable and to what
extent different traits are genetically related. Multivariate GREML improves
over existing bivariate methods by ensuring the internally consistency of the
resulting multivariate correlation matrix and by decreasing the computational
burden required for parameter estimation. By employing this method using data
from the UK Biobank Imaging study, I study genetic correlations across brain
regions and behavioural outcomes. By doing so, I show that the method can
effectively deal with large datasets.
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Samenvatting
Over de afgelopen decennia is het duidelijk geworden dat alle eigenschappen
(inclusief voorkeuren) bij mensen erfelijk zijn. Het gebruik van de inzichten uit
genetica om onze kennis van hoe economische agenten handelen te vergroten
wordt “genoeconomie” genoemd. In dit proefschrift ontwikkel en vergelijk ik
methoden om de opkomst van het veld genoeconomie te bevorderen. Tevens doe
ik een aantal genetisch geïnformeerde empirische analyses om onze kennis van
rookgedrag, ondernemerschap en de structuur van het brein te vergroten.
Het eerste hoofdstuk van dit proefschrift beschrijft vier manieren hoe genoe-
conomie kan bijdragen aan economie: (i) genen kunnen een directe maatstaf zijn
voor voorheen latente variabelen, (ii) genen kunnen biologische mechanismen
blootleggen die leiden tot verschillen in economisch gedrag, (iii) genen kunnen
worden gebruikt als controle of instrumentele variabele in economische modellen,
and (iv) genen kunnen gebruikt worden voor gerichte interventies. Het huidige
proefschrift draagt bij aan de realisatie van deze manieren door te bestuderen hoe
genen gebruikt kunnen worden als instrumentele variabelen (Deel 1: Hoofdstuk
2 en 3), bestuderen hoe genen helpen om uit te leggen waarom individuen on-
dernemer worden en waarom individuen individuen verschillende keuzes maken
als reactie op een verhoging van tabaksaccijnzen (Deel 2: Hoofdstuk 4 en 5), en
het ontwikkelen van een methode om een beter inzicht te krijgen in de gedeelde
genetische structuur van economisch gedrag en andere eigenschappen (Deel 3:
Hoofdstuk 6).
In het eerste deel van mijn proefschrift (Hoofdstuk 2 en 3), vergelijk ik
methoden die genetische varianten gebruiken als instrumentele variabelen. In
situaties waar een traditioneel gerandomiseerd onderzoek lastig of niet mogelijk
is, kunnen deze zogenaamde Mendeliaanse randomisatie studies helpen om te
schatten of er een causaal verband is. Door ernstige zorgen over of bepaalde
aannames die ten grondslag liggen aan Mendeliaanse randomisatie, zijn er
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verschillende robuuste Mendeliaanse randomisatie methoden voorgesteld. In
deze hoofdstukken bekijk ik de voordelen van deze verschillende methoden en
vergelijk ik ze onderling om duidelijke richtlijnen te geven voor wetenschappers
die deze methodes gebruiken.
In het tweede deel van mijn proefschrift (Hoofdstukken 4 en 5), bestudeer ik
empirisch hoe genen kunnen worden gebruikt om gedrag te verklaren. Individu-
ele genetische varianten verklaren over het algemeen slechts een kleine fractie
van de variantie in gedrag, en daarom pleit ik voor het gebruik van gewogen com-
binaties van genetische varianten - polygene risicoscores - in deze hoofdstukken.
In Hoofdstuk 4 gebruik ik deze polygene risicoscores om te verklaren waarom
individuen beginnen aan ondernemerschap. Het meest opmerkelijke is dat ik
vind dat genen die geassocieerd zijn met ADHD (Attention Deficit/Hyperactivity
Disorder) ook geassocieerd zijn met ondernemerschap. In Hoofdstuk 5 laat ik
zien dat de polygene risicoscores voorspellend zijn voor voor rookgedrag (gemeten
als initiatie en intensiteit van tabaksconsumptie). Daarnaast laten mijn analyses
zien dat een individu’s genetische aanleg voor rookgedrag een moderator is voor
het effect van tabaksaccijnzen op rookgedrag, maar enkel op de extensieve marge
(roken tegenover niet roken).
In het derde deel van mijn proefschrift (Hoofdstuk 6), ontwikkel ik een multi-
variate versie van GREML (Genome-based restricted maximum likelihood). Met
deze methode kan geschat worden welk deel van een eigenschap erfelijk is en
in hoeverre verschillende eigenschappen genetisch verwant zijn. Multivariate
GREML verbetert de huidige bivariate methodiek door te garanderen dat de
geschatte multivariate correlatie matrix intern consistent is en door de computa-
tionele belasting te verlagen die nodig is om het model te schatten. Door deze
methodiek toe te passen op data van de UK Biobank Imaging Study, bestudeer ik
genetische correlaties tussen brein regio’s en gedragsuitkomsten. Hiermee laat
ik zien dat deze methode efficiënt om kan gaan met grote datasets.
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